{
  "abstract": {
    "textEnglish": "Ectopeptidases are particularly interesting due to their potential to regulate/dysregulate the peptide mediated signaling cellular pathways because the active site located to the extracellular space. Dipeptidyl peptidase IV (DPP-IV, EC 3.4.14.5) is currently one of the ectopeptidases that has a great and complex influence on important physiological and pathological processes. Due to its influence on the immune system, type 2 diabetes mellitus, pulmonary pathologies, cardiovascular system, viral infections and cancer, DPP-IV is very attractive as a possible therapeutic target. However, its versatility makes such expectations very difficult. The aim of this work is to summarize relevant structural and functional aspects of DPP-IV and the role of this protein in several pathologies with special emphasis on cancer. DPP-IV role in cancer seems to depend on specific location, histologic type of tumour, tumour microenvironment, and presence/absence of molecules able to interact with DPP-IV. Because of DPP-IV controversial effects, generalizations are difficult and most of the time the role of DPP-IV must be analyzed case by case. However, new evidences in cell lines, animal models and clinical studies suggest that DPP-IV inhibitors open a promissory window through new therapeutic strategies against some cancers."
  },
  "authors": [
    {
      "affiliation": [
        {
          "affPubRaw": "Center for Protein Studies, Faculty of Biology, University of Havana, Havana, Cuba"
        }
      ],
      "name": {
        "given_name": "Yarini",
        "surname": "Arrebola S\u00e1nchez"
      }
    },
    {
      "affiliation": [
        {
          "affPubRaw": "Center for Protein Studies, Faculty of Biology, University of Havana, Havana, Cuba"
        }
      ],
      "name": {
        "given_name": "Fabiola",
        "surname": "Almeida Garc\u00eda"
      }
    },
    {
      "affiliation": [
        {
          "affPubRaw": "Center for Protein Studies, Faculty of Biology, University of Havana, Havana, Cuba"
        }
      ],
      "name": {
        "given_name": "Daniel",
        "surname": "Ojeda del Sol"
      }
    },
    {
      "affiliation": [
        {
          "affPubRaw": "Center for Protein Studies, Faculty of Biology, University of Havana, Havana, Cuba"
        },
        {
          "affPubRaw": "Department of Biological Sciences, University of Calgary, Calgary, Canada"
        }
      ],
      "name": {
        "given_name": "Mario E.",
        "surname": "Vald\u00e9s-Tresanco"
      }
    },
    {
      "affiliation": [
        {
          "affPubRaw": "Center for Protein Studies, Faculty of Biology, University of Havana, Havana, Cuba"
        }
      ],
      "name": {
        "given_name": "Carlos David",
        "surname": "Ortiz"
      }
    },
    {
      "affiliation": [
        {
          "affPubRaw": "Centro de Inmunolog\u00eda Molecular, La Habana, Cuba"
        }
      ],
      "name": {
        "given_name": "Belinda",
        "surname": "S\u00e1nchez Ram\u00edrez"
      }
    },
    {
      "affiliation": [
        {
          "affPubRaw": "Center for Protein Studies, Faculty of Biology, University of Havana, Havana, Cuba"
        }
      ],
      "attrib": {
        "corresp": true,
        "email": "isel@fbio.uh.cu"
      },
      "name": {
        "given_name": "Isel",
        "surname": "Pascual Alonso"
      }
    }
  ],
  "copyright": {
    "statement": "\u00a9 2023 Walter de Gruyter GmbH, Berlin/Boston",
    "status": true
  },
  "editorialHistory": {
    "acceptedDate": "2023-04-11",
    "receivedDates": [
      "2022-10-30"
    ]
  },
  "funding": [
    {
      "agencyname": "Oficina de Gesti\u00c3\u00b3n de Fondos y Proyectos Internacionales del Ministerio de Ciencia, Tecnolog\u00c3-a y Medio Ambiente de la Rep\u00c3\u00bablica de Cuba",
      "awardnumber": "PN223LH010-010 2021-2023"
    },
    {
      "agencyname": "Ministerio de Ciencia, Tecnolog\u00eda y Medio Ambiente",
      "awardnumber": "Unassigned"
    }
  ],
  "keywords": [
    {
      "keyString": "cancer",
      "keySystem": "misc"
    },
    {
      "keyString": "dipeptidyl peptidase IV",
      "keySystem": "misc"
    },
    {
      "keyString": "ectopeptidases",
      "keySystem": "misc"
    },
    {
      "keyString": "human diseases",
      "keySystem": "misc"
    },
    {
      "keyString": "inhibitors",
      "keySystem": "misc"
    }
  ],
  "pagination": {
    "firstPage": "2541",
    "lastPage": "2596",
    "pageCount": "056",
    "pageRange": "2541-2596"
  },
  "persistentIDs": [
    {
      "DOI": "10.1515/psr-2022-0288"
    }
  ],
  "pubDate": {
    "electrDate": "2023-05-11"
  },
  "publication": {
    "ISSN": [
      {
        "issnString": "2365-659X",
        "pubtype": "epub"
      }
    ],
    "issueNum": "8",
    "pubName": "Physical Sciences Reviews",
    "pubYear": "2023",
    "publisher": "De Gruyter",
    "volumeNum": "9"
  },
  "publisherIDs": [
    {
      "Identifier": "psr-2022-0288",
      "attribute": "publisher-id"
    }
  ],
  "recordData": {
    "createdTime": "",
    "loadFormat": "JATS",
    "loadLocation": "",
    "loadType": "fromFile",
    "parsedTime": "",
    "recordOrigin": ""
  },
  "references": [
    "<ref id=\"j_psr-2022-0288_ref_001\"> <label>1.</label> <mixed-citation>Bray, F, Soerjomataram, I. Chapter 01: global burden of cancer: current and future. In: Minghui, R, editor \t\t\t\t\t<italic>WHO report on cancer: setting priorities, investing wisely and providing care for all</italic>. Geneva, Switzerland: World Health Organization; 2020. pp. 23\u201337. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <name> <surname>Bray</surname> <given-names>F</given-names> </name> <name> <surname>Soerjomataram</surname> <given-names>I</given-names> </name> </person-group> <article-title>Chapter 01: global burden of cancer: current and future</article-title> <person-group person-group-type=\"editor\"> <name> <surname>Minghui</surname> <given-names>R</given-names> </name> </person-group> <source>WHO report on cancer: setting priorities, investing wisely and providing care for all</source> <publisher-loc>Geneva, Switzerland</publisher-loc> <publisher-name>World Health Organization</publisher-name> <year>2020</year> <fpage>23</fpage> <lpage>37</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_002\"> <label>2.</label> <mixed-citation>Hanahan, D. Hallmarks of cancer: new dimensions. \t\t\t\t\t<italic>Cancer Discov</italic> 2022;12:31\u201346. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hanahan</surname> <given-names>D</given-names> </name> </person-group> <article-title>Hallmarks of cancer: new dimensions</article-title> <source>Cancer Discov</source> <year>2022</year> <volume>12</volume> <fpage>31</fpage> <lpage>46</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_003\"> <label>3.</label> <mixed-citation>Carl-McGrath, S, Lendeckel, U, Ebert, M, Rocken, C. Ectopeptidases in tumour biology: a review. \t\t\t\t\t<italic>Histol Histopathol</italic> 2006;21:1339\u201353. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Carl-McGrath</surname> <given-names>S</given-names> </name> <name> <surname>Lendeckel</surname> <given-names>U</given-names> </name> <name> <surname>Ebert</surname> <given-names>M</given-names> </name> <name> <surname>Rocken</surname> <given-names>C</given-names> </name> </person-group> <article-title>Ectopeptidases in tumour biology: a review</article-title> <source>Histol Histopathol</source> <year>2006</year> <volume>21</volume> <fpage>1339</fpage> <lpage>53</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_004\"> <label>4.</label> <mixed-citation>Barnieh, FM, Loadman, PM, Falconer, RA. Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique? \t\t\t\t\t<italic>Biochim Biophys Acta Rev Cancer</italic> 2021, 1876:188641. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Barnieh</surname> <given-names>FM</given-names> </name> <name> <surname>Loadman</surname> <given-names>PM</given-names> </name> <name> <surname>Falconer</surname> <given-names>RA</given-names> </name> </person-group> <article-title>Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?</article-title> <source>Biochim Biophys Acta Rev Cancer</source> <year>2021</year> <volume>1876</volume> <elocation-id>188641</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_005\"> <label>5.</label> <mixed-citation>Drinkwater, N, Lee, J, Yang, W, Malcolm, TR, McGowan, S. M1 aminopeptidases as drug targets: broad applications or therapeutic niche? \t\t\t\t\t<italic>FEBS J</italic> 2017;284:1473\u201388. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Drinkwater</surname> <given-names>N</given-names> </name> <name> <surname>Lee</surname> <given-names>J</given-names> </name> <name> <surname>Yang</surname> <given-names>W</given-names> </name> <name> <surname>Malcolm</surname> <given-names>TR</given-names> </name> <name> <surname>McGowan</surname> <given-names>S</given-names> </name> </person-group> <article-title>M1 aminopeptidases as drug targets: broad applications or therapeutic niche?</article-title> <source>FEBS J</source> <year>2017</year> <volume>284</volume> <fpage>1473</fpage> <lpage>88</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_006\"> <label>6.</label> <mixed-citation>Amin, M, Adhikari, N, Jha, T. Design of aminopeptidase N (APN) inhibitors as anticancer agents. \t\t\t\t\t<italic>J Med Chem</italic> 2018;61:6468\u201390. \t\t\t\t\t<ext-link ext-link-type=\"doi\" xlink:href=\"https://doi.org/10.1021/acs.jmedchem.7b00782\">https://doi.org/10.1021/acs.jmedchem.7b00782</ext-link>. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Amin</surname> <given-names>M</given-names> </name> <name> <surname>Adhikari</surname> <given-names>N</given-names> </name> <name> <surname>Jha</surname> <given-names>T</given-names> </name> </person-group> <article-title>Design of aminopeptidase N (APN) inhibitors as anticancer agents</article-title> <source>J Med Chem</source> <year>2018</year> <volume>61</volume> <fpage>6468</fpage> <lpage>90</lpage> <ext-link ext-link-type=\"doi\" xlink:href=\"https://doi.org/10.1021/acs.jmedchem.7b00782\">https://doi.org/10.1021/acs.jmedchem.7b00782</ext-link> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_007\"> <label>7.</label> <mixed-citation>Li, FJ, Hu, JH, Ren, X, Zhou, CM, Liu, Q, Zhang, YQ. Toad venom: a comprehensive review of chemical constituents, anticancer activities, and mechanisms. \t\t\t\t\t<italic>Arch Pharmazie</italic> 2021;354:2100060. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Li</surname> <given-names>FJ</given-names> </name> <name> <surname>Hu</surname> <given-names>JH</given-names> </name> <name> <surname>Ren</surname> <given-names>X</given-names> </name> <name> <surname>Zhou</surname> <given-names>CM</given-names> </name> <name> <surname>Liu</surname> <given-names>Q</given-names> </name> <name> <surname>Zhang</surname> <given-names>YQ</given-names> </name> </person-group> <article-title>Toad venom: a comprehensive review of chemical constituents, anticancer activities, and mechanisms</article-title> <source>Arch Pharmazie</source> <year>2021</year> <volume>354</volume> <elocation-id>2100060</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_008\"> <label>8.</label> <mixed-citation>Turk, B. Targeting proteases: successes, failures and future prospects. \t\t\t\t\t<italic>Nat Rev Drug Discov</italic> 2006;5:785\u201399. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Turk</surname> <given-names>B</given-names> </name> </person-group> <article-title>Targeting proteases: successes, failures and future prospects</article-title> <source>Nat Rev Drug Discov</source> <year>2006</year> <volume>5</volume> <fpage>785</fpage> <lpage>99</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_009\"> <label>9.</label> <mixed-citation>Leung, D, Abbenante, G, Fairlie, DP. Protease inhibitors: current status and future prospects. \t\t\t\t\t<italic>J Med Chem</italic> 2000;43:305\u201341. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Leung</surname> <given-names>D</given-names> </name> <name> <surname>Abbenante</surname> <given-names>G</given-names> </name> <name> <surname>Fairlie</surname> <given-names>DP</given-names> </name> </person-group> <article-title>Protease inhibitors: current status and future prospects</article-title> <source>J Med Chem</source> <year>2000</year> <volume>43</volume> <fpage>305</fpage> <lpage>41</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_010\"> <label>10.</label> <mixed-citation>Abbenante, G, Fairlie, DP. Protease inhibitors in the clinic. \t\t\t\t\t<italic>Med Chem</italic> 2005;1:71\u2013104. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Abbenante</surname> <given-names>G</given-names> </name> <name> <surname>Fairlie</surname> <given-names>DP</given-names> </name> </person-group> <article-title>Protease inhibitors in the clinic</article-title> <source>Med Chem</source> <year>2005</year> <volume>1</volume> <fpage>71</fpage> <lpage>104</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_011\"> <label>11.</label> <mixed-citation>Pascual, I, Valiente, PA, Garc\u00eda, G, Vald\u00e9s, ME, Arrebola, Y, D\u00edaz, L, et al.. Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN). \t\t\t\t\t<italic>Biochimie</italic> 2017;142:216\u201325. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Valiente</surname> <given-names>PA</given-names> </name> <name> <surname>Garc\u00eda</surname> <given-names>G</given-names> </name> <name> <surname>Vald\u00e9s</surname> <given-names>ME</given-names> </name> <name> <surname>Arrebola</surname> <given-names>Y</given-names> </name> <name> <surname>D\u00edaz</surname> <given-names>L</given-names> </name> <etal/> </person-group> <article-title>Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN)</article-title> <source>Biochimie</source> <year>2017</year> <volume>142</volume> <fpage>216</fpage> <lpage>25</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_012\"> <label>12.</label> <mixed-citation>Rawlings, ND, Barrett, JA, Thomas, PD, Huang, X. The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. \t\t\t\t\t<italic>Nucleic Acids Res</italic> 2018;46:624\u201332. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rawlings</surname> <given-names>ND</given-names> </name> <name> <surname>Barrett</surname> <given-names>JA</given-names> </name> <name> <surname>Thomas</surname> <given-names>PD</given-names> </name> <name> <surname>Huang</surname> <given-names>X</given-names> </name> </person-group> <article-title>The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database</article-title> <source>Nucleic Acids Res</source> <year>2018</year> <volume>46</volume> <fpage>624</fpage> <lpage>32</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_013\"> <label>13.</label> <mixed-citation>Kameoka, J, Tanaka, T, Nojima, Y, Schlossman, SF, Morimoto, C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. \t\t\t\t\t<italic>Science</italic> 1993;261:466\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kameoka</surname> <given-names>J</given-names> </name> <name> <surname>Tanaka</surname> <given-names>T</given-names> </name> <name> <surname>Nojima</surname> <given-names>Y</given-names> </name> <name> <surname>Schlossman</surname> <given-names>SF</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>Direct association of adenosine deaminase with a T cell activation antigen, CD26</article-title> <source>Science</source> <year>1993</year> <volume>261</volume> <fpage>466</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_014\"> <label>14.</label> <mixed-citation>Wagner, L, Klemann, C, Stephan, M, von Horsten, S. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH)proteins. \t\t\t\t\t<italic>Clin Exp Imm</italic> 2016;184:265\u201383. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wagner</surname> <given-names>L</given-names> </name> <name> <surname>Klemann</surname> <given-names>C</given-names> </name> <name> <surname>Stephan</surname> <given-names>M</given-names> </name> <name> <surname>von Horsten</surname> <given-names>S</given-names> </name> </person-group> <article-title>Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH)proteins</article-title> <source>Clin Exp Imm</source> <year>2016</year> <volume>184</volume> <fpage>265</fpage> <lpage>83</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_015\"> <label>15.</label> <mixed-citation>Klemann, C, Wagner, L, Stephan, M, von Horsten, S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2032s (DPP4) entanglement in the immune system. \t\t\t\t\t<italic>Clin Exp Imm</italic> 2016;185:1\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Klemann</surname> <given-names>C</given-names> </name> <name> <surname>Wagner</surname> <given-names>L</given-names> </name> <name> <surname>Stephan</surname> <given-names>M</given-names> </name> <name> <surname>von Horsten</surname> <given-names>S</given-names> </name> </person-group> <article-title>Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2032s (DPP4) entanglement in the immune system</article-title> <source>Clin Exp Imm</source> <year>2016</year> <volume>185</volume> <fpage>1</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_016\"> <label>16.</label> <mixed-citation>Shao, S, Xu, Q, Yu, X, Pan, R, Chen, Y. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions. \t\t\t\t\t<italic>Pharmacol Ther</italic> 2020;209:107503. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Shao</surname> <given-names>S</given-names> </name> <name> <surname>Xu</surname> <given-names>Q</given-names> </name> <name> <surname>Yu</surname> <given-names>X</given-names> </name> <name> <surname>Pan</surname> <given-names>R</given-names> </name> <name> <surname>Chen</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions</article-title> <source>Pharmacol Ther</source> <year>2020</year> <volume>209</volume> <elocation-id>107503</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_017\"> <label>17.</label> <mixed-citation>Arrebola, YM, G\u00f3mez, H, Valiente, PA, Ch\u00e1vez, MA, Pascual, I. \t\t\t\t\t<italic>Biotecnol Apl</italic> 2014;31:102\u201310. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Arrebola</surname> <given-names>YM</given-names> </name> <name> <surname>G\u00f3mez</surname> <given-names>H</given-names> </name> <name> <surname>Valiente</surname> <given-names>PA</given-names> </name> <name> <surname>Ch\u00e1vez</surname> <given-names>MA</given-names> </name> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> </person-group> <source>Biotecnol Apl</source> <year>2014</year> <volume>31</volume> <fpage>102</fpage> <lpage>10</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_018\"> <label>18.</label> <mixed-citation>Schuetz, CA, Ong, SH, Bl\u00fcher, M. Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease. \t\t\t\t\t<italic>Clinicoecon Outcomes Res</italic> 2015;7:313\u201323. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Schuetz</surname> <given-names>CA</given-names> </name> <name> <surname>Ong</surname> <given-names>SH</given-names> </name> <name> <surname>Bl\u00fcher</surname> <given-names>M</given-names> </name> </person-group> <article-title>Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease</article-title> <source>Clinicoecon Outcomes Res</source> <year>2015</year> <volume>7</volume> <fpage>313</fpage> <lpage>23</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_019\"> <label>19.</label> <mixed-citation>Klemann, C, Wagner, L, Stephan, M, von H\u00f6rsten, S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system. \t\t\t\t\t<italic>Clin Exp Immunol</italic> 2016;185:1\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Klemann</surname> <given-names>C</given-names> </name> <name> <surname>Wagner</surname> <given-names>L</given-names> </name> <name> <surname>Stephan</surname> <given-names>M</given-names> </name> <name> <surname>von H\u00f6rsten</surname> <given-names>S</given-names> </name> </person-group> <article-title>Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system</article-title> <source>Clin Exp Immunol</source> <year>2016</year> <volume>185</volume> <fpage>1</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_020\"> <label>20.</label> <mixed-citation>Florentin, M, Kostapanos, MS, Papazafiropoulou, AK. Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment. \t\t\t\t\t<italic>World J Diabetes</italic> 2022;13:85\u201396. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Florentin</surname> <given-names>M</given-names> </name> <name> <surname>Kostapanos</surname> <given-names>MS</given-names> </name> <name> <surname>Papazafiropoulou</surname> <given-names>AK</given-names> </name> </person-group> <article-title>Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment</article-title> <source>World J Diabetes</source> <year>2022</year> <volume>13</volume> <fpage>85</fpage> <lpage>96</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_021\"> <label>21.</label> <mixed-citation>Zhang, T, Tong, X, Zhang, S, Wang, D, Wang, L, Wang, Q, et al.. The roles of dipeptidyl peptidase 4 (DPP4) and DPP4 inhibitors in different lung diseases: new evidence. \t\t\t\t\t<italic>Front Pharmacol</italic> 2021;12:731453. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhang</surname> <given-names>T</given-names> </name> <name> <surname>Tong</surname> <given-names>X</given-names> </name> <name> <surname>Zhang</surname> <given-names>S</given-names> </name> <name> <surname>Wang</surname> <given-names>D</given-names> </name> <name> <surname>Wang</surname> <given-names>L</given-names> </name> <name> <surname>Wang</surname> <given-names>Q</given-names> </name> <etal/> </person-group> <article-title>The roles of dipeptidyl peptidase 4 (DPP4) and DPP4 inhibitors in different lung diseases: new evidence</article-title> <source>Front Pharmacol</source> <year>2021</year> <volume>12</volume> <elocation-id>731453</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_022\"> <label>22.</label> <mixed-citation>Green, BD, Flatt, PR, Bailey, CJ. Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes. \t\t\t\t\t<italic>Diab Vasc. Dis Res</italic> 2006;3:159\u201365. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Green</surname> <given-names>BD</given-names> </name> <name> <surname>Flatt</surname> <given-names>PR</given-names> </name> <name> <surname>Bailey</surname> <given-names>CJ</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes</article-title> <source>Diab Vasc. Dis Res</source> <year>2006</year> <volume>3</volume> <fpage>159</fpage> <lpage>65</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_023\"> <label>23.</label> <mixed-citation>Wu, D, Li, L, Liu, C. Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2014;16:30\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wu</surname> <given-names>D</given-names> </name> <name> <surname>Li</surname> <given-names>L</given-names> </name> <name> <surname>Liu</surname> <given-names>C</given-names> </name> </person-group> <article-title>Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis</article-title> <source>Diabetes Obes Metab</source> <year>2014</year> <volume>16</volume> <fpage>30</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_024\"> <label>24.</label> <mixed-citation>R\u00f6hrborn, D, Wronkowitz, N, Eckel, J. DPP4 in diabetes. \t\t\t\t\t<italic>Front Immunol</italic> 2015;6:1\u201320. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>R\u00f6hrborn</surname> <given-names>D</given-names> </name> <name> <surname>Wronkowitz</surname> <given-names>N</given-names> </name> <name> <surname>Eckel</surname> <given-names>J</given-names> </name> </person-group> <article-title>DPP4 in diabetes</article-title> <source>Front Immunol</source> <year>2015</year> <volume>6</volume> <fpage>1</fpage> <lpage>20</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_025\"> <label>25.</label> <mixed-citation>Shimizu, S, Hosooka, T, Matsuda, T, Asahara, S, Koyanagi-Kimura, M, Kanno, A, et al.. DPP4 inhibitor vildagliptin preserves-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice. \t\t\t\t\t<italic>J Mol Endocrinol</italic> 2012;49:125\u201335. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Shimizu</surname> <given-names>S</given-names> </name> <name> <surname>Hosooka</surname> <given-names>T</given-names> </name> <name> <surname>Matsuda</surname> <given-names>T</given-names> </name> <name> <surname>Asahara</surname> <given-names>S</given-names> </name> <name> <surname>Koyanagi-Kimura</surname> <given-names>M</given-names> </name> <name> <surname>Kanno</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>DPP4 inhibitor vildagliptin preserves-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice</article-title> <source>J Mol Endocrinol</source> <year>2012</year> <volume>49</volume> <fpage>125</fpage> <lpage>35</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_026\"> <label>26.</label> <mixed-citation>De, S, Banerjee, S, Kumar, SK, Paira, P. Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer. \t\t\t\t\t<italic>Mini Rev Med Chem</italic> 2018;19:88\u201397. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>De</surname> <given-names>S</given-names> </name> <name> <surname>Banerjee</surname> <given-names>S</given-names> </name> <name> <surname>Kumar</surname> <given-names>SK</given-names> </name> <name> <surname>Paira</surname> <given-names>P</given-names> </name> </person-group> <article-title>Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer</article-title> <source>Mini Rev Med Chem</source> <year>2018</year> <volume>19</volume> <fpage>88</fpage> <lpage>97</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_027\"> <label>27.</label> <mixed-citation>Ahr\u00e9n, B. DPP-4 inhibition and the path to clinical proof. \t\t\t\t\t<italic>Front Endocrinol</italic> 2019;10:1\u201318. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ahr\u00e9n</surname> <given-names>B</given-names> </name> </person-group> <article-title>DPP-4 inhibition and the path to clinical proof</article-title> <source>Front Endocrinol</source> <year>2019</year> <volume>10</volume> <fpage>1</fpage> <lpage>18</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_028\"> <label>28.</label> <mixed-citation>Arwert, EN, Mentink, RA, Driskell, RR, Hoste, E, Goldie, SJ, Quist, S. Upregulation of CD26 expression in epithelial cells and stromalcells during wound-induced skin tumour formation. \t\t\t\t\t<italic>Oncogene</italic> 2012;31:992\u20131000. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Arwert</surname> <given-names>EN</given-names> </name> <name> <surname>Mentink</surname> <given-names>RA</given-names> </name> <name> <surname>Driskell</surname> <given-names>RR</given-names> </name> <name> <surname>Hoste</surname> <given-names>E</given-names> </name> <name> <surname>Goldie</surname> <given-names>SJ</given-names> </name> <name> <surname>Quist</surname> <given-names>S</given-names> </name> </person-group> <article-title>Upregulation of CD26 expression in epithelial cells and stromalcells during wound-induced skin tumour formation</article-title> <source>Oncogene</source> <year>2012</year> <volume>31</volume> <fpage>992</fpage> <lpage>1000</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_029\"> <label>29.</label> <mixed-citation>Yamamoto, S, Tokuhara, T, Nishikawa, M, Nishizawa, S, Nishioka, T, Nozawa, A, et al.. Spontaneous regression of hepatocellular carcinoma after improving diabetes mellitus: possibly responsible for immune system. \t\t\t\t\t<italic>Kanzo</italic> 2012;53:164\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yamamoto</surname> <given-names>S</given-names> </name> <name> <surname>Tokuhara</surname> <given-names>T</given-names> </name> <name> <surname>Nishikawa</surname> <given-names>M</given-names> </name> <name> <surname>Nishizawa</surname> <given-names>S</given-names> </name> <name> <surname>Nishioka</surname> <given-names>T</given-names> </name> <name> <surname>Nozawa</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Spontaneous regression of hepatocellular carcinoma after improving diabetes mellitus: possibly responsible for immune system</article-title> <source>Kanzo</source> <year>2012</year> <volume>53</volume> <fpage>164</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_030\"> <label>30.</label> <mixed-citation>Abd Elhameed, AG, Helal, MG, Said, E, Salem, HA. Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: a novel suppressive impact on Wnt/Hedgehog/Notch1 signaling. \t\t\t\t\t<italic>Environ Toxicol Pharmacol</italic> 2021;86:103668. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Abd Elhameed</surname> <given-names>AG</given-names> </name> <name> <surname>Helal</surname> <given-names>MG</given-names> </name> <name> <surname>Said</surname> <given-names>E</given-names> </name> <name> <surname>Salem</surname> <given-names>HA</given-names> </name> </person-group> <article-title>Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: a novel suppressive impact on Wnt/Hedgehog/Notch1 signaling</article-title> <source>Environ Toxicol Pharmacol</source> <year>2021</year> <volume>86</volume> <elocation-id>103668</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_031\"> <label>31.</label> <mixed-citation>Qin, CJ, Zhao, LH, Zhou, X, Zhang, HL, Wen, W, Tang, L, et al.. Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2. \t\t\t\t\t<italic>Cancer Lett</italic> 2018;420:26\u201337. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Qin</surname> <given-names>CJ</given-names> </name> <name> <surname>Zhao</surname> <given-names>LH</given-names> </name> <name> <surname>Zhou</surname> <given-names>X</given-names> </name> <name> <surname>Zhang</surname> <given-names>HL</given-names> </name> <name> <surname>Wen</surname> <given-names>W</given-names> </name> <name> <surname>Tang</surname> <given-names>L</given-names> </name> <etal/> </person-group> <article-title>Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2</article-title> <source>Cancer Lett</source> <year>2018</year> <volume>420</volume> <fpage>26</fpage> <lpage>37</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_032\"> <label>32.</label> <mixed-citation>Jang, JH, Baerts, L, Waumans, Y, De Meester, I, Yamada, Y, Limani, P, et al.. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. \t\t\t\t\t<italic>Clin Exp Metastasis</italic> 2015;32:677\u201387. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Jang</surname> <given-names>JH</given-names> </name> <name> <surname>Baerts</surname> <given-names>L</given-names> </name> <name> <surname>Waumans</surname> <given-names>Y</given-names> </name> <name> <surname>De Meester</surname> <given-names>I</given-names> </name> <name> <surname>Yamada</surname> <given-names>Y</given-names> </name> <name> <surname>Limani</surname> <given-names>P</given-names> </name> <etal/> </person-group> <article-title>Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice</article-title> <source>Clin Exp Metastasis</source> <year>2015</year> <volume>32</volume> <fpage>677</fpage> <lpage>87</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_033\"> <label>33.</label> <mixed-citation>Nyborg, NC, Molck, AM, Madsen, LW, Knudsen, LB. The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. \t\t\t\t\t<italic>Diabetes</italic> 2012;61:1243\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nyborg</surname> <given-names>NC</given-names> </name> <name> <surname>Molck</surname> <given-names>AM</given-names> </name> <name> <surname>Madsen</surname> <given-names>LW</given-names> </name> <name> <surname>Knudsen</surname> <given-names>LB</given-names> </name> </person-group> <article-title>The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species</article-title> <source>Diabetes</source> <year>2012</year> <volume>61</volume> <fpage>1243</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_034\"> <label>34.</label> <mixed-citation>Ligumsky, H, Wolf, I, Israeli, S, Haimsohn, M, Ferber, S, Karasik, A. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. \t\t\t\t\t<italic>Breast Cancer Res Treat</italic> 2012;132:449\u201361. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ligumsky</surname> <given-names>H</given-names> </name> <name> <surname>Wolf</surname> <given-names>I</given-names> </name> <name> <surname>Israeli</surname> <given-names>S</given-names> </name> <name> <surname>Haimsohn</surname> <given-names>M</given-names> </name> <name> <surname>Ferber</surname> <given-names>S</given-names> </name> <name> <surname>Karasik</surname> <given-names>A</given-names> </name> </person-group> <article-title>The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells</article-title> <source>Breast Cancer Res Treat</source> <year>2012</year> <volume>132</volume> <fpage>449</fpage> <lpage>61</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_035\"> <label>35.</label> <mixed-citation>Rivera, L, Arrebola, Y, Vald\u00e9s-Tresanco, ME, D\u00edaz-Guevara, L, Bergado, G, S\u00e1nchez, B, et al.. Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability. \t\t\t\t\t<italic>Int J Biol Macromol</italic> 2020;164:2944\u201352. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rivera</surname> <given-names>L</given-names> </name> <name> <surname>Arrebola</surname> <given-names>Y</given-names> </name> <name> <surname>Vald\u00e9s-Tresanco</surname> <given-names>ME</given-names> </name> <name> <surname>D\u00edaz-Guevara</surname> <given-names>L</given-names> </name> <name> <surname>Bergado</surname> <given-names>G</given-names> </name> <name> <surname>S\u00e1nchez</surname> <given-names>B</given-names> </name> <etal/> </person-group> <article-title>Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability</article-title> <source>Int J Biol Macromol</source> <year>2020</year> <volume>164</volume> <fpage>2944</fpage> <lpage>52</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_036\"> <label>36.</label> <mixed-citation>Rathmann, W, Kostev, K. Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer. \t\t\t\t\t<italic>J Diabetes Complicat</italic> 2017;31:687\u201392. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rathmann</surname> <given-names>W</given-names> </name> <name> <surname>Kostev</surname> <given-names>K</given-names> </name> </person-group> <article-title>Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer</article-title> <source>J Diabetes Complicat</source> <year>2017</year> <volume>31</volume> <fpage>687</fpage> <lpage>92</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_037\"> <label>37.</label> <mixed-citation>Noh, Y, Jeon, SM, Shin, S. Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy. \t\t\t\t\t<italic>Int J Cancer</italic> 2019;144:1530\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Noh</surname> <given-names>Y</given-names> </name> <name> <surname>Jeon</surname> <given-names>SM</given-names> </name> <name> <surname>Shin</surname> <given-names>S</given-names> </name> </person-group> <article-title>Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy</article-title> <source>Int J Cancer</source> <year>2019</year> <volume>144</volume> <fpage>1530</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_038\"> <label>38.</label> <mixed-citation>Matteucci, E, Giampietro, O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. \t\t\t\t\t<italic>Curr Med Chem</italic> 2009;16:2943\u201351. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Matteucci</surname> <given-names>E</given-names> </name> <name> <surname>Giampietro</surname> <given-names>O</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme</article-title> <source>Curr Med Chem</source> <year>2009</year> <volume>16</volume> <fpage>2943</fpage> <lpage>51</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_039\"> <label>39.</label> <mixed-citation>Klemann, C, Wagner, L, Stephan, M, von H\u00f6rsten, S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system. \t\t\t\t\t<italic>Clin Exp Immunol</italic> 2016;185:1\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Klemann</surname> <given-names>C</given-names> </name> <name> <surname>Wagner</surname> <given-names>L</given-names> </name> <name> <surname>Stephan</surname> <given-names>M</given-names> </name> <name> <surname>von H\u00f6rsten</surname> <given-names>S</given-names> </name> </person-group> <article-title>Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system</article-title> <source>Clin Exp Immunol</source> <year>2016</year> <volume>185</volume> <fpage>1</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_040\"> <label>40.</label> <mixed-citation>Hopsu-Havu, VK, Glenner, GG. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-\u03b2-naphthylamide. \t\t\t\t\t<italic>Histochemie</italic> 1966;7:197\u2013201. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hopsu-Havu</surname> <given-names>VK</given-names> </name> <name> <surname>Glenner</surname> <given-names>GG</given-names> </name> </person-group> <article-title>A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-\u03b2-naphthylamide</article-title> <source>Histochemie</source> <year>1966</year> <volume>7</volume> <fpage>197</fpage> <lpage>201</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_041\"> <label>41.</label> <mixed-citation>Yu, DM, Yao, TW, Chowdhury, S, Nadvi, NA, Osborne, B, Church, WB. The dipeptidyl peptidase IV family in cancer and cell biology. \t\t\t\t\t<italic>FEBS J</italic> 2010;277:1126\u201344. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yu</surname> <given-names>DM</given-names> </name> <name> <surname>Yao</surname> <given-names>TW</given-names> </name> <name> <surname>Chowdhury</surname> <given-names>S</given-names> </name> <name> <surname>Nadvi</surname> <given-names>NA</given-names> </name> <name> <surname>Osborne</surname> <given-names>B</given-names> </name> <name> <surname>Church</surname> <given-names>WB</given-names> </name> </person-group> <article-title>The dipeptidyl peptidase IV family in cancer and cell biology</article-title> <source>FEBS J</source> <year>2010</year> <volume>277</volume> <fpage>1126</fpage> <lpage>44</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_042\"> <label>42.</label> <mixed-citation>Mulvihill, EE, Drucker, DJ. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. \t\t\t\t\t<italic>Endocr Rev</italic> 2014;35:992\u20131019. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mulvihill</surname> <given-names>EE</given-names> </name> <name> <surname>Drucker</surname> <given-names>DJ</given-names> </name> </person-group> <article-title>Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors</article-title> <source>Endocr Rev</source> <year>2014</year> <volume>35</volume> <fpage>992</fpage> <lpage>1019</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_043\"> <label>43.</label> <mixed-citation>Klemann, C, Wagner, L, Stephan, M, von Horsten, S. Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system. \t\t\t\t\t<italic>Clin Exp Immunol</italic> 2016;185:1\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Klemann</surname> <given-names>C</given-names> </name> <name> <surname>Wagner</surname> <given-names>L</given-names> </name> <name> <surname>Stephan</surname> <given-names>M</given-names> </name> <name> <surname>von Horsten</surname> <given-names>S</given-names> </name> </person-group> <article-title>Cut to the chase: a review of CD26/dipeptidyl peptidase-4\u2019s (DPP4) entanglement in the immune system</article-title> <source>Clin Exp Immunol</source> <year>2016</year> <volume>185</volume> <fpage>1</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_044\"> <label>44.</label> <mixed-citation>Gutheil, WG, Subramanyam, M, Flentke, GR, Sanford, DG, Munoz, E, Huber, BT, et al.. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat\u2019s immunosuppressive activity. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 1994;91:6594\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gutheil</surname> <given-names>WG</given-names> </name> <name> <surname>Subramanyam</surname> <given-names>M</given-names> </name> <name> <surname>Flentke</surname> <given-names>GR</given-names> </name> <name> <surname>Sanford</surname> <given-names>DG</given-names> </name> <name> <surname>Munoz</surname> <given-names>E</given-names> </name> <name> <surname>Huber</surname> <given-names>BT</given-names> </name> <etal/> </person-group> <article-title>Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat\u2019s immunosuppressive activity</article-title> <source>Proc Natl Acad Sci USA</source> <year>1994</year> <volume>91</volume> <fpage>6594</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_045\"> <label>45.</label> <mixed-citation>Blanco, J, Valenzuela, A, Herrera, C, Lluis, C, Hovanessian, AG, Franco, R. The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression. \t\t\t\t\t<italic>FEBS Lett</italic> 2000;477:123\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Blanco</surname> <given-names>J</given-names> </name> <name> <surname>Valenzuela</surname> <given-names>A</given-names> </name> <name> <surname>Herrera</surname> <given-names>C</given-names> </name> <name> <surname>Lluis</surname> <given-names>C</given-names> </name> <name> <surname>Hovanessian</surname> <given-names>AG</given-names> </name> <name> <surname>Franco</surname> <given-names>R</given-names> </name> </person-group> <article-title>The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression</article-title> <source>FEBS Lett</source> <year>2000</year> <volume>477</volume> <fpage>123</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_046\"> <label>46.</label> <mixed-citation>Lu, G, Hu, Y, Wang, Q, Qi, J, Gao, F, Li, Y, et al.. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. \t\t\t\t\t<italic>Nature</italic> 2013;500:227\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lu</surname> <given-names>G</given-names> </name> <name> <surname>Hu</surname> <given-names>Y</given-names> </name> <name> <surname>Wang</surname> <given-names>Q</given-names> </name> <name> <surname>Qi</surname> <given-names>J</given-names> </name> <name> <surname>Gao</surname> <given-names>F</given-names> </name> <name> <surname>Li</surname> <given-names>Y</given-names> </name> <etal/> </person-group> <article-title>Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26</article-title> <source>Nature</source> <year>2013</year> <volume>500</volume> <fpage>227</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_047\"> <label>47.</label> <mixed-citation>Bohm, SK, Gum, JR, Erickson, RH, Hicks, JW, Kim, YS. Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. \t\t\t\t\t<italic>Biochem J</italic> 1995;311:835\u201343. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bohm</surname> <given-names>SK</given-names> </name> <name> <surname>Gum</surname> <given-names>JR</given-names> </name> <name> <surname>Erickson</surname> <given-names>RH</given-names> </name> <name> <surname>Hicks</surname> <given-names>JW</given-names> </name> <name> <surname>Kim</surname> <given-names>YS</given-names> </name> </person-group> <article-title>Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter</article-title> <source>Biochem J</source> <year>1995</year> <volume>311</volume> <fpage>835</fpage> <lpage>43</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_048\"> <label>48.</label> <mixed-citation>The Human Protein Atlas; 2003. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue\">http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue</ext-link> [Accessed 11 Sep 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>The Human Protein Atlas</surname> </name> </person-group> <year>2003</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue\">http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">11 Sep 2022</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_049\"> <label>49.</label> <mixed-citation>NLH National Library of Medicine, National Center for Biotechnology Information; 2023. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=1803\">http://www.ncbi.nlm.hih.gov/protein/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=1803</ext-link> [Accessed 10 Feb 2023]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>NLH National Library of Medicine</surname> </name> </person-group> <publisher-name>National Center for Biotechnology Information</publisher-name> <year>2023</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=1803\">http://www.ncbi.nlm.hih.gov/protein/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=1803</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2023</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_050\"> <label>50.</label> <mixed-citation>NLH National Library of Medicine, National Center for Biotechnology Information; 2023. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1</ext-link> [Accessed 10 Feb 2023]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>NLH National Library of Medicine</surname> </name> </person-group> <publisher-name>National Center for Biotechnology Information</publisher-name> <year>2023</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2023</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_051\"> <label>51.</label> <mixed-citation>NLH National Library of Medicine, National Center for Biotechnology Information; 2023. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001926.2\">http://www.ncbi.nlm.hih.gov/protein/NP_001926.2</ext-link> [Accessed 10 Feb 2023]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>NLH National Library of Medicine</surname> </name> </person-group> <publisher-name>National Center for Biotechnology Information</publisher-name> <year>2023</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001926.2\">http://www.ncbi.nlm.hih.gov/protein/NP_001926.2</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2023</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_052\"> <label>52.</label> <mixed-citation>NLH National Library of Medicine, National Center for Biotechnology Information; 2023. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366533.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366533.1</ext-link> [Accessed 10 Feb 2023]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>NLH National Library of Medicine</surname> </name> </person-group> <publisher-name>National Center for Biotechnology Information</publisher-name> <year>2023</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366533.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366533.1</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2023</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_053\"> <label>53.</label> <mixed-citation>NLH National Library of Medicine, National Center for Biotechnology Information; 2023. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366534.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366534.1</ext-link> [Accessed 10 Feb 2023]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>NLH National Library of Medicine</surname> </name> </person-group> <publisher-name>National Center for Biotechnology Information</publisher-name> <year>2023</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366534.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366534.1</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2023</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_054\"> <label>54.</label> <mixed-citation> <collab>NLH National Library of Medicine</collab>. National Center for Biotechnology Information; 2023. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1</ext-link> [Accessed 10 Feb 2023]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <collab>NLH National Library of Medicine</collab> </person-group> <publisher-name>National Center for Biotechnology Information</publisher-name> <year>2023</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1\">http://www.ncbi.nlm.hih.gov/protein/NP_001366535.1</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2023</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_055\"> <label>55.</label> <mixed-citation>Kahne, T, Kroning, H, Thiel, U, Ulmer, AJ, Flad, HD, Ansorge, S. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. \t\t\t\t\t<italic>Cell Immunol</italic> 1996;170:63\u201370. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kahne</surname> <given-names>T</given-names> </name> <name> <surname>Kroning</surname> <given-names>H</given-names> </name> <name> <surname>Thiel</surname> <given-names>U</given-names> </name> <name> <surname>Ulmer</surname> <given-names>AJ</given-names> </name> <name> <surname>Flad</surname> <given-names>HD</given-names> </name> <name> <surname>Ansorge</surname> <given-names>S</given-names> </name> </person-group> <article-title>Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation</article-title> <source>Cell Immunol</source> <year>1996</year> <volume>170</volume> <fpage>63</fpage> <lpage>70</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_056\"> <label>56.</label> <mixed-citation>The Human Protein Atlas; 2003. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.proteinatlas.org/ENSG00000197635-DPP4/mRNA\">http://www.proteinatlas.org/ENSG00000197635-DPP4/mRNA</ext-link> [Accessed 10 Feb 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>The Human Protein Atlas</surname> </name> </person-group> <year>2003</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.proteinatlas.org/ENSG00000197635-DPP4/mRNA\">http://www.proteinatlas.org/ENSG00000197635-DPP4/mRNA</ext-link> <comment>[Accessed</comment> <date-in-citation content-type=\"access\">10 Feb 2022</date-in-citation> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_057\"> <label>57.</label> <mixed-citation>Engel, M, Hoffmann, T, Wagner, L, Wermann, M, Heiser, U, Kiefersauer, R. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 2003;100:5063\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Engel</surname> <given-names>M</given-names> </name> <name> <surname>Hoffmann</surname> <given-names>T</given-names> </name> <name> <surname>Wagner</surname> <given-names>L</given-names> </name> <name> <surname>Wermann</surname> <given-names>M</given-names> </name> <name> <surname>Heiser</surname> <given-names>U</given-names> </name> <name> <surname>Kiefersauer</surname> <given-names>R</given-names> </name> </person-group> <article-title>The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism</article-title> <source>Proc Natl Acad Sci USA</source> <year>2003</year> <volume>100</volume> <fpage>5063</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_058\"> <label>58.</label> <mixed-citation>Rasmussen, HB, Branner, S, Wiberg, FC, Wagtmann, N. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. \t\t\t\t\t<italic>Nat Struct Biol</italic> 2003;10:19\u201325. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rasmussen</surname> <given-names>HB</given-names> </name> <name> <surname>Branner</surname> <given-names>S</given-names> </name> <name> <surname>Wiberg</surname> <given-names>FC</given-names> </name> <name> <surname>Wagtmann</surname> <given-names>N</given-names> </name> </person-group> <article-title>Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog</article-title> <source>Nat Struct Biol</source> <year>2003</year> <volume>10</volume> <fpage>19</fpage> <lpage>25</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_059\"> <label>59.</label> <mixed-citation>Duke-Cohan, JS, Morimoto, C, Rocker, JA, Schlossman, SF. Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. \t\t\t\t\t<italic>J Immunol</italic> 1996;156:1714\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Duke-Cohan</surname> <given-names>JS</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> <name> <surname>Rocker</surname> <given-names>JA</given-names> </name> <name> <surname>Schlossman</surname> <given-names>SF</given-names> </name> </person-group> <article-title>Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells</article-title> <source>J Immunol</source> <year>1996</year> <volume>156</volume> <fpage>1714</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_060\"> <label>60.</label> <mixed-citation>Pascual, I, Gomez, H, Pons, T, Chappe, M, Vargas, MA, Valdes, G. Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV. \t\t\t\t\t<italic>Int J Biochem Cell Biol</italic> 2011;43:363\u201371. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Gomez</surname> <given-names>H</given-names> </name> <name> <surname>Pons</surname> <given-names>T</given-names> </name> <name> <surname>Chappe</surname> <given-names>M</given-names> </name> <name> <surname>Vargas</surname> <given-names>MA</given-names> </name> <name> <surname>Valdes</surname> <given-names>G</given-names> </name> </person-group> <article-title>Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV</article-title> <source>Int J Biochem Cell Biol</source> <year>2011</year> <volume>43</volume> <fpage>363</fpage> <lpage>71</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_061\"> <label>61.</label> <mixed-citation>Gomez, H, Chappe, M, Valiente, PA, Pons, T, Chavez, ML, Charli, JL. Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV. \t\t\t\t\t<italic>J Biosci</italic> 2013;38:461\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gomez</surname> <given-names>H</given-names> </name> <name> <surname>Chappe</surname> <given-names>M</given-names> </name> <name> <surname>Valiente</surname> <given-names>PA</given-names> </name> <name> <surname>Pons</surname> <given-names>T</given-names> </name> <name> <surname>Chavez</surname> <given-names>ML</given-names> </name> <name> <surname>Charli</surname> <given-names>JL</given-names> </name> </person-group> <article-title>Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV</article-title> <source>J Biosci</source> <year>2013</year> <volume>38</volume> <fpage>461</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_062\"> <label>62.</label> <mixed-citation>Mentlein, R. Dipeptidyl-peptidase IV (CD26) Role in the inactivation of regulatory peptides. \t\t\t\t\t<italic>Regul Pept</italic> 1999;85:9\u201324. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mentlein</surname> <given-names>R</given-names> </name> </person-group> <article-title>Dipeptidyl-peptidase IV (CD26) Role in the inactivation of regulatory peptides</article-title> <source>Regul Pept</source> <year>1999</year> <volume>85</volume> <fpage>9</fpage> <lpage>24</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_063\"> <label>63.</label> <mixed-citation>Lee, KN, Jackson, KW, Christiansen, VJ, Chung, KH, McKee, PA. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. \t\t\t\t\t<italic>Blood</italic> 2004;103:3783\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lee</surname> <given-names>KN</given-names> </name> <name> <surname>Jackson</surname> <given-names>KW</given-names> </name> <name> <surname>Christiansen</surname> <given-names>VJ</given-names> </name> <name> <surname>Chung</surname> <given-names>KH</given-names> </name> <name> <surname>McKee</surname> <given-names>PA</given-names> </name> </person-group> <article-title>A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion</article-title> <source>Blood</source> <year>2004</year> <volume>103</volume> <fpage>3783</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_064\"> <label>64.</label> <mixed-citation>Ajami, K, Abbott, CA, McCaughan, GW, Gorrell, MD. Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. \t\t\t\t\t<italic>Biochim Biophys Acta</italic> 2004;1679:18\u201328. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ajami</surname> <given-names>K</given-names> </name> <name> <surname>Abbott</surname> <given-names>CA</given-names> </name> <name> <surname>McCaughan</surname> <given-names>GW</given-names> </name> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity</article-title> <source>Biochim Biophys Acta</source> <year>2004</year> <volume>1679</volume> <fpage>18</fpage> <lpage>28</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_065\"> <label>65.</label> <mixed-citation>Delacour, D, Gouyer, V, Leteurtre, E, Ait-Slimane, T, Drobecq, H, Lenoir, C. 1-benzyl-2-acetamido-2-deoxy-alphaD-galactopyranoside blocks the apical biosynthetic pathway in polarized HT-29 cells. \t\t\t\t\t<italic>J Biol Chem</italic> 2003;278:37799\u2013809. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Delacour</surname> <given-names>D</given-names> </name> <name> <surname>Gouyer</surname> <given-names>V</given-names> </name> <name> <surname>Leteurtre</surname> <given-names>E</given-names> </name> <name> <surname>Ait-Slimane</surname> <given-names>T</given-names> </name> <name> <surname>Drobecq</surname> <given-names>H</given-names> </name> <name> <surname>Lenoir</surname> <given-names>C</given-names> </name> </person-group> <article-title>1-benzyl-2-acetamido-2-deoxy-alphaD-galactopyranoside blocks the apical biosynthetic pathway in polarized HT-29 cells</article-title> <source>J Biol Chem</source> <year>2003</year> <volume>278</volume> <fpage>37799</fpage> <lpage>809</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_066\"> <label>66.</label> <mixed-citation>Thoma, R, Loffler, B, Stihle, M, Huber, W, Ruf, A, Hennig, M. Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. \t\t\t\t\t<italic>Structure</italic> 2003;11:947\u201359. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Thoma</surname> <given-names>R</given-names> </name> <name> <surname>Loffler</surname> <given-names>B</given-names> </name> <name> <surname>Stihle</surname> <given-names>M</given-names> </name> <name> <surname>Huber</surname> <given-names>W</given-names> </name> <name> <surname>Ruf</surname> <given-names>A</given-names> </name> <name> <surname>Hennig</surname> <given-names>M</given-names> </name> </person-group> <article-title>Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV</article-title> <source>Structure</source> <year>2003</year> <volume>11</volume> <fpage>947</fpage> <lpage>59</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_067\"> <label>67.</label> <mixed-citation>Aertgeerts, K, Ye, S, Tennant, MG, Kraus, ML, Rogers, J, Sang, BC. Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation. \t\t\t\t\t<italic>Protein Sci</italic> 2004;13:412\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Aertgeerts</surname> <given-names>K</given-names> </name> <name> <surname>Ye</surname> <given-names>S</given-names> </name> <name> <surname>Tennant</surname> <given-names>MG</given-names> </name> <name> <surname>Kraus</surname> <given-names>ML</given-names> </name> <name> <surname>Rogers</surname> <given-names>J</given-names> </name> <name> <surname>Sang</surname> <given-names>BC</given-names> </name> </person-group> <article-title>Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation</article-title> <source>Protein Sci</source> <year>2004</year> <volume>13</volume> <fpage>412</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_068\"> <label>68.</label> <mixed-citation>Abbott, CA, McCaughan, GW, Gorrell, MD. Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. \t\t\t\t\t<italic>FEBS Lett</italic> 1999;458:278\u201384. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Abbott</surname> <given-names>CA</given-names> </name> <name> <surname>McCaughan</surname> <given-names>GW</given-names> </name> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> </person-group> <article-title>Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity</article-title> <source>FEBS Lett</source> <year>1999</year> <volume>458</volume> <fpage>278</fpage> <lpage>84</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_069\"> <label>69.</label> <mixed-citation>Ajami, K, Abbott, CA, Obradovic, M, Gysbers, V, Kahne, T, McCaughan, GW. Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. \t\t\t\t\t<italic>Biochemistry</italic> 2003;42:694\u2013701. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ajami</surname> <given-names>K</given-names> </name> <name> <surname>Abbott</surname> <given-names>CA</given-names> </name> <name> <surname>Obradovic</surname> <given-names>M</given-names> </name> <name> <surname>Gysbers</surname> <given-names>V</given-names> </name> <name> <surname>Kahne</surname> <given-names>T</given-names> </name> <name> <surname>McCaughan</surname> <given-names>GW</given-names> </name> </person-group> <article-title>Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family</article-title> <source>Biochemistry</source> <year>2003</year> <volume>42</volume> <fpage>694</fpage> <lpage>701</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_070\"> <label>70.</label> <mixed-citation>Chien, CH, Huang, LH, Chou, CY, Chen, YS, Han, YS, Chang, GG. One site mutation disrupts dimer formation in human DPP-IV proteins. \t\t\t\t\t<italic>J Biol Chem</italic> 2004;279:52338\u201345. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chien</surname> <given-names>CH</given-names> </name> <name> <surname>Huang</surname> <given-names>LH</given-names> </name> <name> <surname>Chou</surname> <given-names>CY</given-names> </name> <name> <surname>Chen</surname> <given-names>YS</given-names> </name> <name> <surname>Han</surname> <given-names>YS</given-names> </name> <name> <surname>Chang</surname> <given-names>GG</given-names> </name> </person-group> <article-title>One site mutation disrupts dimer formation in human DPP-IV proteins</article-title> <source>J Biol Chem</source> <year>2004</year> <volume>279</volume> <fpage>52338</fpage> <lpage>45</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_071\"> <label>71.</label> <mixed-citation>Varghese, JN, Laver, WG, Colman, PM. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. \t\t\t\t\t<italic>Nature</italic> 1983;303:35\u201340. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Varghese</surname> <given-names>JN</given-names> </name> <name> <surname>Laver</surname> <given-names>WG</given-names> </name> <name> <surname>Colman</surname> <given-names>PM</given-names> </name> </person-group> <article-title>Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution</article-title> <source>Nature</source> <year>1983</year> <volume>303</volume> <fpage>35</fpage> <lpage>40</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_072\"> <label>72.</label> <mixed-citation>Vellieux, FM, Huitema, F, Groendijk, H, Kalk, KH, Jzn, JF, Jongejan, JA. Structure of quinoprotein methylamine dehydrogenase at 2.25 A resolution. \t\t\t\t\t<italic>EMBO J</italic> 1989;8:2171\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Vellieux</surname> <given-names>FM</given-names> </name> <name> <surname>Huitema</surname> <given-names>F</given-names> </name> <name> <surname>Groendijk</surname> <given-names>H</given-names> </name> <name> <surname>Kalk</surname> <given-names>KH</given-names> </name> <name> <surname>Jzn</surname> <given-names>JF</given-names> </name> <name> <surname>Jongejan</surname> <given-names>JA</given-names> </name> </person-group> <article-title>Structure of quinoprotein methylamine dehydrogenase at 2.25 A resolution</article-title> <source>EMBO J</source> <year>1989</year> <volume>8</volume> <fpage>2171</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_073\"> <label>73.</label> <mixed-citation>Ito, N, Phillips, SE, Stevens, C, Ogel, ZB, McPherson, MJ, Keen, JN. Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. \t\t\t\t\t<italic>Nature</italic> 1983;350:87\u201390. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ito</surname> <given-names>N</given-names> </name> <name> <surname>Phillips</surname> <given-names>SE</given-names> </name> <name> <surname>Stevens</surname> <given-names>C</given-names> </name> <name> <surname>Ogel</surname> <given-names>ZB</given-names> </name> <name> <surname>McPherson</surname> <given-names>MJ</given-names> </name> <name> <surname>Keen</surname> <given-names>JN</given-names> </name> </person-group> <article-title>Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase</article-title> <source>Nature</source> <year>1983</year> <volume>350</volume> <fpage>87</fpage> <lpage>90</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_074\"> <label>74.</label> <mixed-citation>Xia, ZX, Dai, WW, Xiong, JP, Hao, ZP, Davidson, VL, White, S. The three-dimensional structures of methanol dehydrogenase from two methylotrophic bacteria at 2.6-A resolution. \t\t\t\t\t<italic>J Biol Chem</italic> 1992;267:22289\u201397. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Xia</surname> <given-names>ZX</given-names> </name> <name> <surname>Dai</surname> <given-names>WW</given-names> </name> <name> <surname>Xiong</surname> <given-names>JP</given-names> </name> <name> <surname>Hao</surname> <given-names>ZP</given-names> </name> <name> <surname>Davidson</surname> <given-names>VL</given-names> </name> <name> <surname>White</surname> <given-names>S</given-names> </name> </person-group> <article-title>The three-dimensional structures of methanol dehydrogenase from two methylotrophic bacteria at 2.6-A resolution</article-title> <source>J Biol Chem</source> <year>1992</year> <volume>267</volume> <fpage>22289</fpage> <lpage>97</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_075\"> <label>75.</label> <mixed-citation>Murzin, AG. Structural principles for the propeller assembly of beta-sheets: the preference for seven-fold symmetry. \t\t\t\t\t<italic>Proteins</italic> 1992;14:191\u2013201. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Murzin</surname> <given-names>AG</given-names> </name> </person-group> <article-title>Structural principles for the propeller assembly of beta-sheets: the preference for seven-fold symmetry</article-title> <source>Proteins</source> <year>1992</year> <volume>14</volume> <fpage>191</fpage> <lpage>201</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_076\"> <label>76.</label> <mixed-citation>F\u00fcl\u00f6p, V, Jones, DT. Beta propellers: structural rigidity and functional diversity. \t\t\t\t\t<italic>Curr Opin Struct Biol</italic> 1999;9:715\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>F\u00fcl\u00f6p</surname> <given-names>V</given-names> </name> <name> <surname>Jones</surname> <given-names>DT</given-names> </name> </person-group> <article-title>Beta propellers: structural rigidity and functional diversity</article-title> <source>Curr Opin Struct Biol</source> <year>1999</year> <volume>9</volume> <fpage>715</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_077\"> <label>77.</label> <mixed-citation>Paoli, M. Protein folds propelled by diversity. \t\t\t\t\t<italic>Prog Biophys Mol Biol</italic> 2001;76:103\u201330. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Paoli</surname> <given-names>M</given-names> </name> </person-group> <article-title>Protein folds propelled by diversity</article-title> <source>Prog Biophys Mol Biol</source> <year>2001</year> <volume>76</volume> <fpage>103</fpage> <lpage>30</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_078\"> <label>78.</label> <mixed-citation>Jawad, Z, Paoli, M. Novel sequences propel familiar folds. \t\t\t\t\t<italic>Structure</italic> 2002;10:447\u201354. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Jawad</surname> <given-names>Z</given-names> </name> <name> <surname>Paoli</surname> <given-names>M</given-names> </name> </person-group> <article-title>Novel sequences propel familiar folds</article-title> <source>Structure</source> <year>2002</year> <volume>10</volume> <fpage>447</fpage> <lpage>54</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_079\"> <label>79.</label> <mixed-citation>Adams, J, Kelso, R, Cooley, L. The kelch repeat superfamily of proteins: propellers of cell function. \t\t\t\t\t<italic>Trends Cell Biol</italic> 2000;10:17\u201324. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Adams</surname> <given-names>J</given-names> </name> <name> <surname>Kelso</surname> <given-names>R</given-names> </name> <name> <surname>Cooley</surname> <given-names>L</given-names> </name> </person-group> <article-title>The kelch repeat superfamily of proteins: propellers of cell function</article-title> <source>Trends Cell Biol</source> <year>2000</year> <volume>10</volume> <fpage>17</fpage> <lpage>24</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_080\"> <label>80.</label> <mixed-citation>Russell, RB, Sasieni, PD, Sternberg, MJ. Supersites within superfolds. Binding site similarity in the absence of homology. \t\t\t\t\t<italic>J Mol Biol</italic> 1998;282:903\u201318. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Russell</surname> <given-names>RB</given-names> </name> <name> <surname>Sasieni</surname> <given-names>PD</given-names> </name> <name> <surname>Sternberg</surname> <given-names>MJ</given-names> </name> </person-group> <article-title>Supersites within superfolds. Binding site similarity in the absence of homology</article-title> <source>J Mol Biol</source> <year>1998</year> <volume>282</volume> <fpage>903</fpage> <lpage>18</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_081\"> <label>81.</label> <mixed-citation>Todd, AE, Orengo, CA, Thornton, JM. Evolution of function in protein superfamilies, from a structural perspective. \t\t\t\t\t<italic>J Mol Biol</italic> 2001;307:1113\u201343. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Todd</surname> <given-names>AE</given-names> </name> <name> <surname>Orengo</surname> <given-names>CA</given-names> </name> <name> <surname>Thornton</surname> <given-names>JM</given-names> </name> </person-group> <article-title>Evolution of function in protein superfamilies, from a structural perspective</article-title> <source>J Mol Biol</source> <year>2001</year> <volume>307</volume> <fpage>1113</fpage> <lpage>43</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_082\"> <label>82.</label> <mixed-citation>Pons, T, Gomez, R, Chinea, G, Valencia, A. Beta-propellers: associated functions and their role in human diseases. \t\t\t\t\t<italic>Curr Med Chem</italic> 2003;10:505\u201324. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pons</surname> <given-names>T</given-names> </name> <name> <surname>Gomez</surname> <given-names>R</given-names> </name> <name> <surname>Chinea</surname> <given-names>G</given-names> </name> <name> <surname>Valencia</surname> <given-names>A</given-names> </name> </person-group> <article-title>Beta-propellers: associated functions and their role in human diseases</article-title> <source>Curr Med Chem</source> <year>2003</year> <volume>10</volume> <fpage>505</fpage> <lpage>24</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_083\"> <label>83.</label> <mixed-citation>Love, CA, Harlos, K, Mavaddat, N, Davis, SJ, Stuart, DI, Jones, EY. The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. \t\t\t\t\t<italic>Nat Struct Biol</italic> 2003;10:843\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Love</surname> <given-names>CA</given-names> </name> <name> <surname>Harlos</surname> <given-names>K</given-names> </name> <name> <surname>Mavaddat</surname> <given-names>N</given-names> </name> <name> <surname>Davis</surname> <given-names>SJ</given-names> </name> <name> <surname>Stuart</surname> <given-names>DI</given-names> </name> <name> <surname>Jones</surname> <given-names>EY</given-names> </name> </person-group> <article-title>The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D</article-title> <source>Nat Struct Biol</source> <year>2003</year> <volume>10</volume> <fpage>843</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_084\"> <label>84.</label> <mixed-citation>Xiong, JP, Stehle, T, Diefenbach, B, Zhang, R, Dunker, R, Scott, DL. Crystal structure of the extracellular segment of integrin alpha Vbeta3. \t\t\t\t\t<italic>Science</italic> 2001;294:339\u201345. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Xiong</surname> <given-names>JP</given-names> </name> <name> <surname>Stehle</surname> <given-names>T</given-names> </name> <name> <surname>Diefenbach</surname> <given-names>B</given-names> </name> <name> <surname>Zhang</surname> <given-names>R</given-names> </name> <name> <surname>Dunker</surname> <given-names>R</given-names> </name> <name> <surname>Scott</surname> <given-names>DL</given-names> </name> </person-group> <article-title>Crystal structure of the extracellular segment of integrin alpha Vbeta3</article-title> <source>Science</source> <year>2001</year> <volume>294</volume> <fpage>339</fpage> <lpage>45</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_085\"> <label>85.</label> <mixed-citation>Gorrell, MD, Wang, XM, Park, J, Ajami, K, Yu, DM, Knott, H. Structure and function in dipeptidyl peptidase IV and related proteins. \t\t\t\t\t<italic>Adv Exp Med Biol</italic> 2006;575:45\u201354. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> <name> <surname>Wang</surname> <given-names>XM</given-names> </name> <name> <surname>Park</surname> <given-names>J</given-names> </name> <name> <surname>Ajami</surname> <given-names>K</given-names> </name> <name> <surname>Yu</surname> <given-names>DM</given-names> </name> <name> <surname>Knott</surname> <given-names>H</given-names> </name> </person-group> <article-title>Structure and function in dipeptidyl peptidase IV and related proteins</article-title> <source>Adv Exp Med Biol</source> <year>2006</year> <volume>575</volume> <fpage>45</fpage> <lpage>54</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_086\"> <label>86.</label> <mixed-citation>Gorrell, MD. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. \t\t\t\t\t<italic>Clin Sci (Lond)</italic> 2005;108:277\u201392. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</article-title> <source>Clin Sci (Lond)</source> <year>2005</year> <volume>108</volume> <fpage>277</fpage> <lpage>92</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_087\"> <label>87.</label> <mixed-citation>Hiramatsu, H, Yamamoto, A, Kyono, K, Higashiyama, Y, Fukushima, C, Shima, H. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A. \t\t\t\t\t<italic>Biol Chem</italic> 2004;385:561\u20134. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hiramatsu</surname> <given-names>H</given-names> </name> <name> <surname>Yamamoto</surname> <given-names>A</given-names> </name> <name> <surname>Kyono</surname> <given-names>K</given-names> </name> <name> <surname>Higashiyama</surname> <given-names>Y</given-names> </name> <name> <surname>Fukushima</surname> <given-names>C</given-names> </name> <name> <surname>Shima</surname> <given-names>H</given-names> </name> </person-group> <article-title>The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A</article-title> <source>Biol Chem</source> <year>2004</year> <volume>385</volume> <fpage>561</fpage> <lpage>4</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_088\"> <label>88.</label> <mixed-citation>Oefner, C, D\u2019Arcy, A, Mac Sweeney, A, Pierau, S, Gardiner, R, Dale, GE. High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl)amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidine. \t\t\t\t\t<italic>Acta Crystallogr D Biol Crystallogr</italic> 2003;59:1206\u201312. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Oefner</surname> <given-names>C</given-names> </name> <name> <surname>D\u2019Arcy</surname> <given-names>A</given-names> </name> <name> <surname>Mac Sweeney</surname> <given-names>A</given-names> </name> <name> <surname>Pierau</surname> <given-names>S</given-names> </name> <name> <surname>Gardiner</surname> <given-names>R</given-names> </name> <name> <surname>Dale</surname> <given-names>GE</given-names> </name> </person-group> <article-title>High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl)amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidine</article-title> <source>Acta Crystallogr D Biol Crystallogr</source> <year>2003</year> <volume>59</volume> <fpage>1206</fpage> <lpage>12</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_089\"> <label>89.</label> <mixed-citation>Weihofen, WA, Liu, J, Reutter, W, Saenger, W, Fan, H. Crystal structure of CD26 dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. \t\t\t\t\t<italic>J Biol Chem</italic> 2004;279:43330\u20135. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Weihofen</surname> <given-names>WA</given-names> </name> <name> <surname>Liu</surname> <given-names>J</given-names> </name> <name> <surname>Reutter</surname> <given-names>W</given-names> </name> <name> <surname>Saenger</surname> <given-names>W</given-names> </name> <name> <surname>Fan</surname> <given-names>H</given-names> </name> </person-group> <article-title>Crystal structure of CD26 dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface</article-title> <source>J Biol Chem</source> <year>2004</year> <volume>279</volume> <fpage>43330</fpage> <lpage>5</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_090\"> <label>90.</label> <mixed-citation>Abbott, CA, Gorrell, MD. The family of CD26/DPP-IV and related ectopeptidases. In: Langner, J, Ansorge, S, editors. \t\t\t\t\t<italic>Ectopeptidases. CD13/aminopeptidase N and CD26/dipeptidylpeptidase IV in medicine and biology</italic>. New York: Kluwer Academic/Plenum Publishers; 2002. pp. 171\u201395. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <name> <surname>Abbott</surname> <given-names>CA</given-names> </name> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> </person-group> <article-title>The family of CD26/DPP-IV and related ectopeptidases</article-title> <person-group person-group-type=\"editor\"> <name> <surname>Langner</surname> <given-names>J</given-names> </name> <name> <surname>Ansorge</surname> <given-names>S</given-names> </name> </person-group> <source>Ectopeptidases. CD13/aminopeptidase N and CD26/dipeptidylpeptidase IV in medicine and biology</source> <publisher-loc>New York</publisher-loc> <publisher-name>Kluwer Academic/Plenum Publishers</publisher-name> <year>2002</year> <fpage>171</fpage> <lpage>95</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_091\"> <label>91.</label> <mixed-citation>Yoshimoto, T, Tsuru, D. Proline-specifc dipeptidyl aminopeptidase from Flavobacterium meningosepticum. \t\t\t\t\t<italic>J. Biochem</italic> 1982;91:1899\u2013906. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yoshimoto</surname> <given-names>T</given-names> </name> <name> <surname>Tsuru</surname> <given-names>D</given-names> </name> </person-group> <article-title>Proline-specifc dipeptidyl aminopeptidase from Flavobacterium meningosepticum</article-title> <source>J. Biochem</source> <year>1982</year> <volume>91</volume> <fpage>1899</fpage> <lpage>906</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_092\"> <label>92.</label> <mixed-citation>Cox, SW, Eley, BM. Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase IV-like activities in crevicular fuid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifuoromethyl coumarin. \t\t\t\t\t<italic>J Periodontal Res</italic> 1989;24:353\u201361. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cox</surname> <given-names>SW</given-names> </name> <name> <surname>Eley</surname> <given-names>BM</given-names> </name> </person-group> <article-title>Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase IV-like activities in crevicular fuid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifuoromethyl coumarin</article-title> <source>J Periodontal Res</source> <year>1989</year> <volume>24</volume> <fpage>353</fpage> <lpage>61</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_093\"> <label>93.</label> <mixed-citation>Mayo, B. Molecular cloning and sequence analysis of the X-prolyl dipeptidyl aminopeptidase gene from Lactococcus lactis subsp. cremoris. \t\t\t\t\t<italic>Appl Environ Microbiol</italic> 1991;57:38\u201344. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mayo</surname> <given-names>B</given-names> </name> </person-group> <article-title>Molecular cloning and sequence analysis of the X-prolyl dipeptidyl aminopeptidase gene from Lactococcus lactis subsp. cremoris</article-title> <source>Appl Environ Microbiol</source> <year>1991</year> <volume>57</volume> <fpage>38</fpage> <lpage>44</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_094\"> <label>94.</label> <mixed-citation>Kabashima, T, Ito, K, Yoshimoto, T. Dipeptidyl peptidase IV from Xanthomonas maltophilia: sequencing and expression of the enzyme gene and characterization of the expressed enzyme. \t\t\t\t\t<italic>J Biochem</italic> 1996;120:1111\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kabashima</surname> <given-names>T</given-names> </name> <name> <surname>Ito</surname> <given-names>K</given-names> </name> <name> <surname>Yoshimoto</surname> <given-names>T</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV from Xanthomonas maltophilia: sequencing and expression of the enzyme gene and characterization of the expressed enzyme</article-title> <source>J Biochem</source> <year>1996</year> <volume>120</volume> <fpage>1111</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_095\"> <label>95.</label> <mixed-citation>Ogasawara, W, Ogawa, Y, Yano, K, Okada, H, Morikawa, Y. Dipeptidyl aminopeptidase IV from Pseudomonas sp. WO24. \t\t\t\t\t<italic>Biosci. Biotechnol. Biochem</italic> 1996;60:2032\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ogasawara</surname> <given-names>W</given-names> </name> <name> <surname>Ogawa</surname> <given-names>Y</given-names> </name> <name> <surname>Yano</surname> <given-names>K</given-names> </name> <name> <surname>Okada</surname> <given-names>H</given-names> </name> <name> <surname>Morikawa</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Dipeptidyl aminopeptidase IV from Pseudomonas sp. WO24</article-title> <source>Biosci. Biotechnol. Biochem</source> <year>1996</year> <volume>60</volume> <fpage>2032</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_096\"> <label>96.</label> <mixed-citation>Shibata, Y, Miwa, Y, Hirai, K, Fujimura, S. Purification and partial characterization of a dipeptidyl peptidase from Prevotella intermedia. \t\t\t\t\t<italic>Oral Microbiol Immunol</italic> 2003;18:196\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Shibata</surname> <given-names>Y</given-names> </name> <name> <surname>Miwa</surname> <given-names>Y</given-names> </name> <name> <surname>Hirai</surname> <given-names>K</given-names> </name> <name> <surname>Fujimura</surname> <given-names>S</given-names> </name> </person-group> <article-title>Purification and partial characterization of a dipeptidyl peptidase from Prevotella intermedia</article-title> <source>Oral Microbiol Immunol</source> <year>2003</year> <volume>18</volume> <fpage>196</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_097\"> <label>97.</label> <mixed-citation>Kuwahara, T. Genomic analysis of Bacteroides fragilisreveals extensive DNA inversions regulating cell surface adaptation. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 2004;101:14919\u201324. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kuwahara</surname> <given-names>T</given-names> </name> </person-group> <article-title>Genomic analysis of Bacteroides fragilisreveals extensive DNA inversions regulating cell surface adaptation</article-title> <source>Proc Natl Acad Sci USA</source> <year>2004</year> <volume>101</volume> <fpage>14919</fpage> <lpage>24</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_098\"> <label>98.</label> <mixed-citation>Monod, M. Aminopeptidases and dipeptidyl-peptidases secreted by the dermatophyte Trichophyton rubrum. \t\t\t\t\t<italic>Microbiology</italic> 2005;151:145\u201355. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Monod</surname> <given-names>M</given-names> </name> </person-group> <article-title>Aminopeptidases and dipeptidyl-peptidases secreted by the dermatophyte Trichophyton rubrum</article-title> <source>Microbiology</source> <year>2005</year> <volume>151</volume> <fpage>145</fpage> <lpage>55</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_099\"> <label>99.</label> <mixed-citation>Ogasawara, W. Isoforms of dipeptidyl aminopeptidase IV from Pseudomonassp. WO24: role of the signal sequence and overexpression in Escherichia coli. \t\t\t\t\t<italic>Protein Expr Purif</italic> 2005;41:241\u201351. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ogasawara</surname> <given-names>W</given-names> </name> </person-group> <article-title>Isoforms of dipeptidyl aminopeptidase IV from Pseudomonassp. WO24: role of the signal sequence and overexpression in \t\t\t\t\t\t<italic>Escherichia coli</italic> </article-title> <source>Protein Expr Purif</source> <year>2005</year> <volume>41</volume> <fpage>241</fpage> <lpage>51</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_100\"> <label>100.</label> <mixed-citation>Tachi, H, Ito, H, Ichishima, E. An X-prolyl dipeptidyl-aminopeptidase from Aspergillus oryzae. \t\t\t\t\t<italic>Phytochemistry</italic> 1992;31:3707\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Tachi</surname> <given-names>H</given-names> </name> <name> <surname>Ito</surname> <given-names>H</given-names> </name> <name> <surname>Ichishima</surname> <given-names>E</given-names> </name> </person-group> <article-title>An X-prolyl dipeptidyl-aminopeptidase from Aspergillus oryzae</article-title> <source>Phytochemistry</source> <year>1992</year> <volume>31</volume> <fpage>3707</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_101\"> <label>101.</label> <mixed-citation>Beauvais, A. Dipeptidylpeptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans. \t\t\t\t\t<italic>Infect Immun</italic> 1997;65:3042\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Beauvais</surname> <given-names>A</given-names> </name> </person-group> <article-title>Dipeptidylpeptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans</article-title> <source>Infect Immun</source> <year>1997</year> <volume>65</volume> <fpage>3042</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_102\"> <label>102.</label> <mixed-citation>Oya, H, Nagatsu, I, Nagatsu, T. Purifcation and properties ofglycylprolyl-b-naphthylamidase in human submaxillary gland. \t\t\t\t\t<italic>Biochim Biophys Acta</italic> 1972;258:591\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Oya</surname> <given-names>H</given-names> </name> <name> <surname>Nagatsu</surname> <given-names>I</given-names> </name> <name> <surname>Nagatsu</surname> <given-names>T</given-names> </name> </person-group> <article-title>Purifcation and properties ofglycylprolyl-b-naphthylamidase in human submaxillary gland</article-title> <source>Biochim Biophys Acta</source> <year>1972</year> <volume>258</volume> <fpage>591</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_103\"> <label>103.</label> <mixed-citation>Barth, A, Schulz, H, Neubert, K. Studies on the purifcation and characterization of dipeptidyl aminopeptidase IV. \t\t\t\t\t<italic>Acta Biol Med Ger</italic> 1974;32:157\u201374. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Barth</surname> <given-names>A</given-names> </name> <name> <surname>Schulz</surname> <given-names>H</given-names> </name> <name> <surname>Neubert</surname> <given-names>K</given-names> </name> </person-group> <article-title>Studies on the purifcation and characterization of dipeptidyl aminopeptidase IV</article-title> <source>Acta Biol Med Ger</source> <year>1974</year> <volume>32</volume> <fpage>157</fpage> <lpage>74</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_104\"> <label>104.</label> <mixed-citation>Yoshimoto, T, Walter, R. Post-proline dipeptidyl aminopeptidase (dipeptidyl aminopeptidase IV) from lamb kidney. \t\t\t\t\t<italic>Biochim Biophys Acta</italic> 1977;485:391\u2013401. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yoshimoto</surname> <given-names>T</given-names> </name> <name> <surname>Walter</surname> <given-names>R</given-names> </name> </person-group> <article-title>Post-proline dipeptidyl aminopeptidase (dipeptidyl aminopeptidase IV) from lamb kidney</article-title> <source>Biochim Biophys Acta</source> <year>1977</year> <volume>485</volume> <fpage>391</fpage> <lpage>401</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_105\"> <label>105.</label> <mixed-citation>Yoshimoto, T, Kita, T, Ichinose, M, Tsuru, D. Dipeptidyl aminopeptidase IV from porcine pancreas. \t\t\t\t\t<italic>J Biochem</italic> 1982;92:275\u201382. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yoshimoto</surname> <given-names>T</given-names> </name> <name> <surname>Kita</surname> <given-names>T</given-names> </name> <name> <surname>Ichinose</surname> <given-names>M</given-names> </name> <name> <surname>Tsuru</surname> <given-names>D</given-names> </name> </person-group> <article-title>Dipeptidyl aminopeptidase IV from porcine pancreas</article-title> <source>J Biochem</source> <year>1982</year> <volume>92</volume> <fpage>275</fpage> <lpage>82</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_106\"> <label>106.</label> <mixed-citation>Wilson, MJ, Ruhland, AR, Pryor, JL. Prostate specific origin of dipeptidylpeptidase IV (CD26) in human malignant phenotype of melanocytic cells. \t\t\t\t\t<italic>J Exp Med</italic> 1998;190:311\u201322. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wilson</surname> <given-names>MJ</given-names> </name> <name> <surname>Ruhland</surname> <given-names>AR</given-names> </name> <name> <surname>Pryor</surname> <given-names>JL</given-names> </name> </person-group> <article-title>Prostate specific origin of dipeptidylpeptidase IV (CD26) in human malignant phenotype of melanocytic cells</article-title> <source>J Exp Med</source> <year>1998</year> <volume>190</volume> <fpage>311</fpage> <lpage>22</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_107\"> <label>107.</label> <mixed-citation>The Human Protein Atlas; 2003. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue+cell+type\">http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue+cell+type</ext-link> [Accessed Sep 11 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>The Human Protein Atlas</surname> </name> </person-group> <year>2003</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue+cell+type\">http://www.proteinatlas.org/ENSG00000197635-DPP4/tissue+cell+type</ext-link> <comment>[Accessed</comment> <comment>Sep</comment> <volume>11</volume> <fpage>2022</fpage> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_108\"> <label>108.</label> <mixed-citation>Savino, W, Villa-Verde, DM, Lannes-Vieira, J. Extracellular matrix proteins in intrathymic T-cell migration and differentiation? \t\t\t\t\t<italic>Immunol Today</italic> 1993;14:158\u201361. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Savino</surname> <given-names>W</given-names> </name> <name> <surname>Villa-Verde</surname> <given-names>DM</given-names> </name> <name> <surname>Lannes-Vieira</surname> <given-names>J</given-names> </name> </person-group> <article-title>Extracellular matrix proteins in intrathymic T-cell migration and differentiation?</article-title> <source>Immunol Today</source> <year>1993</year> <volume>14</volume> <fpage>158</fpage> <lpage>61</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_109\"> <label>109.</label> <mixed-citation>Zhong, J, Maiseyeu, A, Davis, SN, Rajagopalan, S. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. \t\t\t\t\t<italic>Circ Res</italic> 2015;116:1491\u2013504. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhong</surname> <given-names>J</given-names> </name> <name> <surname>Maiseyeu</surname> <given-names>A</given-names> </name> <name> <surname>Davis</surname> <given-names>SN</given-names> </name> <name> <surname>Rajagopalan</surname> <given-names>S</given-names> </name> </person-group> <article-title>DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition</article-title> <source>Circ Res</source> <year>2015</year> <volume>116</volume> <fpage>1491</fpage> <lpage>504</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_110\"> <label>110.</label> <mixed-citation>Gorrell, MD, Gysbers, V, McCaughan, GW. CD26: a multifunctional integral membrane and secreted protein glucagon-like peptide-1 secretion from the GLUTag cell line. \t\t\t\t\t<italic>Diabetes</italic> 2011;52:1147\u201354. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> <name> <surname>Gysbers</surname> <given-names>V</given-names> </name> <name> <surname>McCaughan</surname> <given-names>GW</given-names> </name> </person-group> <article-title>CD26: a multifunctional integral membrane and secreted protein glucagon-like peptide-1 secretion from the GLUTag cell line</article-title> <source>Diabetes</source> <year>2011</year> <volume>52</volume> <fpage>1147</fpage> <lpage>54</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_111\"> <label>111.</label> <mixed-citation>Girardi, ACC, Degray, BC, Nagy, T, Biemesderfer, D, Aronson, PS. Association of Na+-H+ exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule. \t\t\t\t\t<italic>J Biol Chem</italic> 2001;276:46671\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Girardi</surname> <given-names>ACC</given-names> </name> <name> <surname>Degray</surname> <given-names>BC</given-names> </name> <name> <surname>Nagy</surname> <given-names>T</given-names> </name> <name> <surname>Biemesderfer</surname> <given-names>D</given-names> </name> <name> <surname>Aronson</surname> <given-names>PS</given-names> </name> </person-group> <article-title>Association of Na+-H+ exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule</article-title> <source>J Biol Chem</source> <year>2001</year> <volume>276</volume> <fpage>46671</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_112\"> <label>112.</label> <mixed-citation>Cheng, HC, Abdel-Ghany, M, Pauli, BU. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. \t\t\t\t\t<italic>J Biol Chem</italic> 2003;278:24600\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cheng</surname> <given-names>HC</given-names> </name> <name> <surname>Abdel-Ghany</surname> <given-names>M</given-names> </name> <name> <surname>Pauli</surname> <given-names>BU</given-names> </name> </person-group> <article-title>A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis</article-title> <source>J Biol Chem</source> <year>2003</year> <volume>278</volume> <fpage>24600</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_113\"> <label>113.</label> <mixed-citation>Ohnuma, K, Yamochi, T, Uchiyama, M, Nishibashi, K, Yoshikawa, N, Shimizu, N, et al.. CD26 up-regulates expression of CD86 on antigenpresenting cells by means of caveolin-1. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 2004;101:14186\u201391. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ohnuma</surname> <given-names>K</given-names> </name> <name> <surname>Yamochi</surname> <given-names>T</given-names> </name> <name> <surname>Uchiyama</surname> <given-names>M</given-names> </name> <name> <surname>Nishibashi</surname> <given-names>K</given-names> </name> <name> <surname>Yoshikawa</surname> <given-names>N</given-names> </name> <name> <surname>Shimizu</surname> <given-names>N</given-names> </name> <etal/> </person-group> <article-title>CD26 up-regulates expression of CD86 on antigenpresenting cells by means of caveolin-1</article-title> <source>Proc Natl Acad Sci USA</source> <year>2004</year> <volume>101</volume> <fpage>14186</fpage> <lpage>91</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_114\"> <label>114.</label> <mixed-citation>Pascual, I, L\u00f3pez, A, G\u00f3mez, H, Chapp\u00e9, M, Saroy\u00e1n, A, Gonz\u00e1les, Y. Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms. \t\t\t\t\t<italic>Enzym Microb Technol</italic> 2007;40:414\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>L\u00f3pez</surname> <given-names>A</given-names> </name> <name> <surname>G\u00f3mez</surname> <given-names>H</given-names> </name> <name> <surname>Chapp\u00e9</surname> <given-names>M</given-names> </name> <name> <surname>Saroy\u00e1n</surname> <given-names>A</given-names> </name> <name> <surname>Gonz\u00e1les</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms</article-title> <source>Enzym Microb Technol</source> <year>2007</year> <volume>40</volume> <fpage>414</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_115\"> <label>115.</label> <mixed-citation>Gonz\u00e1lez, L, S\u00e1nchez, RE, Rojas, L, Pascual, I, Garc\u00eda-Fern\u00e1ndez, R, Ch\u00e1vez, MA, et al.. Screening of protease inhibitory activity in aqueous extracts of marine invertebrates from Cuban coast. \t\t\t\t\t<italic>Am J Anal Chem</italic> 2016;7:319\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gonz\u00e1lez</surname> <given-names>L</given-names> </name> <name> <surname>S\u00e1nchez</surname> <given-names>RE</given-names> </name> <name> <surname>Rojas</surname> <given-names>L</given-names> </name> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Garc\u00eda-Fern\u00e1ndez</surname> <given-names>R</given-names> </name> <name> <surname>Ch\u00e1vez</surname> <given-names>MA</given-names> </name> <etal/> </person-group> <article-title>Screening of protease inhibitory activity in aqueous extracts of marine invertebrates from Cuban coast</article-title> <source>Am J Anal Chem</source> <year>2016</year> <volume>7</volume> <fpage>319</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_116\"> <label>116.</label> <mixed-citation>Pascual, I, Arrebola, Y, Almeida, F, Vald\u00e9s, ME, Rivera, L, Hern\u00e1ndez, A, et al.. Marine and coastal organisms: a source of biomedically relevant dipeptidyl peptidase IV inhibitors. \t\t\t\t\t<italic>Rev. Cuba Cienc biol</italic> 2020;8:1\u201316. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Arrebola</surname> <given-names>Y</given-names> </name> <name> <surname>Almeida</surname> <given-names>F</given-names> </name> <name> <surname>Vald\u00e9s</surname> <given-names>ME</given-names> </name> <name> <surname>Rivera</surname> <given-names>L</given-names> </name> <name> <surname>Hern\u00e1ndez</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Marine and coastal organisms: a source of biomedically relevant dipeptidyl peptidase IV inhibitors</article-title> <source>Rev. Cuba Cienc biol</source> <year>2020</year> <volume>8</volume> <fpage>1</fpage> <lpage>16</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_117\"> <label>117.</label> <mixed-citation>Maslov, I, Zinevich, TV, Kirichenko, OG, Trukhan, MV, Shorshnev, SV, Tuaeva, NO, et al.. Synthesis and Biological Evaluation of Neogliptin, a Novel 2 Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4). \t\t\t\t\t<italic>Pharmaceuticals (Basel)</italic> 2022;15:273. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Maslov</surname> <given-names>I</given-names> </name> <name> <surname>Zinevich</surname> <given-names>TV</given-names> </name> <name> <surname>Kirichenko</surname> <given-names>OG</given-names> </name> <name> <surname>Trukhan</surname> <given-names>MV</given-names> </name> <name> <surname>Shorshnev</surname> <given-names>SV</given-names> </name> <name> <surname>Tuaeva</surname> <given-names>NO</given-names> </name> <etal/> </person-group> <article-title>Synthesis and Biological Evaluation of Neogliptin, a Novel 2 Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4)</article-title> <source>Pharmaceuticals (Basel)</source> <year>2022</year> <volume>15</volume> <fpage>273</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_118\"> <label>118.</label> <mixed-citation>Itou, M, Kawaguchi, T, Taniguchi, E, Sata, M. Dipeptidyl peptidase-4: a key player in chronic liver disease. \t\t\t\t\t<italic>World J Gastroenterol</italic> 2013;19:2298\u2013306. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Itou</surname> <given-names>M</given-names> </name> <name> <surname>Kawaguchi</surname> <given-names>T</given-names> </name> <name> <surname>Taniguchi</surname> <given-names>E</given-names> </name> <name> <surname>Sata</surname> <given-names>M</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4: a key player in chronic liver disease</article-title> <source>World J Gastroenterol</source> <year>2013</year> <volume>19</volume> <fpage>2298</fpage> <lpage>306</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_119\"> <label>119.</label> <mixed-citation>Anderluh, M, Kocic, G, Tomovic, K, Kocic, R, Deljanin-Ilic, M, Smelcerovic, A. Cross-talk between the dipeptidyl peptidase-4 and stromal CellDerived factor-1 in stem cell homing and myocardial repair: potential impact of dipeptidyl peptidase-4 inhibitors. \t\t\t\t\t<italic>Pharmacol Ther</italic> 2016;167:100\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Anderluh</surname> <given-names>M</given-names> </name> <name> <surname>Kocic</surname> <given-names>G</given-names> </name> <name> <surname>Tomovic</surname> <given-names>K</given-names> </name> <name> <surname>Kocic</surname> <given-names>R</given-names> </name> <name> <surname>Deljanin-Ilic</surname> <given-names>M</given-names> </name> <name> <surname>Smelcerovic</surname> <given-names>A</given-names> </name> </person-group> <article-title>Cross-talk between the dipeptidyl peptidase-4 and stromal CellDerived factor-1 in stem cell homing and myocardial repair: potential impact of dipeptidyl peptidase-4 inhibitors</article-title> <source>Pharmacol Ther</source> <year>2016</year> <volume>167</volume> <fpage>100</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_120\"> <label>120.</label> <mixed-citation>Beckers, PAJ, Gielis, JF, Van Schil, PE, Adriaensen, D. Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition. \t\t\t\t\t<italic>Ann Transl Med</italic> 2017;5:129. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Beckers</surname> <given-names>PAJ</given-names> </name> <name> <surname>Gielis</surname> <given-names>JF</given-names> </name> <name> <surname>Van Schil</surname> <given-names>PE</given-names> </name> <name> <surname>Adriaensen</surname> <given-names>D</given-names> </name> </person-group> <article-title>Lung ischemia reperfusion injury: the therapeutic role of dipeptidyl peptidase 4 inhibition</article-title> <source>Ann Transl Med</source> <year>2017</year> <volume>5</volume> <fpage>129</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_121\"> <label>121.</label> <mixed-citation>Nausch, I, Mentlein, R, Heymann, E. The degradation of bioactive peptides and proteins by dipeptidil peptidase IV from human placenta. \t\t\t\t\t<italic>Biol Chem</italic> 1990;371:113\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nausch</surname> <given-names>I</given-names> </name> <name> <surname>Mentlein</surname> <given-names>R</given-names> </name> <name> <surname>Heymann</surname> <given-names>E</given-names> </name> </person-group> <article-title>The degradation of bioactive peptides and proteins by dipeptidil peptidase IV from human placenta</article-title> <source>Biol Chem</source> <year>1990</year> <volume>371</volume> <fpage>113</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_122\"> <label>122.</label> <mixed-citation>Ahr\u00e9n, B, Hughes, T. IInhibition of dipeptidil peptidase-4 augments insulin secretion in response to exogenously administrated glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, PItuitary adenylate cyclase-activating polipeptide, and gastrin-releasing peptide in mice. \t\t\t\t\t<italic>Endocrinology</italic> 2004;146:2055\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ahr\u00e9n</surname> <given-names>B</given-names> </name> <name> <surname>Hughes</surname> <given-names>T</given-names> </name> </person-group> <article-title>IInhibition of dipeptidil peptidase-4 augments insulin secretion in response to exogenously administrated glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, PItuitary adenylate cyclase-activating polipeptide, and gastrin-releasing peptide in mice</article-title> <source>Endocrinology</source> <year>2004</year> <volume>146</volume> <fpage>2055</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_123\"> <label>123.</label> <mixed-citation>Hu, CX, Huang, H, Zhang, L, Huang, Y, Shen, ZF, Cheng, KD. A new screening method based on yeast-expressed human dipeptidyl peptidase IV and discovery of novel inhibitors. \t\t\t\t\t<italic>Biotechnol Lett</italic> 2009;31:979\u201384. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hu</surname> <given-names>CX</given-names> </name> <name> <surname>Huang</surname> <given-names>H</given-names> </name> <name> <surname>Zhang</surname> <given-names>L</given-names> </name> <name> <surname>Huang</surname> <given-names>Y</given-names> </name> <name> <surname>Shen</surname> <given-names>ZF</given-names> </name> <name> <surname>Cheng</surname> <given-names>KD</given-names> </name> </person-group> <article-title>A new screening method based on yeast-expressed human dipeptidyl peptidase IV and discovery of novel inhibitors</article-title> <source>Biotechnol Lett</source> <year>2009</year> <volume>31</volume> <fpage>979</fpage> <lpage>84</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_124\"> <label>124.</label> <mixed-citation>Durinx, C, Lambeir, AM, Bosmans, E, Falmagne, JB, Berghmans, R, Haemers, A. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. \t\t\t\t\t<italic>Eur J Biochem</italic> 2000;267:5608\u201313. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Durinx</surname> <given-names>C</given-names> </name> <name> <surname>Lambeir</surname> <given-names>AM</given-names> </name> <name> <surname>Bosmans</surname> <given-names>E</given-names> </name> <name> <surname>Falmagne</surname> <given-names>JB</given-names> </name> <name> <surname>Berghmans</surname> <given-names>R</given-names> </name> <name> <surname>Haemers</surname> <given-names>A</given-names> </name> </person-group> <article-title>Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides</article-title> <source>Eur J Biochem</source> <year>2000</year> <volume>267</volume> <fpage>5608</fpage> <lpage>13</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_125\"> <label>125.</label> <mixed-citation>Bermpohl, F, Loster, K, Reutter, W, Baum, O. Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens. \t\t\t\t\t<italic>FEBS Lett</italic> 1998;428:152\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bermpohl</surname> <given-names>F</given-names> </name> <name> <surname>Loster</surname> <given-names>K</given-names> </name> <name> <surname>Reutter</surname> <given-names>W</given-names> </name> <name> <surname>Baum</surname> <given-names>O</given-names> </name> </person-group> <article-title>Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens</article-title> <source>FEBS Lett</source> <year>1998</year> <volume>428</volume> <fpage>152</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_126\"> <label>126.</label> <mixed-citation>Lambeir, A, Paul, P, Durinx, C, Bal, G, Senten, K, Augustyns, K, et al.. Kinetic Investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. \t\t\t\t\t<italic>J Biol Chem</italic> 2001;276:29839\u201345. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lambeir</surname> <given-names>A</given-names> </name> <name> <surname>Paul</surname> <given-names>P</given-names> </name> <name> <surname>Durinx</surname> <given-names>C</given-names> </name> <name> <surname>Bal</surname> <given-names>G</given-names> </name> <name> <surname>Senten</surname> <given-names>K</given-names> </name> <name> <surname>Augustyns</surname> <given-names>K</given-names> </name> <etal/> </person-group> <article-title>Kinetic Investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family</article-title> <source>J Biol Chem</source> <year>2001</year> <volume>276</volume> <fpage>29839</fpage> <lpage>45</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_127\"> <label>127.</label> <mixed-citation>Orskov, C, Bersanis, M, Johnsen, AH, Hajrupll, P, Holst, J. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. \t\t\t\t\t<italic>J Biol Chem</italic> 1989;264:12826\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Orskov</surname> <given-names>C</given-names> </name> <name> <surname>Bersanis</surname> <given-names>M</given-names> </name> <name> <surname>Johnsen</surname> <given-names>AH</given-names> </name> <name> <surname>Hajrupll</surname> <given-names>P</given-names> </name> <name> <surname>Holst</surname> <given-names>J</given-names> </name> </person-group> <article-title>Complete sequences of glucagon-like peptide-1 from human and pig small intestine</article-title> <source>J Biol Chem</source> <year>1989</year> <volume>264</volume> <fpage>12826</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_128\"> <label>128.</label> <mixed-citation>Pauly, R, Rosche, F, Wermann, M, McIntosh, CHS, Pederson, RA, Demuth, HU. Investigation of glucose-dependent insulinotropic polypeptide-(1\u2013 42) and glucagon-like peptide-1-(7\u201336) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. \t\t\t\t\t<italic>J Biol Chem</italic> 1996;271:23222\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pauly</surname> <given-names>R</given-names> </name> <name> <surname>Rosche</surname> <given-names>F</given-names> </name> <name> <surname>Wermann</surname> <given-names>M</given-names> </name> <name> <surname>McIntosh</surname> <given-names>CHS</given-names> </name> <name> <surname>Pederson</surname> <given-names>RA</given-names> </name> <name> <surname>Demuth</surname> <given-names>HU</given-names> </name> </person-group> <article-title>Investigation of glucose-dependent insulinotropic polypeptide-(1\u2013 42) and glucagon-like peptide-1-(7\u201336) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry</article-title> <source>J Biol Chem</source> <year>1996</year> <volume>271</volume> <fpage>23222</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_129\"> <label>129.</label> <mixed-citation>Hui, H, Farilla, L, Merkel, P, Perfetti, R. The short half-life of glucag\u00f3n-like paptide-1 in plasma does not reflect its long-lasting beneficial effects. \t\t\t\t\t<italic>Eur J Endocrinol</italic> 2002;146:863\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hui</surname> <given-names>H</given-names> </name> <name> <surname>Farilla</surname> <given-names>L</given-names> </name> <name> <surname>Merkel</surname> <given-names>P</given-names> </name> <name> <surname>Perfetti</surname> <given-names>R</given-names> </name> </person-group> <article-title>The short half-life of glucag\u00f3n-like paptide-1 in plasma does not reflect its long-lasting beneficial effects</article-title> <source>Eur J Endocrinol</source> <year>2002</year> <volume>146</volume> <fpage>863</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_130\"> <label>130.</label> <mixed-citation>Zhu, L, Tamvakopoulos, C, Xie, D, Dragovic, J, Shen, X, Fenyk-Melody, JE, et al.. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides. \t\t\t\t\t<italic>J Biol Chem</italic> 2003;278:22418\u201323. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhu</surname> <given-names>L</given-names> </name> <name> <surname>Tamvakopoulos</surname> <given-names>C</given-names> </name> <name> <surname>Xie</surname> <given-names>D</given-names> </name> <name> <surname>Dragovic</surname> <given-names>J</given-names> </name> <name> <surname>Shen</surname> <given-names>X</given-names> </name> <name> <surname>Fenyk-Melody</surname> <given-names>JE</given-names> </name> <etal/> </person-group> <article-title>The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides</article-title> <source>J Biol Chem</source> <year>2003</year> <volume>278</volume> <fpage>22418</fpage> <lpage>23</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_131\"> <label>131.</label> <mixed-citation>Alters, S, McLaughlin, B, Spink, B, Lachiyan, T, Wang, C, Podust, V, et al.. Correction: GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in rats Crohn\u2019s disease model. \t\t\t\t\t<italic>PLoS One</italic> 2013;8:1371. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Alters</surname> <given-names>S</given-names> </name> <name> <surname>McLaughlin</surname> <given-names>B</given-names> </name> <name> <surname>Spink</surname> <given-names>B</given-names> </name> <name> <surname>Lachiyan</surname> <given-names>T</given-names> </name> <name> <surname>Wang</surname> <given-names>C</given-names> </name> <name> <surname>Podust</surname> <given-names>V</given-names> </name> <etal/> </person-group> <article-title>Correction: GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in rats Crohn\u2019s disease model</article-title> <source>PLoS One</source> <year>2013</year> <volume>8</volume> <fpage>1371</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_132\"> <label>132.</label> <mixed-citation>Irwin, N, Flatt, P. Chapter gastric inhibitory polipeptide. In: \t\t\t\t\t<italic>Williams Textbook of Endocrinology</italic>, 12th ed. Philadelphia, United States: Saunders; 2012. pp. 1697\u2013716. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <name> <surname>Irwin</surname> <given-names>N</given-names> </name> <name> <surname>Flatt</surname> <given-names>P</given-names> </name> </person-group> <article-title>Chapter gastric inhibitory polipeptide</article-title> <source>Williams Textbook of Endocrinology</source> <edition>12th ed.</edition> <publisher-loc>Philadelphia, United States</publisher-loc> <publisher-name>Saunders</publisher-name> <year>2012</year> <fpage>1697</fpage> <lpage>716</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_133\"> <label>133.</label> <mixed-citation>Birk, S, Sitarz, J, Petersen, K, Oturai, P, Kruuse, C, Fahrenkrug, J, et al.. The effect of interavenous PACAP38 on cerebral hemodynamics in healthy volunteers. \t\t\t\t\t<italic>Regul Pept</italic> 2007;140:185\u201391. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Birk</surname> <given-names>S</given-names> </name> <name> <surname>Sitarz</surname> <given-names>J</given-names> </name> <name> <surname>Petersen</surname> <given-names>K</given-names> </name> <name> <surname>Oturai</surname> <given-names>P</given-names> </name> <name> <surname>Kruuse</surname> <given-names>C</given-names> </name> <name> <surname>Fahrenkrug</surname> <given-names>J</given-names> </name> <etal/> </person-group> <article-title>The effect of interavenous PACAP38 on cerebral hemodynamics in healthy volunteers</article-title> <source>Regul Pept</source> <year>2007</year> <volume>140</volume> <fpage>185</fpage> <lpage>91</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_134\"> <label>134.</label> <mixed-citation>Bourgault, S, Vaudry, D, Botia, B, Couvineau, A, Laburthe, M, Vaudry, H, et al.. Nobel stable PACAP analogs with potent activity towards the PAC1 receptor. \t\t\t\t\t<italic>Peptides</italic> 2008;29:919\u201332. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bourgault</surname> <given-names>S</given-names> </name> <name> <surname>Vaudry</surname> <given-names>D</given-names> </name> <name> <surname>Botia</surname> <given-names>B</given-names> </name> <name> <surname>Couvineau</surname> <given-names>A</given-names> </name> <name> <surname>Laburthe</surname> <given-names>M</given-names> </name> <name> <surname>Vaudry</surname> <given-names>H</given-names> </name> <etal/> </person-group> <article-title>Nobel stable PACAP analogs with potent activity towards the PAC1 receptor</article-title> <source>Peptides</source> <year>2008</year> <volume>29</volume> <fpage>919</fpage> <lpage>32</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_135\"> <label>135.</label> <mixed-citation>Pocai, A. Action and therapeutic potential of oxytomodulin. \t\t\t\t\t<italic>Mol Metab</italic> 2013;3:241\u201351. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pocai</surname> <given-names>A</given-names> </name> </person-group> <article-title>Action and therapeutic potential of oxytomodulin</article-title> <source>Mol Metab</source> <year>2013</year> <volume>3</volume> <fpage>241</fpage> <lpage>51</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_136\"> <label>136.</label> <mixed-citation>Kolts, B, McGuian, J. Radioimmunoassay measurement of secretin half-life time in man. \t\t\t\t\t<italic>Gastroenterology</italic> 1977;72:55\u201370. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kolts</surname> <given-names>B</given-names> </name> <name> <surname>McGuian</surname> <given-names>J</given-names> </name> </person-group> <article-title>Radioimmunoassay measurement of secretin half-life time in man</article-title> <source>Gastroenterology</source> <year>1977</year> <volume>72</volume> <fpage>55</fpage> <lpage>70</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_137\"> <label>137.</label> <mixed-citation>Boissard, C, Marie, J, Hejblum, G, Gespach, C, Rosselin, G. Vasoactive intestinal peptide receptor regulation and reversible desensibilization in human colonic carcinoma cells in culture. \t\t\t\t\t<italic>Cancer Res</italic> 1986;46:4406\u201313. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Boissard</surname> <given-names>C</given-names> </name> <name> <surname>Marie</surname> <given-names>J</given-names> </name> <name> <surname>Hejblum</surname> <given-names>G</given-names> </name> <name> <surname>Gespach</surname> <given-names>C</given-names> </name> <name> <surname>Rosselin</surname> <given-names>G</given-names> </name> </person-group> <article-title>Vasoactive intestinal peptide receptor regulation and reversible desensibilization in human colonic carcinoma cells in culture</article-title> <source>Cancer Res</source> <year>1986</year> <volume>46</volume> <fpage>4406</fpage> <lpage>13</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_138\"> <label>138.</label> <mixed-citation>Frohman, L, Downs, T, Williams, T, Heimer, E, Pan, Y, Felix, A. Rapid enzymatic degradation of growth hormone-relasing hormone by plasma in vitro and in vivo to a biologically inactive, N-terminally cleaved product. \t\t\t\t\t<italic>J Clin Invest</italic> 1986;78:906\u201313. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Frohman</surname> <given-names>L</given-names> </name> <name> <surname>Downs</surname> <given-names>T</given-names> </name> <name> <surname>Williams</surname> <given-names>T</given-names> </name> <name> <surname>Heimer</surname> <given-names>E</given-names> </name> <name> <surname>Pan</surname> <given-names>Y</given-names> </name> <name> <surname>Felix</surname> <given-names>A</given-names> </name> </person-group> <article-title>Rapid enzymatic degradation of growth hormone-relasing hormone by plasma in vitro and in vivo to a biologically inactive, N-terminally cleaved product</article-title> <source>J Clin Invest</source> <year>1986</year> <volume>78</volume> <fpage>906</fpage> <lpage>13</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_139\"> <label>139.</label> <mixed-citation>Wojcik, E, Kulpa, J. Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response. \t\t\t\t\t<italic>Lung Cancer</italic> 2017;8:231\u201340. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wojcik</surname> <given-names>E</given-names> </name> <name> <surname>Kulpa</surname> <given-names>J</given-names> </name> </person-group> <article-title>Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response</article-title> <source>Lung Cancer</source> <year>2017</year> <volume>8</volume> <fpage>231</fpage> <lpage>40</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_140\"> <label>140.</label> <mixed-citation>Mashaghi, A, Marmalidou, A, Mohsen, T, Grace, P, Pothoulakis, C, Dana, R. Neuropeptide substance P and the immune response. \t\t\t\t\t<italic>Cell Mol Life Sci</italic> 2016;73:4249\u201364. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mashaghi</surname> <given-names>A</given-names> </name> <name> <surname>Marmalidou</surname> <given-names>A</given-names> </name> <name> <surname>Mohsen</surname> <given-names>T</given-names> </name> <name> <surname>Grace</surname> <given-names>P</given-names> </name> <name> <surname>Pothoulakis</surname> <given-names>C</given-names> </name> <name> <surname>Dana</surname> <given-names>R</given-names> </name> </person-group> <article-title>Neuropeptide substance P and the immune response</article-title> <source>Cell Mol Life Sci</source> <year>2016</year> <volume>73</volume> <fpage>4249</fpage> <lpage>64</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_141\"> <label>141.</label> <mixed-citation>Takemoto, K, Neuropeptide, Y. Complete amino acid sequence of the brain peptide. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 1982;79:5485\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Takemoto</surname> <given-names>K</given-names> </name> <name> <surname>Neuropeptide</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Complete amino acid sequence of the brain peptide</article-title> <source>Proc Natl Acad Sci USA</source> <year>1982</year> <volume>79</volume> <fpage>5485</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_142\"> <label>142.</label> <mixed-citation>Ahlborg, G, Weitzberg, E, Sollevi, A, Lundberg, J. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man. \t\t\t\t\t<italic>Acta Physiol Scand</italic> 1992;145:139\u201349. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ahlborg</surname> <given-names>G</given-names> </name> <name> <surname>Weitzberg</surname> <given-names>E</given-names> </name> <name> <surname>Sollevi</surname> <given-names>A</given-names> </name> <name> <surname>Lundberg</surname> <given-names>J</given-names> </name> </person-group> <article-title>Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man</article-title> <source>Acta Physiol Scand</source> <year>1992</year> <volume>145</volume> <fpage>139</fpage> <lpage>49</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_143\"> <label>143.</label> <mixed-citation>Takemoto, K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 1982;79:2514\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Takemoto</surname> <given-names>K</given-names> </name> </person-group> <article-title>Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion</article-title> <source>Proc Natl Acad Sci USA</source> <year>1982</year> <volume>79</volume> <fpage>2514</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_144\"> <label>144.</label> <mixed-citation>Adrian, T, Sagor, G, Savage, A, Bacarese-Hamilton, A, Hall, G, Bloom, S. Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. \t\t\t\t\t<italic>J Clin Endocrinol Metab</italic> 1986;63:803\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Adrian</surname> <given-names>T</given-names> </name> <name> <surname>Sagor</surname> <given-names>G</given-names> </name> <name> <surname>Savage</surname> <given-names>A</given-names> </name> <name> <surname>Bacarese-Hamilton</surname> <given-names>A</given-names> </name> <name> <surname>Hall</surname> <given-names>G</given-names> </name> <name> <surname>Bloom</surname> <given-names>S</given-names> </name> </person-group> <article-title>Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man</article-title> <source>J Clin Endocrinol Metab</source> <year>1986</year> <volume>63</volume> <fpage>803</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_145\"> <label>145.</label> <mixed-citation> <collab>Uniprot</collab>. \t\t\t\t\t<italic>The amino acid sequence of human chorionic gonadotropin the alpha subunit and the beta subunit</italic>; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://uniprot.org/citations/1150658\">http://uniprot.org/citations/1150658</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <collab>Uniprot</collab> </person-group> <source>The amino acid sequence of human chorionic gonadotropin the alpha subunit and the beta subunit</source> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://uniprot.org/citations/1150658\">http://uniprot.org/citations/1150658</ext-link> <comment>[Accessed 14</comment> <comment>Oct 2022]</comment> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_146\"> <label>146.</label> <mixed-citation>Tan, E, Hershman, J. Chapter hyperthyroidism and trophoblastic disease. In: Frederic, E, Radovick, S, editors. \t\t\t\t\t<italic>Clinical management of thyroid disease</italic>. Amsterdam, Netherlands: Elsevier B.V; 2009. pp. 407\u201323. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <name> <surname>Tan</surname> <given-names>E</given-names> </name> <name> <surname>Hershman</surname> <given-names>J</given-names> </name> </person-group> <article-title>Chapter hyperthyroidism and trophoblastic disease</article-title> <person-group person-group-type=\"editor\"> <name> <surname>Frederic</surname> <given-names>E</given-names> </name> <name> <surname>Radovick</surname> <given-names>S</given-names> </name> </person-group> <source>Clinical management of thyroid disease</source> <publisher-loc>Amsterdam, Netherlands</publisher-loc> <publisher-name>Elsevier B.V</publisher-name> <year>2009</year> <fpage>407</fpage> <lpage>23</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_147\"> <label>147.</label> <mixed-citation>Genscript. Human pancreatic polipeptide; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.genscript.com/peptide/RP10398-Pancreatic_Polypeptide_human.html\">http://www.genscript.com/peptide/RP10398-Pancreatic_Polypeptide_human.html</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <comment>Genscript. Human pancreatic polipeptide; 2022. Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.genscript.com/peptide/RP10398-Pancreatic_Polypeptide_human.html\">http://www.genscript.com/peptide/RP10398-Pancreatic_Polypeptide_human.html</ext-link> <comment>[Accessed 14</comment> <year>Oct 2022]</year> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_148\"> <label>148.</label> <mixed-citation>Cuenco, J, Minnion, J, Tan, T, Scott, R, Germain, N, Ling, Y, et al.. Degradation paradigm of the gut hormone, pancreatic polipetide, by hepatic and renal peptidases. \t\t\t\t\t<italic>Endocrinology</italic> 2017;158:1755\u201365. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cuenco</surname> <given-names>J</given-names> </name> <name> <surname>Minnion</surname> <given-names>J</given-names> </name> <name> <surname>Tan</surname> <given-names>T</given-names> </name> <name> <surname>Scott</surname> <given-names>R</given-names> </name> <name> <surname>Germain</surname> <given-names>N</given-names> </name> <name> <surname>Ling</surname> <given-names>Y</given-names> </name> <etal/> </person-group> <article-title>Degradation paradigm of the gut hormone, pancreatic polipetide, by hepatic and renal peptidases</article-title> <source>Endocrinology</source> <year>2017</year> <volume>158</volume> <fpage>1755</fpage> <lpage>65</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_149\"> <label>149.</label> <mixed-citation>Gianoulakis, C, Seidah, N, Routhier, R, Chr\u00e9tien, M. Biosynthesis and characterization of adenocorticotropic hormone, alpha-melanocite-stimulating hormone, and NH2-terminal fragment of the adenocorticotropic hormone/beta-lipoprotein precursor from rats pars intermedia. \t\t\t\t\t<italic>J Biol Chem</italic> 1979;254:1903\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gianoulakis</surname> <given-names>C</given-names> </name> <name> <surname>Seidah</surname> <given-names>N</given-names> </name> <name> <surname>Routhier</surname> <given-names>R</given-names> </name> <name> <surname>Chr\u00e9tien</surname> <given-names>M</given-names> </name> </person-group> <article-title>Biosynthesis and characterization of adenocorticotropic hormone, alpha-melanocite-stimulating hormone, and NH2-terminal fragment of the adenocorticotropic hormone/beta-lipoprotein precursor from rats pars intermedia</article-title> <source>J Biol Chem</source> <year>1979</year> <volume>254</volume> <fpage>1903</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_150\"> <label>150.</label> <mixed-citation>Veldhuis, J, Iranmanesh, A, Naftolowitz, D, Tathan, N, Cassidy, F, Carroll, B. Corticotropin secretory dynamics in humans under low glucocorticoid feedbac. \t\t\t\t\t<italic>J Clin Endocrinol Metab</italic> 2001;86:5554\u201363. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Veldhuis</surname> <given-names>J</given-names> </name> <name> <surname>Iranmanesh</surname> <given-names>A</given-names> </name> <name> <surname>Naftolowitz</surname> <given-names>D</given-names> </name> <name> <surname>Tathan</surname> <given-names>N</given-names> </name> <name> <surname>Cassidy</surname> <given-names>F</given-names> </name> <name> <surname>Carroll</surname> <given-names>B</given-names> </name> </person-group> <article-title>Corticotropin secretory dynamics in humans under low glucocorticoid feedbac</article-title> <source>J Clin Endocrinol Metab</source> <year>2001</year> <volume>86</volume> <fpage>5554</fpage> <lpage>63</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_151\"> <label>151.</label> <mixed-citation>Mentlein, R, Gallwits, B, Schmidt, WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagons-like peptide-1(7\u201336)amide, peptide histidine methionine and is responsible for their degradation in human serum. \t\t\t\t\t<italic>Eur J Biochem</italic> 1993;213:829\u201335. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mentlein</surname> <given-names>R</given-names> </name> <name> <surname>Gallwits</surname> <given-names>B</given-names> </name> <name> <surname>Schmidt</surname> <given-names>WE</given-names> </name> </person-group> <article-title>Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagons-like peptide-1(7\u201336)amide, peptide histidine methionine and is responsible for their degradation in human serum</article-title> <source>Eur J Biochem</source> <year>1993</year> <volume>213</volume> <fpage>829</fpage> <lpage>35</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_152\"> <label>152.</label> <mixed-citation>Kiefer, TJ, McIntosh, CH, Pederson, RA. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagons-like peptide 1 in vitroand in vivoby dipeptidyl peptidase IV. \t\t\t\t\t<italic>Endocrinology</italic> 1995;136:3585\u201396. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kiefer</surname> <given-names>TJ</given-names> </name> <name> <surname>McIntosh</surname> <given-names>CH</given-names> </name> <name> <surname>Pederson</surname> <given-names>RA</given-names> </name> </person-group> <article-title>Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagons-like peptide 1 in vitroand in vivoby dipeptidyl peptidase IV</article-title> <source>Endocrinology</source> <year>1995</year> <volume>136</volume> <fpage>3585</fpage> <lpage>96</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_153\"> <label>153.</label> <mixed-citation>Combettes, M. GLP-1 and type 2 diabetes: physiology and new clinical advances. \t\t\t\t\t<italic>Curr Opin Pharmacol</italic> 2006;6:598\u2013605. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Combettes</surname> <given-names>M</given-names> </name> </person-group> <article-title>GLP-1 and type 2 diabetes: physiology and new clinical advances</article-title> <source>Curr Opin Pharmacol</source> <year>2006</year> <volume>6</volume> <fpage>598</fpage> <lpage>605</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_154\"> <label>154.</label> <mixed-citation>ChemSpider; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.sitagliptin.html\">http://chemispider.com/Chemical-Structure.sitagliptin.html</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>ChemSpider</surname> </name> </person-group> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.sitagliptin.html\">http://chemispider.com/Chemical-Structure.sitagliptin.html</ext-link> <comment>[Accessed 14</comment> <comment>Oct 2022]</comment> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_155\"> <label>155.</label> <mixed-citation>Zhou, ST, Cui, W, Kong, L, Yang, X. Efficacy of sitagliptin on Nonalcoholic fatty liver disease in high-fat-diet-fed diabetic mice. \t\t\t\t\t<italic>Curr Med Sci</italic> 2022;42:513\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhou</surname> <given-names>ST</given-names> </name> <name> <surname>Cui</surname> <given-names>W</given-names> </name> <name> <surname>Kong</surname> <given-names>L</given-names> </name> <name> <surname>Yang</surname> <given-names>X</given-names> </name> </person-group> <article-title>Efficacy of sitagliptin on Nonalcoholic fatty liver disease in high-fat-diet-fed diabetic mice</article-title> <source>Curr Med Sci</source> <year>2022</year> <volume>42</volume> <fpage>513</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_156\"> <label>156.</label> <mixed-citation>Trocha, M, Fleszar, MG, Fortuna, P, Lewandowski, L, Gostomska-Pampuch, K, Sozanski, T, et al.. Sitagliptin modulates oxidative, nitrative and halogenative stress and inflammatory response in rat model of hepatic ischemia-reperfusion. \t\t\t\t\t<italic>Antioxidants</italic> 2021;10:1168. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Trocha</surname> <given-names>M</given-names> </name> <name> <surname>Fleszar</surname> <given-names>MG</given-names> </name> <name> <surname>Fortuna</surname> <given-names>P</given-names> </name> <name> <surname>Lewandowski</surname> <given-names>L</given-names> </name> <name> <surname>Gostomska-Pampuch</surname> <given-names>K</given-names> </name> <name> <surname>Sozanski</surname> <given-names>T</given-names> </name> <etal/> </person-group> <article-title>Sitagliptin modulates oxidative, nitrative and halogenative stress and inflammatory response in rat model of hepatic ischemia-reperfusion</article-title> <source>Antioxidants</source> <year>2021</year> <volume>10</volume> <fpage>1168</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_157\"> <label>157.</label> <mixed-citation>Prakash, S, Rai, U, Kosuru, R, Tiwari, V, Singh, S. Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice. \t\t\t\t\t<italic>Biochimie</italic> 2020;168:198\u2013209. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Prakash</surname> <given-names>S</given-names> </name> <name> <surname>Rai</surname> <given-names>U</given-names> </name> <name> <surname>Kosuru</surname> <given-names>R</given-names> </name> <name> <surname>Tiwari</surname> <given-names>V</given-names> </name> <name> <surname>Singh</surname> <given-names>S</given-names> </name> </person-group> <article-title>Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice</article-title> <source>Biochimie</source> <year>2020</year> <volume>168</volume> <fpage>198</fpage> <lpage>209</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_158\"> <label>158.</label> <mixed-citation>ChemSpider; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.alogliptin.html\">http://chemispider.com/Chemical-Structure.alogliptin.html</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>ChemSpider</surname> </name> </person-group> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.alogliptin.html\">http://chemispider.com/Chemical-Structure.alogliptin.html</ext-link> <comment>[Accessed 14</comment> <comment>Oct 2022]</comment> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_159\"> <label>159.</label> <mixed-citation>White, JR. Alogliptin for the treatment of type 2 diabetes. \t\t\t\t\t<italic>Drugs Today</italic> 2011;47:99\u2013107. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>White</surname> <given-names>JR</given-names> </name> </person-group> <article-title>Alogliptin for the treatment of type 2 diabetes</article-title> <source>Drugs Today</source> <year>2011</year> <volume>47</volume> <fpage>99</fpage> <lpage>107</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_160\"> <label>160.</label> <mixed-citation>Agency, E.M.: \t\t\t\t\t<italic>summary of product characteristics</italic>; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ema.europa.eu/en/documents/productinformation/vipidia-eparproductinformation.en.pdf\">https://www.ema.europa.eu/en/documents/productinformation/vipidia-eparproductinformation.en.pdf</ext-link> [Accessed 10 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <name> <surname>Agency</surname> <given-names>E.M.</given-names> </name> </person-group> <source>summary of product characteristics</source> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ema.europa.eu/en/documents/productinformation/vipidia-eparproductinformation.en.pdf\">https://www.ema.europa.eu/en/documents/productinformation/vipidia-eparproductinformation.en.pdf</ext-link> <comment>[Accessed 10</comment> <comment>Oct</comment> <comment>2022]</comment> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_161\"> <label>161.</label> <mixed-citation>El-Sahar, AE, Shiha, NA, El Sayed, NS, Ahmed, LA. Alogliptin attenuates lipopolysaccharide-induced neuroinflammation in mice through modulation of TLR4/MYD88/NF-kappaB and miRNA-155/SOCS-1 signaling pathways. \t\t\t\t\t<italic>Int J Neuropsychopharmacol</italic> 2021;24:158\u201369. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>El-Sahar</surname> <given-names>AE</given-names> </name> <name> <surname>Shiha</surname> <given-names>NA</given-names> </name> <name> <surname>El Sayed</surname> <given-names>NS</given-names> </name> <name> <surname>Ahmed</surname> <given-names>LA</given-names> </name> </person-group> <article-title>Alogliptin attenuates lipopolysaccharide-induced neuroinflammation in mice through modulation of TLR4/MYD88/NF-kappaB and miRNA-155/SOCS-1 signaling pathways</article-title> <source>Int J Neuropsychopharmacol</source> <year>2021</year> <volume>24</volume> <fpage>158</fpage> <lpage>69</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_162\"> <label>162.</label> <mixed-citation>Salama, RM, Nasr, MM, Abdelhakeem, JI, Roshdy, OK, ElGamal, MA. Alogliptin attenuates cyclophosphamide-induced nephrotoxicity: a novel therapeutic approach through modulating MAP3K/JNK/SMAD3 signaling cascade. \t\t\t\t\t<italic>Drug Chem Toxicol</italic> 2022;45:1254\u201363. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Salama</surname> <given-names>RM</given-names> </name> <name> <surname>Nasr</surname> <given-names>MM</given-names> </name> <name> <surname>Abdelhakeem</surname> <given-names>JI</given-names> </name> <name> <surname>Roshdy</surname> <given-names>OK</given-names> </name> <name> <surname>ElGamal</surname> <given-names>MA</given-names> </name> </person-group> <article-title>Alogliptin attenuates cyclophosphamide-induced nephrotoxicity: a novel therapeutic approach through modulating MAP3K/JNK/SMAD3 signaling cascade</article-title> <source>Drug Chem Toxicol</source> <year>2022</year> <volume>45</volume> <fpage>1254</fpage> <lpage>63</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_163\"> <label>163.</label> <mixed-citation>ChemSpider; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.vildaliptin.html\">http://chemispider.com/Chemical-Structure.vildaliptin.html</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>ChemSpider</surname> </name> </person-group> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.vildaliptin.html\">http://chemispider.com/Chemical-Structure.vildaliptin.html</ext-link> <comment>[Accessed 14</comment> <comment>Oct 2022]</comment> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_164\"> <label>164.</label> <mixed-citation>Agency, E.M.: \t\t\t\t\t<italic>summary of product characteristics</italic>; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ema.europa.eu/en/documents/product-information/galvus-eparproduct-information_en.pdf\">https://www.ema.europa.eu/en/documents/product-information/galvus-eparproduct-information_en.pdf</ext-link> [Accessed 10 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"book\"> <person-group person-group-type=\"author\"> <name> <surname>Agency</surname> <given-names>E.M.</given-names> </name> </person-group> <source>summary of product characteristics</source> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"https://www.ema.europa.eu/en/documents/product-information/galvus-eparproduct-information_en.pdf\">https://www.ema.europa.eu/en/documents/product-information/galvus-eparproduct-information_en.pdf</ext-link> <comment>[Accessed 10</comment> <comment>Oct</comment> <comment>2022]</comment> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_165\"> <label>165.</label> <mixed-citation>Yang, M, Chen, X, Chen, X, Liu, H, Zhang, Z. Protective effect of vildagliptin on myocardial injury in septic rats by regulating TLR-4/NF-kappaB pathway. \t\t\t\t\t<italic>Minerva Med</italic> 2021;112:522\u20134. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yang</surname> <given-names>M</given-names> </name> <name> <surname>Chen</surname> <given-names>X</given-names> </name> <name> <surname>Chen</surname> <given-names>X</given-names> </name> <name> <surname>Liu</surname> <given-names>H</given-names> </name> <name> <surname>Zhang</surname> <given-names>Z</given-names> </name> </person-group> <article-title>Protective effect of vildagliptin on myocardial injury in septic rats by regulating TLR-4/NF-kappaB pathway</article-title> <source>Minerva Med</source> <year>2021</year> <volume>112</volume> <fpage>522</fpage> <lpage>4</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_166\"> <label>166.</label> <mixed-citation>Khalil, R, Shata, A, Abd El-Kader, EM, Sharaf, H, Abdo, WS, Amin, NA, et al.. Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38alpha, and NF-kappaB signaling. \t\t\t\t\t<italic>Toxicol Appl Pharmacol</italic> 2020;407:115246. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Khalil</surname> <given-names>R</given-names> </name> <name> <surname>Shata</surname> <given-names>A</given-names> </name> <name> <surname>Abd El-Kader</surname> <given-names>EM</given-names> </name> <name> <surname>Sharaf</surname> <given-names>H</given-names> </name> <name> <surname>Abdo</surname> <given-names>WS</given-names> </name> <name> <surname>Amin</surname> <given-names>NA</given-names> </name> <etal/> </person-group> <article-title>Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38alpha, and NF-kappaB signaling</article-title> <source>Toxicol Appl Pharmacol</source> <year>2020</year> <volume>407</volume> <elocation-id>115246</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_167\"> <label>167.</label> <mixed-citation>Liu, Y, Qi, Y. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix. \t\t\t\t\t<italic>Int Immunopharmacol</italic> 2020;87:106774. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Liu</surname> <given-names>Y</given-names> </name> <name> <surname>Qi</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix</article-title> <source>Int Immunopharmacol</source> <year>2020</year> <volume>87</volume> <elocation-id>106774</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_168\"> <label>168.</label> <mixed-citation>ChemSpider; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.saxagliptin.html\">http://chemispider.com/Chemical-Structure.saxagliptin.html</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>ChemSpider</surname> </name> </person-group> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.saxagliptin.html\">http://chemispider.com/Chemical-Structure.saxagliptin.html</ext-link> <comment>[Accessed 14</comment> <comment>Oct 2022]</comment> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_169\"> <label>169.</label> <mixed-citation>Mulvihill, EE, Drucker, DJ. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. \t\t\t\t\t<italic>Endocr Rev</italic> 2014;35:992\u20131019. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mulvihill</surname> <given-names>EE</given-names> </name> <name> <surname>Drucker</surname> <given-names>DJ</given-names> </name> </person-group> <article-title>Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors</article-title> <source>Endocr Rev</source> <year>2014</year> <volume>35</volume> <fpage>992</fpage> <lpage>1019</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_170\"> <label>170.</label> <mixed-citation>Chen, Z, Yu, J, Fu, M, Dong, R, Yang, Y, Luo, J, et al.. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway. \t\t\t\t\t<italic>Biochem Pharmacol</italic> 2020;177:113951. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chen</surname> <given-names>Z</given-names> </name> <name> <surname>Yu</surname> <given-names>J</given-names> </name> <name> <surname>Fu</surname> <given-names>M</given-names> </name> <name> <surname>Dong</surname> <given-names>R</given-names> </name> <name> <surname>Yang</surname> <given-names>Y</given-names> </name> <name> <surname>Luo</surname> <given-names>J</given-names> </name> <etal/> </person-group> <article-title>Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway</article-title> <source>Biochem Pharmacol</source> <year>2020</year> <volume>177</volume> <elocation-id>113951</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_171\"> <label>171.</label> <mixed-citation>ChemSpider; 2022. Available from: \t\t\t\t\t<ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.linagliptin.html\">http://chemispider.com/Chemical-Structure.linagliptin.html</ext-link> [Accessed 14 Oct 2022]. \t\t\t\t</mixed-citation> <element-citation publication-type=\"other\"> <person-group person-group-type=\"author\"> <name> <surname>ChemSpider</surname> </name> </person-group> <year>2022</year> <comment>Available from:</comment> <ext-link ext-link-type=\"uri\" xlink:href=\"http://chemispider.com/Chemical-Structure.linagliptin.html\">http://chemispider.com/Chemical-Structure.linagliptin.html</ext-link> <comment>[Accessed 14</comment> <comment>Oct 2022]</comment> <source>.</source> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_172\"> <label>172.</label> <mixed-citation>Graefe-Mody, U, Retlich, S, Friedrich, C. Clinical pharmacokinetics and pharmacodynamics of linagliptin. \t\t\t\t\t<italic>Clin Pharmacokinet</italic> 2012;51:411\u201327. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Graefe-Mody</surname> <given-names>U</given-names> </name> <name> <surname>Retlich</surname> <given-names>S</given-names> </name> <name> <surname>Friedrich</surname> <given-names>C</given-names> </name> </person-group> <article-title>Clinical pharmacokinetics and pharmacodynamics of linagliptin</article-title> <source>Clin Pharmacokinet</source> <year>2012</year> <volume>51</volume> <fpage>411</fpage> <lpage>27</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_173\"> <label>173.</label> <mixed-citation>Baranov, O, Kahle, M, Deacon, CF, Holst, JJ, Nauck, MA. Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2016;18:1100\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Baranov</surname> <given-names>O</given-names> </name> <name> <surname>Kahle</surname> <given-names>M</given-names> </name> <name> <surname>Deacon</surname> <given-names>CF</given-names> </name> <name> <surname>Holst</surname> <given-names>JJ</given-names> </name> <name> <surname>Nauck</surname> <given-names>MA</given-names> </name> </person-group> <article-title>Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment</article-title> <source>Diabetes Obes Metab</source> <year>2016</year> <volume>18</volume> <fpage>1100</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_174\"> <label>174.</label> <mixed-citation>Mayer, AL, Scheitacker, I, Ebert, N, Klein, T, Amann, K, Daniel, C. The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritis. \t\t\t\t\t<italic>Br J Pharmacol</italic> 2021;178:878\u201395. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mayer</surname> <given-names>AL</given-names> </name> <name> <surname>Scheitacker</surname> <given-names>I</given-names> </name> <name> <surname>Ebert</surname> <given-names>N</given-names> </name> <name> <surname>Klein</surname> <given-names>T</given-names> </name> <name> <surname>Amann</surname> <given-names>K</given-names> </name> <name> <surname>Daniel</surname> <given-names>C</given-names> </name> </person-group> <article-title>The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritis</article-title> <source>Br J Pharmacol</source> <year>2021</year> <volume>178</volume> <fpage>878</fpage> <lpage>95</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_175\"> <label>175.</label> <mixed-citation>Zhang, G, Kim, S, Gu, X, Yu, SP, Wei, L. DPP-4 inhibitor linagliptin is neuroprotective in hyperglycemic mice with stroke via the AKT/mTOR pathway and anti-apoptotic effects. \t\t\t\t\t<italic>Neurosci Bull</italic> 2020;36:407\u201318. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhang</surname> <given-names>G</given-names> </name> <name> <surname>Kim</surname> <given-names>S</given-names> </name> <name> <surname>Gu</surname> <given-names>X</given-names> </name> <name> <surname>Yu</surname> <given-names>SP</given-names> </name> <name> <surname>Wei</surname> <given-names>L</given-names> </name> </person-group> <article-title>DPP-4 inhibitor linagliptin is neuroprotective in hyperglycemic mice with stroke via the AKT/mTOR pathway and anti-apoptotic effects</article-title> <source>Neurosci Bull</source> <year>2020</year> <volume>36</volume> <fpage>407</fpage> <lpage>18</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_176\"> <label>176.</label> <mixed-citation>Aboulmagd, YM, El-Bahy, AAZ, Menze, ET, Azab, SS, El-Demerdash, E. Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats. \t\t\t\t\t<italic>Eur J Pharmacol</italic> 2020;881:173224. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Aboulmagd</surname> <given-names>YM</given-names> </name> <name> <surname>El-Bahy</surname> <given-names>AAZ</given-names> </name> <name> <surname>Menze</surname> <given-names>ET</given-names> </name> <name> <surname>Azab</surname> <given-names>SS</given-names> </name> <name> <surname>El-Demerdash</surname> <given-names>E</given-names> </name> </person-group> <article-title>Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats</article-title> <source>Eur J Pharmacol</source> <year>2020</year> <volume>881</volume> <elocation-id>173224</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_177\"> <label>177.</label> <mixed-citation>Schwehm, C, Li, J, Song, H, Hu, X, Kellam, B, Stocks, MJ. Synthesis of new DPP-4 inhibitors based on a novel tricyclic scaffold. \t\t\t\t\t<italic>ACS Med Chem Lett</italic> 2015;6:324\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Schwehm</surname> <given-names>C</given-names> </name> <name> <surname>Li</surname> <given-names>J</given-names> </name> <name> <surname>Song</surname> <given-names>H</given-names> </name> <name> <surname>Hu</surname> <given-names>X</given-names> </name> <name> <surname>Kellam</surname> <given-names>B</given-names> </name> <name> <surname>Stocks</surname> <given-names>MJ</given-names> </name> </person-group> <article-title>Synthesis of new DPP-4 inhibitors based on a novel tricyclic scaffold</article-title> <source>ACS Med Chem Lett</source> <year>2015</year> <volume>6</volume> <fpage>324</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_178\"> <label>178.</label> <mixed-citation>Berger, JP, SinhaRoy, R, Pocai, A, Kelly, TM, Scapin, G, Gao, YD, et al.. A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice. \t\t\t\t\t<italic>Endocrinol Diabetes Metab</italic> 2018;1:e00002. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Berger</surname> <given-names>JP</given-names> </name> <name> <surname>SinhaRoy</surname> <given-names>R</given-names> </name> <name> <surname>Pocai</surname> <given-names>A</given-names> </name> <name> <surname>Kelly</surname> <given-names>TM</given-names> </name> <name> <surname>Scapin</surname> <given-names>G</given-names> </name> <name> <surname>Gao</surname> <given-names>YD</given-names> </name> <etal/> </person-group> <article-title>A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice</article-title> <source>Endocrinol Diabetes Metab</source> <year>2018</year> <volume>1</volume> <elocation-id>e00002</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_179\"> <label>179.</label> <mixed-citation>Stano, J, Kovacs, P, Kakoniova, D, Kirilova, ND, Komov, VP. Activity of dipeptidyl peptidase IV in gingseng callus culture. \t\t\t\t\t<italic>Biologia</italic> 1994;49:353\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Stano</surname> <given-names>J</given-names> </name> <name> <surname>Kovacs</surname> <given-names>P</given-names> </name> <name> <surname>Kakoniova</surname> <given-names>D</given-names> </name> <name> <surname>Kirilova</surname> <given-names>ND</given-names> </name> <name> <surname>Komov</surname> <given-names>VP</given-names> </name> </person-group> <article-title>Activity of dipeptidyl peptidase IV in gingseng callus culture</article-title> <source>Biologia</source> <year>1994</year> <volume>49</volume> <fpage>353</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_180\"> <label>180.</label> <mixed-citation>P\u00e9rez-Macedonio, CP, Flores-Alfaro, E, Alarc\u00f3n-Romero, LC, Vences-Vel\u00e1zquez, A, Castro-Alarc\u00f3n, N, Mart\u00ednezMart\u00ednez, E, et al.. CD14 and CD26 from serum exosomes are associated with type 2 diabetes, exosomal Cystatin C and CD14 are associated with metabolic syndrome and atherogenic index of plasma. \t\t\t\t\t<italic>PeerJ</italic> 2022;10:e13656. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>P\u00e9rez-Macedonio</surname> <given-names>CP</given-names> </name> <name> <surname>Flores-Alfaro</surname> <given-names>E</given-names> </name> <name> <surname>Alarc\u00f3n-Romero</surname> <given-names>LC</given-names> </name> <name> <surname>Vences-Vel\u00e1zquez</surname> <given-names>A</given-names> </name> <name> <surname>Castro-Alarc\u00f3n</surname> <given-names>N</given-names> </name> <name> <surname>Mart\u00ednezMart\u00ednez</surname> <given-names>E</given-names> </name> <etal/> </person-group> <article-title>CD14 and CD26 from serum exosomes are associated with type 2 diabetes, exosomal Cystatin C and CD14 are associated with metabolic syndrome and atherogenic index of plasma</article-title> <source>PeerJ</source> <year>2022</year> <volume>10</volume> <elocation-id>e13656</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_181\"> <label>181.</label> <mixed-citation>Bo, L, Yan, R, Quian, Z, Shi, H, Yun, D, Jing, W, et al.. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice. \t\t\t\t\t<italic>Vasc Pharmacol</italic> 2021;140:106854. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bo</surname> <given-names>L</given-names> </name> <name> <surname>Yan</surname> <given-names>R</given-names> </name> <name> <surname>Quian</surname> <given-names>Z</given-names> </name> <name> <surname>Shi</surname> <given-names>H</given-names> </name> <name> <surname>Yun</surname> <given-names>D</given-names> </name> <name> <surname>Jing</surname> <given-names>W</given-names> </name> <etal/> </person-group> <article-title>Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice</article-title> <source>Vasc Pharmacol</source> <year>2021</year> <volume>140</volume> <elocation-id>106854</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_182\"> <label>182.</label> <mixed-citation>Conarello, S, Li, Z, Ronan, J. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 2003;100:6825\u201330. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Conarello</surname> <given-names>S</given-names> </name> <name> <surname>Li</surname> <given-names>Z</given-names> </name> <name> <surname>Ronan</surname> <given-names>J</given-names> </name> </person-group> <article-title>Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance</article-title> <source>Proc Natl Acad Sci USA</source> <year>2003</year> <volume>100</volume> <fpage>6825</fpage> <lpage>30</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_183\"> <label>183.</label> <mixed-citation>Tremblay, AJ, Lamarche, B, Deacon, CF, Weisnagel, SJ, Couture, P. Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2011;13:366\u201373. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Tremblay</surname> <given-names>AJ</given-names> </name> <name> <surname>Lamarche</surname> <given-names>B</given-names> </name> <name> <surname>Deacon</surname> <given-names>CF</given-names> </name> <name> <surname>Weisnagel</surname> <given-names>SJ</given-names> </name> <name> <surname>Couture</surname> <given-names>P</given-names> </name> </person-group> <article-title>Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes</article-title> <source>Diabetes Obes Metab</source> <year>2011</year> <volume>13</volume> <fpage>366</fpage> <lpage>73</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_184\"> <label>184.</label> <mixed-citation>Rohmann, N, Schlicht, K, Geisler, C, Hollstein, T, Knappe, C, Krause, L. Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation. \t\t\t\t\t<italic>J Clin Endocrinol Metab</italic> 2021;106:e592\u2013e601. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rohmann</surname> <given-names>N</given-names> </name> <name> <surname>Schlicht</surname> <given-names>K</given-names> </name> <name> <surname>Geisler</surname> <given-names>C</given-names> </name> <name> <surname>Hollstein</surname> <given-names>T</given-names> </name> <name> <surname>Knappe</surname> <given-names>C</given-names> </name> <name> <surname>Krause</surname> <given-names>L</given-names> </name> </person-group> <article-title>Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation</article-title> <source>J Clin Endocrinol Metab</source> <year>2021</year> <volume>106</volume> <fpage>e592</fpage> <lpage>e601</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_185\"> <label>185.</label> <mixed-citation>Barchetta, I, Ceccarelli, V, Cimini, FA, Barone, E, Sentinelli, F, Coluzzi, M. Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease. \t\t\t\t\t<italic>J Endocrinol Invest</italic> 2021;44:979\u201388. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Barchetta</surname> <given-names>I</given-names> </name> <name> <surname>Ceccarelli</surname> <given-names>V</given-names> </name> <name> <surname>Cimini</surname> <given-names>FA</given-names> </name> <name> <surname>Barone</surname> <given-names>E</given-names> </name> <name> <surname>Sentinelli</surname> <given-names>F</given-names> </name> <name> <surname>Coluzzi</surname> <given-names>M</given-names> </name> </person-group> <article-title>Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease</article-title> <source>J Endocrinol Invest</source> <year>2021</year> <volume>44</volume> <fpage>979</fpage> <lpage>88</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_186\"> <label>186.</label> <mixed-citation>Christopherson, KW, Cooper, S, Broxmeyer, HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. \t\t\t\t\t<italic>Blood</italic> 2003;101:4680\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Christopherson</surname> <given-names>KW</given-names> </name> <name> <surname>Cooper</surname> <given-names>S</given-names> </name> <name> <surname>Broxmeyer</surname> <given-names>HE</given-names> </name> </person-group> <article-title>Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells</article-title> <source>Blood</source> <year>2003</year> <volume>101</volume> <fpage>4680</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_187\"> <label>187.</label> <mixed-citation>Chistopherson, KW, Cooper, S, Hangoc, G, Broxmeyer, HE. CD26 isessential for normal G-CSF-induced progenitor cell mobilization as determined by CD26\u2212/\u2212 mice. \t\t\t\t\t<italic>Exp Hematol</italic> 2003;31:1126\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chistopherson</surname> <given-names>KW</given-names> </name> <name> <surname>Cooper</surname> <given-names>S</given-names> </name> <name> <surname>Hangoc</surname> <given-names>G</given-names> </name> <name> <surname>Broxmeyer</surname> <given-names>HE</given-names> </name> </person-group> <article-title>CD26 isessential for normal G-CSF-induced progenitor cell mobilization as determined by CD26\u2212/\u2212 mice</article-title> <source>Exp Hematol</source> <year>2003</year> <volume>31</volume> <fpage>1126</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_188\"> <label>188.</label> <mixed-citation>Morimoto, C, Torimoto, Y, Levinson, G, Rudd, CE, Schrieber, M, Dang, NH, et al.. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. \t\t\t\t\t<italic>J Immunol</italic> 1989;143:3430\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> <name> <surname>Torimoto</surname> <given-names>Y</given-names> </name> <name> <surname>Levinson</surname> <given-names>G</given-names> </name> <name> <surname>Rudd</surname> <given-names>CE</given-names> </name> <name> <surname>Schrieber</surname> <given-names>M</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <etal/> </person-group> <article-title>1F7, a novel cell surface molecule, involved in helper function of CD4 cells</article-title> <source>J Immunol</source> <year>1989</year> <volume>143</volume> <fpage>3430</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_189\"> <label>189.</label> <mixed-citation>Waumans, Y, Baerts, L, Kehoe, K, Lambeir, AM, De Meester, I. The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis. \t\t\t\t\t<italic>Front Immunol</italic> 2015;6:387. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Waumans</surname> <given-names>Y</given-names> </name> <name> <surname>Baerts</surname> <given-names>L</given-names> </name> <name> <surname>Kehoe</surname> <given-names>K</given-names> </name> <name> <surname>Lambeir</surname> <given-names>AM</given-names> </name> <name> <surname>De Meester</surname> <given-names>I</given-names> </name> </person-group> <article-title>The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis</article-title> <source>Front Immunol</source> <year>2015</year> <volume>6</volume> <fpage>387</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_190\"> <label>190.</label> <mixed-citation>Bengsch, B, Seigel, B, Flecken, T, Wolanski, J, Blum, HE, Thimme, R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). \t\t\t\t\t<italic>J Immunol</italic> 2012;188:5438\u201347. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bengsch</surname> <given-names>B</given-names> </name> <name> <surname>Seigel</surname> <given-names>B</given-names> </name> <name> <surname>Flecken</surname> <given-names>T</given-names> </name> <name> <surname>Wolanski</surname> <given-names>J</given-names> </name> <name> <surname>Blum</surname> <given-names>HE</given-names> </name> <name> <surname>Thimme</surname> <given-names>R</given-names> </name> </person-group> <article-title>Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)</article-title> <source>J Immunol</source> <year>2012</year> <volume>188</volume> <fpage>5438</fpage> <lpage>47</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_191\"> <label>191.</label> <mixed-citation>Dang, NH, Hafler, DA, Schlossman, SF, Breitmeyer, JB. FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation. \t\t\t\t\t<italic>Cell Immunol</italic> 1990;125:42\u201357. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Hafler</surname> <given-names>DA</given-names> </name> <name> <surname>Schlossman</surname> <given-names>SF</given-names> </name> <name> <surname>Breitmeyer</surname> <given-names>JB</given-names> </name> </person-group> <article-title>FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation</article-title> <source>Cell Immunol</source> <year>1990</year> <volume>125</volume> <fpage>42</fpage> <lpage>57</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_192\"> <label>192.</label> <mixed-citation>Dang, NH, Torimoto, Y, Deusch, K, Schlossman, SF, Morimoto, C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. \t\t\t\t\t<italic>J Immunol</italic> 1990;144:4092\u2013100. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Torimoto</surname> <given-names>Y</given-names> </name> <name> <surname>Deusch</surname> <given-names>K</given-names> </name> <name> <surname>Schlossman</surname> <given-names>SF</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways</article-title> <source>J Immunol</source> <year>1990</year> <volume>144</volume> <fpage>4092</fpage> <lpage>100</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_193\"> <label>193.</label> <mixed-citation>Dang, NH, Torimoto, Y, Sugita, K, Daley, JF, Schow, P, Prado, C, et al.. Cell surface modulation of CD26 by anti-1F7 monclonal antibody: analysis of surface expression and human T cell activation. \t\t\t\t\t<italic>J Immunol</italic> 1990;145:3963\u201371. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Torimoto</surname> <given-names>Y</given-names> </name> <name> <surname>Sugita</surname> <given-names>K</given-names> </name> <name> <surname>Daley</surname> <given-names>JF</given-names> </name> <name> <surname>Schow</surname> <given-names>P</given-names> </name> <name> <surname>Prado</surname> <given-names>C</given-names> </name> <etal/> </person-group> <article-title>Cell surface modulation of CD26 by anti-1F7 monclonal antibody: analysis of surface expression and human T cell activation</article-title> <source>J Immunol</source> <year>1990</year> <volume>145</volume> <fpage>3963</fpage> <lpage>71</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_194\"> <label>194.</label> <mixed-citation>Torimoto, Y, Dang, NH, Tanaka, T, Prado, C, Schlossman, SF, Morimoto, C. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. \t\t\t\t\t<italic>Mol Immunol</italic> 1992;29:183\u201392. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Torimoto</surname> <given-names>Y</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Tanaka</surname> <given-names>T</given-names> </name> <name> <surname>Prado</surname> <given-names>C</given-names> </name> <name> <surname>Schlossman</surname> <given-names>SF</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies</article-title> <source>Mol Immunol</source> <year>1992</year> <volume>29</volume> <fpage>183</fpage> <lpage>92</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_195\"> <label>195.</label> <mixed-citation>Torimoto, Y, Dang, NH, Vivier, E, Tanaka, T, Schlossman, SF, Morimoto, C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. \t\t\t\t\t<italic>J Immunol</italic> 1991;147:2514\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Torimoto</surname> <given-names>Y</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Vivier</surname> <given-names>E</given-names> </name> <name> <surname>Tanaka</surname> <given-names>T</given-names> </name> <name> <surname>Schlossman</surname> <given-names>SF</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes</article-title> <source>J Immunol</source> <year>1991</year> <volume>147</volume> <fpage>2514</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_196\"> <label>196.</label> <mixed-citation>Ishii, T, Ohnuma, K, Marakami, A, Takasawa, N, Kobayashi, S, Dang, NH, et al.. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 2001;98:12138\u201343. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ishii</surname> <given-names>T</given-names> </name> <name> <surname>Ohnuma</surname> <given-names>K</given-names> </name> <name> <surname>Marakami</surname> <given-names>A</given-names> </name> <name> <surname>Takasawa</surname> <given-names>N</given-names> </name> <name> <surname>Kobayashi</surname> <given-names>S</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <etal/> </person-group> <article-title>CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO</article-title> <source>Proc Natl Acad Sci USA</source> <year>2001</year> <volume>98</volume> <fpage>12138</fpage> <lpage>43</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_197\"> <label>197.</label> <mixed-citation>Kobayashi, S, Ohnuma, K, Uchiyama, M, Iino, K, Iwata, S, Dang, NH, et al.. Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. \t\t\t\t\t<italic>Blood</italic> 2004;103:1002\u201310. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kobayashi</surname> <given-names>S</given-names> </name> <name> <surname>Ohnuma</surname> <given-names>K</given-names> </name> <name> <surname>Uchiyama</surname> <given-names>M</given-names> </name> <name> <surname>Iino</surname> <given-names>K</given-names> </name> <name> <surname>Iwata</surname> <given-names>S</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <etal/> </person-group> <article-title>Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation</article-title> <source>Blood</source> <year>2004</year> <volume>103</volume> <fpage>1002</fpage> <lpage>10</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_198\"> <label>198.</label> <mixed-citation>Hatano, R, Ohnuma, K, Yamamoto, J, Dang, NH, Morimoto, C. CD26-mediated Co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production. \t\t\t\t\t<italic>Immunology</italic> 2013;138:165\u201372. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hatano</surname> <given-names>R</given-names> </name> <name> <surname>Ohnuma</surname> <given-names>K</given-names> </name> <name> <surname>Yamamoto</surname> <given-names>J</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>CD26-mediated Co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production</article-title> <source>Immunology</source> <year>2013</year> <volume>138</volume> <fpage>165</fpage> <lpage>72</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_199\"> <label>199.</label> <mixed-citation>Green, H, Chan, T. Pyrimidine starvation induced by adenosine infibroblasts and lymphoid cells: role of adenosine deaminase. \t\t\t\t\t<italic>Science</italic> 1973;182:836\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Green</surname> <given-names>H</given-names> </name> <name> <surname>Chan</surname> <given-names>T</given-names> </name> </person-group> <article-title>Pyrimidine starvation induced by adenosine infibroblasts and lymphoid cells: role of adenosine deaminase</article-title> <source>Science</source> <year>1973</year> <volume>182</volume> <fpage>836</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_200\"> <label>200.</label> <mixed-citation>Brezinschek, RI, Lipsky, PE, Galea, P, Vita, R, Oppenheimer-Marks, N. Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. \t\t\t\t\t<italic>J Immunol</italic> 1995;154:3062\u201377. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Brezinschek</surname> <given-names>RI</given-names> </name> <name> <surname>Lipsky</surname> <given-names>PE</given-names> </name> <name> <surname>Galea</surname> <given-names>P</given-names> </name> <name> <surname>Vita</surname> <given-names>R</given-names> </name> <name> <surname>Oppenheimer-Marks</surname> <given-names>N</given-names> </name> </person-group> <article-title>Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity</article-title> <source>J Immunol</source> <year>1995</year> <volume>154</volume> <fpage>3062</fpage> <lpage>77</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_201\"> <label>201.</label> <mixed-citation>Willheim, M, Ebner, C, Baier, K, Kern, W, Schrattbauer, K, Thien, R. Cell surface characterization of T lymphocytes and allergen-specific t cell clones: correlation of CD26 expression with T(H1) subsets. \t\t\t\t\t<italic>J Allergy Clin Immunol</italic> 1997;100:348\u201355. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Willheim</surname> <given-names>M</given-names> </name> <name> <surname>Ebner</surname> <given-names>C</given-names> </name> <name> <surname>Baier</surname> <given-names>K</given-names> </name> <name> <surname>Kern</surname> <given-names>W</given-names> </name> <name> <surname>Schrattbauer</surname> <given-names>K</given-names> </name> <name> <surname>Thien</surname> <given-names>R</given-names> </name> </person-group> <article-title>Cell surface characterization of T lymphocytes and allergen-specific t cell clones: correlation of CD26 expression with T(H1) subsets</article-title> <source>J Allergy Clin Immunol</source> <year>1997</year> <volume>100</volume> <fpage>348</fpage> <lpage>55</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_202\"> <label>202.</label> <mixed-citation>Pacheco, R, Martinez-Navio, JM, Lejeune, M, Climent, N, Oliva, H, Gatell, JM, et al.. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. \t\t\t\t\t<italic>Proc Natl Acad Sci USA</italic> 2005;102:9583\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pacheco</surname> <given-names>R</given-names> </name> <name> <surname>Martinez-Navio</surname> <given-names>JM</given-names> </name> <name> <surname>Lejeune</surname> <given-names>M</given-names> </name> <name> <surname>Climent</surname> <given-names>N</given-names> </name> <name> <surname>Oliva</surname> <given-names>H</given-names> </name> <name> <surname>Gatell</surname> <given-names>JM</given-names> </name> <etal/> </person-group> <article-title>CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse</article-title> <source>Proc Natl Acad Sci USA</source> <year>2005</year> <volume>102</volume> <fpage>9583</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_203\"> <label>203.</label> <mixed-citation>Bengsch, B, Seigel, B, Flecken, T, Wolanski, J, Blum, HE, Thimme, R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). \t\t\t\t\t<italic>J Immunol</italic> 2012;188:5438\u201347. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bengsch</surname> <given-names>B</given-names> </name> <name> <surname>Seigel</surname> <given-names>B</given-names> </name> <name> <surname>Flecken</surname> <given-names>T</given-names> </name> <name> <surname>Wolanski</surname> <given-names>J</given-names> </name> <name> <surname>Blum</surname> <given-names>HE</given-names> </name> <name> <surname>Thimme</surname> <given-names>R</given-names> </name> </person-group> <article-title>Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)</article-title> <source>J Immunol</source> <year>2012</year> <volume>188</volume> <fpage>5438</fpage> <lpage>47</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_204\"> <label>204.</label> <mixed-citation>Yamada, Y, Jang, JH, De Meester, I, Baerts, L, Vliegen, G, Inci, I, et al.. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression. \t\t\t\t\t<italic>J Heart Lung Transplant</italic> 2016;35:508\u201317. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yamada</surname> <given-names>Y</given-names> </name> <name> <surname>Jang</surname> <given-names>JH</given-names> </name> <name> <surname>De Meester</surname> <given-names>I</given-names> </name> <name> <surname>Baerts</surname> <given-names>L</given-names> </name> <name> <surname>Vliegen</surname> <given-names>G</given-names> </name> <name> <surname>Inci</surname> <given-names>I</given-names> </name> <etal/> </person-group> <article-title>CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression</article-title> <source>J Heart Lung Transplant</source> <year>2016</year> <volume>35</volume> <fpage>508</fpage> <lpage>17</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_205\"> <label>205.</label> <mixed-citation>Pinheiro, MM, Stoppa, CL, Valduga, CJ, Okuyama, CE, Gorjao, R, Pereira, RM, et al.. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro. \t\t\t\t\t<italic>Eur J Pharmaceut Sci</italic> 2017;100:17\u201324. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pinheiro</surname> <given-names>MM</given-names> </name> <name> <surname>Stoppa</surname> <given-names>CL</given-names> </name> <name> <surname>Valduga</surname> <given-names>CJ</given-names> </name> <name> <surname>Okuyama</surname> <given-names>CE</given-names> </name> <name> <surname>Gorjao</surname> <given-names>R</given-names> </name> <name> <surname>Pereira</surname> <given-names>RM</given-names> </name> <etal/> </person-group> <article-title>Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro</article-title> <source>Eur J Pharmaceut Sci</source> <year>2017</year> <volume>100</volume> <fpage>17</fpage> <lpage>24</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_206\"> <label>206.</label> <mixed-citation>Ghorpade, DS, Ozcan, L, Zheng, Z, Nicoloro, SM, Shen, Y, Chen, E, et al.. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. \t\t\t\t\t<italic>Nature</italic> 2018;555:673\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ghorpade</surname> <given-names>DS</given-names> </name> <name> <surname>Ozcan</surname> <given-names>L</given-names> </name> <name> <surname>Zheng</surname> <given-names>Z</given-names> </name> <name> <surname>Nicoloro</surname> <given-names>SM</given-names> </name> <name> <surname>Shen</surname> <given-names>Y</given-names> </name> <name> <surname>Chen</surname> <given-names>E</given-names> </name> <etal/> </person-group> <article-title>Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance</article-title> <source>Nature</source> <year>2018</year> <volume>555</volume> <fpage>673</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_207\"> <label>207.</label> <mixed-citation>Nieto-Fontarigo, JJ, Gonz\u00e1lez-Barcala, FJ, San Jos\u00e9, E, Arias, P, Nogueira, M, Salgado, FJ. CD26 and asthma: a comprehensive review. \t\t\t\t\t<italic>Clin Rev Allergy Immunol</italic> 2019;56:139\u201360. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nieto-Fontarigo</surname> <given-names>JJ</given-names> </name> <name> <surname>Gonz\u00e1lez-Barcala</surname> <given-names>FJ</given-names> </name> <name> <surname>San Jos\u00e9</surname> <given-names>E</given-names> </name> <name> <surname>Arias</surname> <given-names>P</given-names> </name> <name> <surname>Nogueira</surname> <given-names>M</given-names> </name> <name> <surname>Salgado</surname> <given-names>FJ</given-names> </name> </person-group> <article-title>CD26 and asthma: a comprehensive review</article-title> <source>Clin Rev Allergy Immunol</source> <year>2019</year> <volume>56</volume> <fpage>139</fpage> <lpage>60</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_208\"> <label>208.</label> <mixed-citation>Christopherson, KW, Hangoc, G, Mantel, CR, Broxmeyer, HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. \t\t\t\t\t<italic>Science</italic> 2004;305:1000\u20133. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Christopherson</surname> <given-names>KW</given-names> </name> <name> <surname>Hangoc</surname> <given-names>G</given-names> </name> <name> <surname>Mantel</surname> <given-names>CR</given-names> </name> <name> <surname>Broxmeyer</surname> <given-names>HE</given-names> </name> </person-group> <article-title>Modulation of hematopoietic stem cell homing and engraftment by CD26</article-title> <source>Science</source> <year>2004</year> <volume>305</volume> <fpage>1000</fpage> <lpage>3</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_209\"> <label>209.</label> <mixed-citation>Lee, DS, Lee, ES, Alam, MM, Jang, JH, Lee, HS, Oh, H. Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate. \t\t\t\t\t<italic>Metabolism</italic> 2016;65:89\u2013101. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lee</surname> <given-names>DS</given-names> </name> <name> <surname>Lee</surname> <given-names>ES</given-names> </name> <name> <surname>Alam</surname> <given-names>MM</given-names> </name> <name> <surname>Jang</surname> <given-names>JH</given-names> </name> <name> <surname>Lee</surname> <given-names>HS</given-names> </name> <name> <surname>Oh</surname> <given-names>H</given-names> </name> </person-group> <article-title>Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate</article-title> <source>Metabolism</source> <year>2016</year> <volume>65</volume> <fpage>89</fpage> <lpage>101</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_210\"> <label>210.</label> <mixed-citation>Wronkowitz, N, G\u00f6rgens, SW, Romacho, T, Villalobos, LA, S\u00e1nchez-Ferrer, CF, Peir\u00f3, C. Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2. \t\t\t\t\t<italic>Biochim Biophys Acta</italic> 2014;1842:1613\u201321. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wronkowitz</surname> <given-names>N</given-names> </name> <name> <surname>G\u00f6rgens</surname> <given-names>SW</given-names> </name> <name> <surname>Romacho</surname> <given-names>T</given-names> </name> <name> <surname>Villalobos</surname> <given-names>LA</given-names> </name> <name> <surname>S\u00e1nchez-Ferrer</surname> <given-names>CF</given-names> </name> <name> <surname>Peir\u00f3</surname> <given-names>C</given-names> </name> </person-group> <article-title>Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2</article-title> <source>Biochim Biophys Acta</source> <year>2014</year> <volume>1842</volume> <fpage>1613</fpage> <lpage>21</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_211\"> <label>211.</label> <mixed-citation>Kawasaki, T, Chen, W, Htwe, YM, Tatsumi, K, Dudek, SM. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice. \t\t\t\t\t<italic>Am J Physiol Lung Cell Mol Physiol</italic> 2018;315:L834\u2013l845. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kawasaki</surname> <given-names>T</given-names> </name> <name> <surname>Chen</surname> <given-names>W</given-names> </name> <name> <surname>Htwe</surname> <given-names>YM</given-names> </name> <name> <surname>Tatsumi</surname> <given-names>K</given-names> </name> <name> <surname>Dudek</surname> <given-names>SM</given-names> </name> </person-group> <article-title>DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice</article-title> <source>Am J Physiol Lung Cell Mol Physiol</source> <year>2018</year> <volume>315</volume> <fpage>L834</fpage> <lpage>l845</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_212\"> <label>212.</label> <mixed-citation>Zhao, X, Zhang, K, Daniel, P, Wisbrun, N, Fuchs, H, Fan, H. Delayed allogeneic skin graft rejection in CD26-deficient mice. \t\t\t\t\t<italic>Cell Mol Immunol</italic> 2019;16:557\u201367. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhao</surname> <given-names>X</given-names> </name> <name> <surname>Zhang</surname> <given-names>K</given-names> </name> <name> <surname>Daniel</surname> <given-names>P</given-names> </name> <name> <surname>Wisbrun</surname> <given-names>N</given-names> </name> <name> <surname>Fuchs</surname> <given-names>H</given-names> </name> <name> <surname>Fan</surname> <given-names>H</given-names> </name> </person-group> <article-title>Delayed allogeneic skin graft rejection in CD26-deficient mice</article-title> <source>Cell Mol Immunol</source> <year>2019</year> <volume>16</volume> <fpage>557</fpage> <lpage>67</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_213\"> <label>213.</label> <mixed-citation>Bauvois, B, Dauzonne, D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. \t\t\t\t\t<italic>Med Res Rev</italic> 2006;26:88\u2013130. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bauvois</surname> <given-names>B</given-names> </name> <name> <surname>Dauzonne</surname> <given-names>D</given-names> </name> </person-group> <article-title>Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects</article-title> <source>Med Res Rev</source> <year>2006</year> <volume>26</volume> <fpage>88</fpage> <lpage>130</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_214\"> <label>214.</label> <mixed-citation>Wang, Q, Wong, G, Lu, G. MERS-CoV spike protein: targets for vaccines and therapeutics. \t\t\t\t\t<italic>Antiviral Res</italic> 2016;133:165\u201377. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wang</surname> <given-names>Q</given-names> </name> <name> <surname>Wong</surname> <given-names>G</given-names> </name> <name> <surname>Lu</surname> <given-names>G</given-names> </name> </person-group> <article-title>MERS-CoV spike protein: targets for vaccines and therapeutics</article-title> <source>Antiviral Res</source> <year>2016</year> <volume>133</volume> <fpage>165</fpage> <lpage>77</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_215\"> <label>215.</label> <mixed-citation>Mucha, A, Drag, M, Dalton, JP, Kafarski, P. Metallo-aminopeptidase inhibitors. \t\t\t\t\t<italic>Biochimie</italic> 2010;92:1509\u201329. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mucha</surname> <given-names>A</given-names> </name> <name> <surname>Drag</surname> <given-names>M</given-names> </name> <name> <surname>Dalton</surname> <given-names>JP</given-names> </name> <name> <surname>Kafarski</surname> <given-names>P</given-names> </name> </person-group> <article-title>Metallo-aminopeptidase inhibitors</article-title> <source>Biochimie</source> <year>2010</year> <volume>92</volume> <fpage>1509</fpage> <lpage>29</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_216\"> <label>216.</label> <mixed-citation>Raj, VS, Mou, H, Smits, SL, Dekkers, DH, M\u00fcller, MA, Dijkman, R. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. \t\t\t\t\t<italic>Nature</italic> 2013;495:251\u20134. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Raj</surname> <given-names>VS</given-names> </name> <name> <surname>Mou</surname> <given-names>H</given-names> </name> <name> <surname>Smits</surname> <given-names>SL</given-names> </name> <name> <surname>Dekkers</surname> <given-names>DH</given-names> </name> <name> <surname>M\u00fcller</surname> <given-names>MA</given-names> </name> <name> <surname>Dijkman</surname> <given-names>R</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</article-title> <source>Nature</source> <year>2013</year> <volume>495</volume> <fpage>251</fpage> <lpage>4</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_217\"> <label>217.</label> <mixed-citation>Ohnuma, K, Haagmans, BL, Hatano, R, Raj, VS, Mou, H, Iwata, S. Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody. \t\t\t\t\t<italic>J Virol</italic> 2013;87:13892\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ohnuma</surname> <given-names>K</given-names> </name> <name> <surname>Haagmans</surname> <given-names>BL</given-names> </name> <name> <surname>Hatano</surname> <given-names>R</given-names> </name> <name> <surname>Raj</surname> <given-names>VS</given-names> </name> <name> <surname>Mou</surname> <given-names>H</given-names> </name> <name> <surname>Iwata</surname> <given-names>S</given-names> </name> </person-group> <article-title>Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody</article-title> <source>J Virol</source> <year>2013</year> <volume>87</volume> <fpage>13892</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_218\"> <label>218.</label> <mixed-citation>Inn, KS, Kim, Y, Aigerim, A, Park, U, Hwang, ES, Choi, MS. Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus. \t\t\t\t\t<italic>Virology</italic> 2018;518:324\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Inn</surname> <given-names>KS</given-names> </name> <name> <surname>Kim</surname> <given-names>Y</given-names> </name> <name> <surname>Aigerim</surname> <given-names>A</given-names> </name> <name> <surname>Park</surname> <given-names>U</given-names> </name> <name> <surname>Hwang</surname> <given-names>ES</given-names> </name> <name> <surname>Choi</surname> <given-names>MS</given-names> </name> </person-group> <article-title>Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus</article-title> <source>Virology</source> <year>2018</year> <volume>518</volume> <fpage>324</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_219\"> <label>219.</label> <mixed-citation>Algaissi, A, Agrawal, AS, Han, S, Peng, BH, Luo, C, Li, F. Elevated human dipeptidyl-peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to Middle East respiratory syndrome coronavirus infection and disease. \t\t\t\t\t<italic>J Infect Dis</italic> 2019;219:829\u201335. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Algaissi</surname> <given-names>A</given-names> </name> <name> <surname>Agrawal</surname> <given-names>AS</given-names> </name> <name> <surname>Han</surname> <given-names>S</given-names> </name> <name> <surname>Peng</surname> <given-names>BH</given-names> </name> <name> <surname>Luo</surname> <given-names>C</given-names> </name> <name> <surname>Li</surname> <given-names>F</given-names> </name> </person-group> <article-title>Elevated human dipeptidyl-peptidase 4 expression reduces the susceptibility of hDPP4 transgenic mice to Middle East respiratory syndrome coronavirus infection and disease</article-title> <source>J Infect Dis</source> <year>2019</year> <volume>219</volume> <fpage>829</fpage> <lpage>35</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_220\"> <label>220.</label> <mixed-citation>Vankadari, N, Wilce, JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. \t\t\t\t\t<italic>Emerg Microbes Infect</italic> 2020;9:601\u20134. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Vankadari</surname> <given-names>N</given-names> </name> <name> <surname>Wilce</surname> <given-names>JA</given-names> </name> </person-group> <article-title>Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</article-title> <source>Emerg Microbes Infect</source> <year>2020</year> <volume>9</volume> <fpage>601</fpage> <lpage>4</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_221\"> <label>221.</label> <mixed-citation>Tai, W, He, L, Zhang, X, Pu, J, Voronin, D, Jiang, S. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral Attachment inhibitor and vaccine. \t\t\t\t\t<italic>Cell Mol Immunol</italic> 2020;17:613\u201320. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Tai</surname> <given-names>W</given-names> </name> <name> <surname>He</surname> <given-names>L</given-names> </name> <name> <surname>Zhang</surname> <given-names>X</given-names> </name> <name> <surname>Pu</surname> <given-names>J</given-names> </name> <name> <surname>Voronin</surname> <given-names>D</given-names> </name> <name> <surname>Jiang</surname> <given-names>S</given-names> </name> </person-group> <article-title>Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral Attachment inhibitor and vaccine</article-title> <source>Cell Mol Immunol</source> <year>2020</year> <volume>17</volume> <fpage>613</fpage> <lpage>20</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_222\"> <label>222.</label> <mixed-citation>Zhou, F, Yu, T, Du, R, Fan, G, Liu, Y, Liu, Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. \t\t\t\t\t<italic>Lancet</italic> 2020;395:1054\u201362. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhou</surname> <given-names>F</given-names> </name> <name> <surname>Yu</surname> <given-names>T</given-names> </name> <name> <surname>Du</surname> <given-names>R</given-names> </name> <name> <surname>Fan</surname> <given-names>G</given-names> </name> <name> <surname>Liu</surname> <given-names>Y</given-names> </name> <name> <surname>Liu</surname> <given-names>Z</given-names> </name> </person-group> <article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title> <source>Lancet</source> <year>2020</year> <volume>395</volume> <fpage>1054</fpage> <lpage>62</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_223\"> <label>223.</label> <mixed-citation>Solerte, SB, D\u2019addio, F, Trevisan, R, Lovati, E, Rossi, A, Pastore, I. Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study. \t\t\t\t\t<italic>Diabetes Care</italic> 2020;43:2999\u20133006. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Solerte</surname> <given-names>SB</given-names> </name> <name> <surname>D\u2019addio</surname> <given-names>F</given-names> </name> <name> <surname>Trevisan</surname> <given-names>R</given-names> </name> <name> <surname>Lovati</surname> <given-names>E</given-names> </name> <name> <surname>Rossi</surname> <given-names>A</given-names> </name> <name> <surname>Pastore</surname> <given-names>I</given-names> </name> </person-group> <article-title>Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study</article-title> <source>Diabetes Care</source> <year>2020</year> <volume>43</volume> <fpage>2999</fpage> <lpage>3006</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_224\"> <label>224.</label> <mixed-citation>Solerte, SB, Di Sabatino, A, Galli, M, Fiorina, P. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. \t\t\t\t\t<italic>Acta Diabeto</italic> 2020;57:779\u201383. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Solerte</surname> <given-names>SB</given-names> </name> <name> <surname>Di Sabatino</surname> <given-names>A</given-names> </name> <name> <surname>Galli</surname> <given-names>M</given-names> </name> <name> <surname>Fiorina</surname> <given-names>P</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19</article-title> <source>Acta Diabeto</source> <year>2020</year> <volume>57</volume> <fpage>779</fpage> <lpage>83</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_225\"> <label>225.</label> <mixed-citation>Pal, R, Banerjee, M, Mukherjee, S, Bhogal, RS, Kaur, A, Bhadada, SK. Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and MetaAnalysis. \t\t\t\t\t<italic>Ther Adv Endocrinol Metab</italic> 2021;12:2042018821996482. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pal</surname> <given-names>R</given-names> </name> <name> <surname>Banerjee</surname> <given-names>M</given-names> </name> <name> <surname>Mukherjee</surname> <given-names>S</given-names> </name> <name> <surname>Bhogal</surname> <given-names>RS</given-names> </name> <name> <surname>Kaur</surname> <given-names>A</given-names> </name> <name> <surname>Bhadada</surname> <given-names>SK</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and MetaAnalysis</article-title> <source>Ther Adv Endocrinol Metab</source> <year>2021</year> <volume>12</volume> <elocation-id>2042018821996482</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_226\"> <label>226.</label> <mixed-citation>Rakhmat, II, Kusmala, YY, Handayani, DR, Juliastuti, H, Nawangsih, EN, Wibowo, A. Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) \u2013 a systematic review, meta-analysis, and meta-regression. \t\t\t\t\t<italic>Diabetes Metab Syndr</italic> 2021;15:777\u201382. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rakhmat</surname> <given-names>II</given-names> </name> <name> <surname>Kusmala</surname> <given-names>YY</given-names> </name> <name> <surname>Handayani</surname> <given-names>DR</given-names> </name> <name> <surname>Juliastuti</surname> <given-names>H</given-names> </name> <name> <surname>Nawangsih</surname> <given-names>EN</given-names> </name> <name> <surname>Wibowo</surname> <given-names>A</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) \u2013 a systematic review, meta-analysis, and meta-regression</article-title> <source>Diabetes Metab Syndr</source> <year>2021</year> <volume>15</volume> <fpage>777</fpage> <lpage>82</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_227\"> <label>227.</label> <mixed-citation>Zhou, JH, Wu, B, Wang, WX, Lei, F, Cheng, X, Qin, JJ. No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19. \t\t\t\t\t<italic>World J Clin Cases</italic> 2020;8:5576\u201388. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhou</surname> <given-names>JH</given-names> </name> <name> <surname>Wu</surname> <given-names>B</given-names> </name> <name> <surname>Wang</surname> <given-names>WX</given-names> </name> <name> <surname>Lei</surname> <given-names>F</given-names> </name> <name> <surname>Cheng</surname> <given-names>X</given-names> </name> <name> <surname>Qin</surname> <given-names>JJ</given-names> </name> </person-group> <article-title>No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19</article-title> <source>World J Clin Cases</source> <year>2020</year> <volume>8</volume> <fpage>5576</fpage> <lpage>88</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_228\"> <label>228.</label> <mixed-citation>Roussel, R, Darmon, P, Pichelin, M, Goronflot, T, Abouleka, Y, Ait Bachir, L. Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2021;23:1162\u201372. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Roussel</surname> <given-names>R</given-names> </name> <name> <surname>Darmon</surname> <given-names>P</given-names> </name> <name> <surname>Pichelin</surname> <given-names>M</given-names> </name> <name> <surname>Goronflot</surname> <given-names>T</given-names> </name> <name> <surname>Abouleka</surname> <given-names>Y</given-names> </name> <name> <surname>Ait Bachir</surname> <given-names>L</given-names> </name> </person-group> <article-title>Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study</article-title> <source>Diabetes Obes Metab</source> <year>2021</year> <volume>23</volume> <fpage>1162</fpage> <lpage>72</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_229\"> <label>229.</label> <mixed-citation>Strollo, R, Maddaloni, E, Dauriz, M, Pedone, C, Buzzetti, R, Pozzilli, P. Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths. \t\t\t\t\t<italic>Diabetes Res Clin Pract</italic> 2021;171:108444. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Strollo</surname> <given-names>R</given-names> </name> <name> <surname>Maddaloni</surname> <given-names>E</given-names> </name> <name> <surname>Dauriz</surname> <given-names>M</given-names> </name> <name> <surname>Pedone</surname> <given-names>C</given-names> </name> <name> <surname>Buzzetti</surname> <given-names>R</given-names> </name> <name> <surname>Pozzilli</surname> <given-names>P</given-names> </name> </person-group> <article-title>Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths</article-title> <source>Diabetes Res Clin Pract</source> <year>2021</year> <volume>171</volume> <elocation-id>108444</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_230\"> <label>230.</label> <mixed-citation>Hariyanto, TI, Kurniawan, A. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression. \t\t\t\t\t<italic>J Diabetes Metab Disord</italic> 2021;20:1\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hariyanto</surname> <given-names>TI</given-names> </name> <name> <surname>Kurniawan</surname> <given-names>A</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression</article-title> <source>J Diabetes Metab Disord</source> <year>2021</year> <volume>20</volume> <fpage>1</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_231\"> <label>231.</label> <mixed-citation>Shiobara, T, Chibana, K, Watanabe, T, Arai, R, Horigane, Y, Nakamura, Y. Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells. \t\t\t\t\t<italic>Respir Res</italic> 2016;17:28. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Shiobara</surname> <given-names>T</given-names> </name> <name> <surname>Chibana</surname> <given-names>K</given-names> </name> <name> <surname>Watanabe</surname> <given-names>T</given-names> </name> <name> <surname>Arai</surname> <given-names>R</given-names> </name> <name> <surname>Horigane</surname> <given-names>Y</given-names> </name> <name> <surname>Nakamura</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells</article-title> <source>Respir Res</source> <year>2016</year> <volume>17</volume> <fpage>28</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_232\"> <label>232.</label> <mixed-citation>Poole, A, Urbanek, C, Eng, C, Schageman, J, Jacobson, S, O\u2019connor, BP. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. \t\t\t\t\t<italic>J Allergy Clin Immunol</italic> 2014;133:670\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Poole</surname> <given-names>A</given-names> </name> <name> <surname>Urbanek</surname> <given-names>C</given-names> </name> <name> <surname>Eng</surname> <given-names>C</given-names> </name> <name> <surname>Schageman</surname> <given-names>J</given-names> </name> <name> <surname>Jacobson</surname> <given-names>S</given-names> </name> <name> <surname>O\u2019connor</surname> <given-names>BP</given-names> </name> </person-group> <article-title>Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease</article-title> <source>J Allergy Clin Immunol</source> <year>2014</year> <volume>133</volume> <fpage>670</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_233\"> <label>233.</label> <mixed-citation>Ranade, K, Pham, TH, Damera, G, Brohawn, PZ, Pilataxi, F, Kuziora, M. Dipeptidyl peptidase-4 (DPP-4) is a novel predictive biomarker for the investigational anti-IL-13 targeted therapy Tralokinumab. \t\t\t\t\t<italic>Am J Respir Crit Care Med</italic> 2016;193:A4332. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ranade</surname> <given-names>K</given-names> </name> <name> <surname>Pham</surname> <given-names>TH</given-names> </name> <name> <surname>Damera</surname> <given-names>G</given-names> </name> <name> <surname>Brohawn</surname> <given-names>PZ</given-names> </name> <name> <surname>Pilataxi</surname> <given-names>F</given-names> </name> <name> <surname>Kuziora</surname> <given-names>M</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 (DPP-4) is a novel predictive biomarker for the investigational anti-IL-13 targeted therapy Tralokinumab</article-title> <source>Am J Respir Crit Care Med</source> <year>2016</year> <volume>193</volume> <fpage>A4332</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_234\"> <label>234.</label> <mixed-citation>Mitchell, J, Dimov, V, Townley, RG. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease. \t\t\t\t\t<italic>Curr Opin Investig Drugs</italic> 2010;11:527\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mitchell</surname> <given-names>J</given-names> </name> <name> <surname>Dimov</surname> <given-names>V</given-names> </name> <name> <surname>Townley</surname> <given-names>RG</given-names> </name> </person-group> <article-title>IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease</article-title> <source>Curr Opin Investig Drugs</source> <year>2010</year> <volume>11</volume> <fpage>527</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_235\"> <label>235.</label> <mixed-citation>Nader, MA. Inhibition of airway inflammation and remodeling by sitagliptin in murine chronic asthma. \t\t\t\t\t<italic>Int Immunopharmacol</italic> 2015;29:761\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nader</surname> <given-names>MA</given-names> </name> </person-group> <article-title>Inhibition of airway inflammation and remodeling by sitagliptin in murine chronic asthma</article-title> <source>Int Immunopharmacol</source> <year>2015</year> <volume>29</volume> <fpage>761</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_236\"> <label>236.</label> <mixed-citation>Helal, MG, Megahed, NA, Abd Elhameed, AG. Saxagliptin Mitigates airway inflammation in a mouse model of acute asthma via modulation of NF-kB and TLR4. \t\t\t\t\t<italic>Life Sci</italic> 2019;239:117017. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Helal</surname> <given-names>MG</given-names> </name> <name> <surname>Megahed</surname> <given-names>NA</given-names> </name> <name> <surname>Abd Elhameed</surname> <given-names>AG</given-names> </name> </person-group> <article-title>Saxagliptin Mitigates airway inflammation in a mouse model of acute asthma via modulation of NF-kB and TLR4</article-title> <source>Life Sci</source> <year>2019</year> <volume>239</volume> <elocation-id>117017</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_237\"> <label>237.</label> <mixed-citation>Anderluh, M, Kocic, G, Tomovic, K, Kocic, H, Smelcerovic, A. DPP-4 inhibition: a novel therapeutic approach to the treatment of pulmonary hypertension. \t\t\t\t\t<italic>Pharmacol Ther</italic> 2019;201:1\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Anderluh</surname> <given-names>M</given-names> </name> <name> <surname>Kocic</surname> <given-names>G</given-names> </name> <name> <surname>Tomovic</surname> <given-names>K</given-names> </name> <name> <surname>Kocic</surname> <given-names>H</given-names> </name> <name> <surname>Smelcerovic</surname> <given-names>A</given-names> </name> </person-group> <article-title>DPP-4 inhibition: a novel therapeutic approach to the treatment of pulmonary hypertension</article-title> <source>Pharmacol Ther</source> <year>2019</year> <volume>201</volume> <fpage>1</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_238\"> <label>238.</label> <mixed-citation>Li, Y, Yang, L, Dong, L, Yang, ZW, Zhang, J, Zhang, SL. Crosstalk between the Akt/mTORC1 and NF-\u039ab signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs. \t\t\t\t\t<italic>Acta Pharmacol Sin</italic> 2019;40:1322\u201333. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Li</surname> <given-names>Y</given-names> </name> <name> <surname>Yang</surname> <given-names>L</given-names> </name> <name> <surname>Dong</surname> <given-names>L</given-names> </name> <name> <surname>Yang</surname> <given-names>ZW</given-names> </name> <name> <surname>Zhang</surname> <given-names>J</given-names> </name> <name> <surname>Zhang</surname> <given-names>SL</given-names> </name> </person-group> <article-title>Crosstalk between the Akt/mTORC1 and NF-\u039ab signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs</article-title> <source>Acta Pharmacol Sin</source> <year>2019</year> <volume>40</volume> <fpage>1322</fpage> <lpage>33</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_239\"> <label>239.</label> <mixed-citation>Xu, J, Wang, J, He, M, Han, H, Xie, W, Wang, H. Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension. \t\t\t\t\t<italic>Lab Invest</italic> 2018;98:1333\u201346. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Xu</surname> <given-names>J</given-names> </name> <name> <surname>Wang</surname> <given-names>J</given-names> </name> <name> <surname>He</surname> <given-names>M</given-names> </name> <name> <surname>Han</surname> <given-names>H</given-names> </name> <name> <surname>Xie</surname> <given-names>W</given-names> </name> <name> <surname>Wang</surname> <given-names>H</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension</article-title> <source>Lab Invest</source> <year>2018</year> <volume>98</volume> <fpage>1333</fpage> <lpage>46</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_240\"> <label>240.</label> <mixed-citation>Wang, J, Yu, M, Xu, J, Cheng, Y, Li, X, Wei, G. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension. \t\t\t\t\t<italic>J Biomed Sci</italic> 2019;26:6. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wang</surname> <given-names>J</given-names> </name> <name> <surname>Yu</surname> <given-names>M</given-names> </name> <name> <surname>Xu</surname> <given-names>J</given-names> </name> <name> <surname>Cheng</surname> <given-names>Y</given-names> </name> <name> <surname>Li</surname> <given-names>X</given-names> </name> <name> <surname>Wei</surname> <given-names>G</given-names> </name> </person-group> <article-title>Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension</article-title> <source>J Biomed Sci</source> <year>2019</year> <volume>26</volume> <fpage>6</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_241\"> <label>241.</label> <mixed-citation>Deacon, CF. Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. \t\t\t\t\t<italic>Front Endocrinol</italic> 2019;10:80. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Deacon</surname> <given-names>CF</given-names> </name> </person-group> <article-title>Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes</article-title> <source>Front Endocrinol</source> <year>2019</year> <volume>10</volume> <fpage>80</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_242\"> <label>242.</label> <mixed-citation>Gangadharan Komala, M, Gross, S, Zaky, A, Pollock, C, Panchapakesan, U. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes. \t\t\t\t\t<italic>Nephrology</italic> 2016;21:423\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gangadharan Komala</surname> <given-names>M</given-names> </name> <name> <surname>Gross</surname> <given-names>S</given-names> </name> <name> <surname>Zaky</surname> <given-names>A</given-names> </name> <name> <surname>Pollock</surname> <given-names>C</given-names> </name> <name> <surname>Panchapakesan</surname> <given-names>U</given-names> </name> </person-group> <article-title>Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes</article-title> <source>Nephrology</source> <year>2016</year> <volume>21</volume> <fpage>423</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_243\"> <label>243.</label> <mixed-citation>Lay, AJ, Zhang, HE, Mccaughan, GW, Gorrell, MD. Fibroblast activation protein in liver fibrosis. \t\t\t\t\t<italic>Front Biosci Landmark</italic> 2019;24:1\u201317. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lay</surname> <given-names>AJ</given-names> </name> <name> <surname>Zhang</surname> <given-names>HE</given-names> </name> <name> <surname>Mccaughan</surname> <given-names>GW</given-names> </name> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> </person-group> <article-title>Fibroblast activation protein in liver fibrosis</article-title> <source>Front Biosci Landmark</source> <year>2019</year> <volume>24</volume> <fpage>1</fpage> <lpage>17</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_244\"> <label>244.</label> <mixed-citation>Soare, A, Gy\u00f6rfi, HA, Matei, AE, Dees, C, Rauber, S, Wohlfahrt, T. Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis. \t\t\t\t\t<italic>Arthritis Rheumatol</italic> 2020;72:137\u201349. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Soare</surname> <given-names>A</given-names> </name> <name> <surname>Gy\u00f6rfi</surname> <given-names>HA</given-names> </name> <name> <surname>Matei</surname> <given-names>AE</given-names> </name> <name> <surname>Dees</surname> <given-names>C</given-names> </name> <name> <surname>Rauber</surname> <given-names>S</given-names> </name> <name> <surname>Wohlfahrt</surname> <given-names>T</given-names> </name> </person-group> <article-title>Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis</article-title> <source>Arthritis Rheumatol</source> <year>2020</year> <volume>72</volume> <fpage>137</fpage> <lpage>49</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_245\"> <label>245.</label> <mixed-citation>Lee, SY, Wu, ST, Liang, YJ, Su, MJ, Huang, CW, Jao, YH. Soluble dipeptidyl peptidase-4 induces fibroblast activation through proteinase-activated receptor-2. \t\t\t\t\t<italic>Front Pharmacol</italic> 2020;11: 552818. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lee</surname> <given-names>SY</given-names> </name> <name> <surname>Wu</surname> <given-names>ST</given-names> </name> <name> <surname>Liang</surname> <given-names>YJ</given-names> </name> <name> <surname>Su</surname> <given-names>MJ</given-names> </name> <name> <surname>Huang</surname> <given-names>CW</given-names> </name> <name> <surname>Jao</surname> <given-names>YH</given-names> </name> </person-group> <article-title>Soluble dipeptidyl peptidase-4 induces fibroblast activation through proteinase-activated receptor-2</article-title> <source>Front Pharmacol</source> <year>2020</year> <volume>11</volume> <elocation-id>552818</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_246\"> <label>246.</label> <mixed-citation>Suzuki, T, Tada, Y, Gladson, S, Nishimura, R, Shimomura, I, Karasawa, S. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide induced lung injury by inhibiting endothelial-to-mesenchymal transition. \t\t\t\t\t<italic>Respir Res</italic> 2017;18:177. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Suzuki</surname> <given-names>T</given-names> </name> <name> <surname>Tada</surname> <given-names>Y</given-names> </name> <name> <surname>Gladson</surname> <given-names>S</given-names> </name> <name> <surname>Nishimura</surname> <given-names>R</given-names> </name> <name> <surname>Shimomura</surname> <given-names>I</given-names> </name> <name> <surname>Karasawa</surname> <given-names>S</given-names> </name> </person-group> <article-title>Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide induced lung injury by inhibiting endothelial-to-mesenchymal transition</article-title> <source>Respir Res</source> <year>2017</year> <volume>18</volume> <fpage>177</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_247\"> <label>247.</label> <mixed-citation>Liu, Y, Qi, Y. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix. \t\t\t\t\t<italic>Int Immunopharmacol</italic> 2020;87:106774. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Liu</surname> <given-names>Y</given-names> </name> <name> <surname>Qi</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix</article-title> <source>Int Immunopharmacol</source> <year>2020</year> <volume>87</volume> <elocation-id>106774</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_248\"> <label>248.</label> <mixed-citation>Kim, KM, Noh, JH, Bodogai, M, Martindale, JL, Yang, X, Indig, FE. Identification of senescent cell surface targetable protein DPP4. \t\t\t\t\t<italic>Genes Dev</italic> 2017;31:1529\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kim</surname> <given-names>KM</given-names> </name> <name> <surname>Noh</surname> <given-names>JH</given-names> </name> <name> <surname>Bodogai</surname> <given-names>M</given-names> </name> <name> <surname>Martindale</surname> <given-names>JL</given-names> </name> <name> <surname>Yang</surname> <given-names>X</given-names> </name> <name> <surname>Indig</surname> <given-names>FE</given-names> </name> </person-group> <article-title>Identification of senescent cell surface targetable protein DPP4</article-title> <source>Genes Dev</source> <year>2017</year> <volume>31</volume> <fpage>1529</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_249\"> <label>249.</label> <mixed-citation>Chen, Z, Yu, J, Fu, M, Dong, R, Yang, Y, Luo, J. Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway. \t\t\t\t\t<italic>Biochem Pharmacol</italic> 2020;177:113951. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chen</surname> <given-names>Z</given-names> </name> <name> <surname>Yu</surname> <given-names>J</given-names> </name> <name> <surname>Fu</surname> <given-names>M</given-names> </name> <name> <surname>Dong</surname> <given-names>R</given-names> </name> <name> <surname>Yang</surname> <given-names>Y</given-names> </name> <name> <surname>Luo</surname> <given-names>J</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 inhibition improves endothelial senescence by activating AMPK/SIRT1/Nrf2 signaling pathway</article-title> <source>Biochem Pharmacol</source> <year>2020</year> <volume>177</volume> <elocation-id>113951</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_250\"> <label>250.</label> <mixed-citation>Schafer, MJ, White, TA, Iijima, K, Haak, AJ, Ligresti, G, Atkinson, EJ. Cellular senescence mediates fibrotic pulmonary disease. \t\t\t\t\t<italic>Nat Commun</italic> 2017;8:14532. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Schafer</surname> <given-names>MJ</given-names> </name> <name> <surname>White</surname> <given-names>TA</given-names> </name> <name> <surname>Iijima</surname> <given-names>K</given-names> </name> <name> <surname>Haak</surname> <given-names>AJ</given-names> </name> <name> <surname>Ligresti</surname> <given-names>G</given-names> </name> <name> <surname>Atkinson</surname> <given-names>EJ</given-names> </name> </person-group> <article-title>Cellular senescence mediates fibrotic pulmonary disease</article-title> <source>Nat Commun</source> <year>2017</year> <volume>8</volume> <elocation-id>14532</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_251\"> <label>251.</label> <mixed-citation>Yao, C, Guan, X, Carraro, G, Parimon, T, Liu, X, Huang, G. Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis. \t\t\t\t\t<italic>Am J Respir Crit Care Med</italic> 2021;203:707\u201317. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yao</surname> <given-names>C</given-names> </name> <name> <surname>Guan</surname> <given-names>X</given-names> </name> <name> <surname>Carraro</surname> <given-names>G</given-names> </name> <name> <surname>Parimon</surname> <given-names>T</given-names> </name> <name> <surname>Liu</surname> <given-names>X</given-names> </name> <name> <surname>Huang</surname> <given-names>G</given-names> </name> </person-group> <article-title>Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis</article-title> <source>Am J Respir Crit Care Med</source> <year>2021</year> <volume>203</volume> <fpage>707</fpage> <lpage>17</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_252\"> <label>252.</label> <mixed-citation>Zhong, J, Maiseyeu, A, Davis, SN, Rajagopalan, S. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition. \t\t\t\t\t<italic>Circ Res</italic> 2015;116:1491\u2013504. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Zhong</surname> <given-names>J</given-names> </name> <name> <surname>Maiseyeu</surname> <given-names>A</given-names> </name> <name> <surname>Davis</surname> <given-names>SN</given-names> </name> <name> <surname>Rajagopalan</surname> <given-names>S</given-names> </name> </person-group> <article-title>DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition</article-title> <source>Circ Res</source> <year>2015</year> <volume>116</volume> <fpage>1491</fpage> <lpage>504</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_253\"> <label>253.</label> <mixed-citation>Kadoglou, N, Korakas, E, Lampropoulos, S, Maratou, E, Kassimis, G, Patsourakos, N, et al.. Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study. \t\t\t\t\t<italic>Cardiovasc Diabetol</italic> 2021;20:166. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kadoglou</surname> <given-names>N</given-names> </name> <name> <surname>Korakas</surname> <given-names>E</given-names> </name> <name> <surname>Lampropoulos</surname> <given-names>S</given-names> </name> <name> <surname>Maratou</surname> <given-names>E</given-names> </name> <name> <surname>Kassimis</surname> <given-names>G</given-names> </name> <name> <surname>Patsourakos</surname> <given-names>N</given-names> </name> <etal/> </person-group> <article-title>Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study</article-title> <source>Cardiovasc Diabetol</source> <year>2021</year> <volume>20</volume> <fpage>166</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_254\"> <label>254.</label> <mixed-citation>Batchu, SN, Yerra, VG, Liu, Y, Advani, SL, Klein, T, Advani, A. The dipeptidyl peptidase-4 inhibitor linagliptin directly enhances the contractile recovery of mouse hearts at a concentration equivalent to that achieved with standard dosing in humans. \t\t\t\t\t<italic>Int J Mol Sci</italic> 2020;21:5756. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Batchu</surname> <given-names>SN</given-names> </name> <name> <surname>Yerra</surname> <given-names>VG</given-names> </name> <name> <surname>Liu</surname> <given-names>Y</given-names> </name> <name> <surname>Advani</surname> <given-names>SL</given-names> </name> <name> <surname>Klein</surname> <given-names>T</given-names> </name> <name> <surname>Advani</surname> <given-names>A</given-names> </name> </person-group> <article-title>The dipeptidyl peptidase-4 inhibitor linagliptin directly enhances the contractile recovery of mouse hearts at a concentration equivalent to that achieved with standard dosing in humans</article-title> <source>Int J Mol Sci</source> <year>2020</year> <volume>21</volume> <fpage>5756</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_255\"> <label>255.</label> <mixed-citation>Fadini, P, Avogaro, A. Cardiovascular effects of DPP-IV inhibition: beyond GLP-1. \t\t\t\t\t<italic>Vasc Pharmacol</italic> 2011;55:10\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Fadini</surname> <given-names>P</given-names> </name> <name> <surname>Avogaro</surname> <given-names>A</given-names> </name> </person-group> <article-title>Cardiovascular effects of DPP-IV inhibition: beyond GLP-1</article-title> <source>Vasc Pharmacol</source> <year>2011</year> <volume>55</volume> <fpage>10</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_256\"> <label>256.</label> <mixed-citation>Murgai, M, Giles, A, Kaplan, R. Physiological, tumour, and metastatic niches: opportunities and challenges for targeting the tumour microenvironment. \t\t\t\t\t<italic>Crit Rev Oncog</italic> 2015;20:301\u201314. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Murgai</surname> <given-names>M</given-names> </name> <name> <surname>Giles</surname> <given-names>A</given-names> </name> <name> <surname>Kaplan</surname> <given-names>R</given-names> </name> </person-group> <article-title>Physiological, tumour, and metastatic niches: opportunities and challenges for targeting the tumour microenvironment</article-title> <source>Crit Rev Oncog</source> <year>2015</year> <volume>20</volume> <fpage>301</fpage> <lpage>14</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_257\"> <label>257.</label> <mixed-citation>Busek, P, Duke-Cohan, JS, Sedo, A. Does DPP-IV inhibition offer new avenues for therapeutic intervention in malignant disease. \t\t\t\t\t<italic>Cancers</italic> 2022;14:2072. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Busek</surname> <given-names>P</given-names> </name> <name> <surname>Duke-Cohan</surname> <given-names>JS</given-names> </name> <name> <surname>Sedo</surname> <given-names>A</given-names> </name> </person-group> <article-title>Does DPP-IV inhibition offer new avenues for therapeutic intervention in malignant disease</article-title> <source>Cancers</source> <year>2022</year> <volume>14</volume> <fpage>2072</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_258\"> <label>258.</label> <mixed-citation>Iwata, S, Morimoto, C. CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. \t\t\t\t\t<italic>J Exp Med</italic> 1999, 190, 301-6. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Iwata</surname> <given-names>S</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation</article-title> <source>J Exp Med</source> <year>1999</year> <volume>190</volume> <fpage>301</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_259\"> <label>259.</label> <mixed-citation>Wesley, UV, Albino, AP, Tiwari, S, Houghton, AN. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. \t\t\t\t\t<italic>J Exp Med</italic> 1999;190:311\u201322. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wesley</surname> <given-names>UV</given-names> </name> <name> <surname>Albino</surname> <given-names>AP</given-names> </name> <name> <surname>Tiwari</surname> <given-names>S</given-names> </name> <name> <surname>Houghton</surname> <given-names>AN</given-names> </name> </person-group> <article-title>A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells</article-title> <source>J Exp Med</source> <year>1999</year> <volume>190</volume> <fpage>311</fpage> <lpage>22</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_260\"> <label>260.</label> <mixed-citation>Asada, Y, Aratake, Y, Kotani, T, Marutsuka, K, Araki, Y, Ohtaki, S. Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. \t\t\t\t\t<italic>Histopathology</italic> 1993;23:265\u201370. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Asada</surname> <given-names>Y</given-names> </name> <name> <surname>Aratake</surname> <given-names>Y</given-names> </name> <name> <surname>Kotani</surname> <given-names>T</given-names> </name> <name> <surname>Marutsuka</surname> <given-names>K</given-names> </name> <name> <surname>Araki</surname> <given-names>Y</given-names> </name> <name> <surname>Ohtaki</surname> <given-names>S</given-names> </name> </person-group> <article-title>Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma</article-title> <source>Histopathology</source> <year>1993</year> <volume>23</volume> <fpage>265</fpage> <lpage>70</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_261\"> <label>261.</label> <mixed-citation>Wesley, UV, Tiwari, S, Houghton, AN. Role for dipeptidyl peptidase IV in tumour suppression of human non small cell lung carcinoma cells. \t\t\t\t\t<italic>Int J Cancer</italic> 2004;109:855\u201366. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wesley</surname> <given-names>UV</given-names> </name> <name> <surname>Tiwari</surname> <given-names>S</given-names> </name> <name> <surname>Houghton</surname> <given-names>AN</given-names> </name> </person-group> <article-title>Role for dipeptidyl peptidase IV in tumour suppression of human non small cell lung carcinoma cells</article-title> <source>Int J Cancer</source> <year>2004</year> <volume>109</volume> <fpage>855</fpage> <lpage>66</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_262\"> <label>262.</label> <mixed-citation>Dimitrova, M, Ivanov, I, Todorova, R, Stefanova, N, Moskova-Doumanova, V, Topouzova-Hristova, T. Comparison of the activity levels and localization of dipeptidyl peptidase IV in normal and tumour human lung cells. \t\t\t\t\t<italic>Tissue Cell</italic> 2012;44:74\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dimitrova</surname> <given-names>M</given-names> </name> <name> <surname>Ivanov</surname> <given-names>I</given-names> </name> <name> <surname>Todorova</surname> <given-names>R</given-names> </name> <name> <surname>Stefanova</surname> <given-names>N</given-names> </name> <name> <surname>Moskova-Doumanova</surname> <given-names>V</given-names> </name> <name> <surname>Topouzova-Hristova</surname> <given-names>T</given-names> </name> </person-group> <article-title>Comparison of the activity levels and localization of dipeptidyl peptidase IV in normal and tumour human lung cells</article-title> <source>Tissue Cell</source> <year>2012</year> <volume>44</volume> <fpage>74</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_263\"> <label>263.</label> <mixed-citation>Khin, EE, Kikkawa, F, Ino, K, Kajiyama, H, Suzuki, T, Shibata, K. Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumour grade. \t\t\t\t\t<italic>Am J Obstet Gynecol</italic> 2003;188:670\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Khin</surname> <given-names>EE</given-names> </name> <name> <surname>Kikkawa</surname> <given-names>F</given-names> </name> <name> <surname>Ino</surname> <given-names>K</given-names> </name> <name> <surname>Kajiyama</surname> <given-names>H</given-names> </name> <name> <surname>Suzuki</surname> <given-names>T</given-names> </name> <name> <surname>Shibata</surname> <given-names>K</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumour grade</article-title> <source>Am J Obstet Gynecol</source> <year>2003</year> <volume>188</volume> <fpage>670</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_264\"> <label>264.</label> <mixed-citation>Bogenrieder, T, Finstad, CL, Freeman, RH, Papandreou, CN, Scher, HI, Albino, AP. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. \t\t\t\t\t<italic>Prostate</italic> 1997;33:225\u201332. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bogenrieder</surname> <given-names>T</given-names> </name> <name> <surname>Finstad</surname> <given-names>CL</given-names> </name> <name> <surname>Freeman</surname> <given-names>RH</given-names> </name> <name> <surname>Papandreou</surname> <given-names>CN</given-names> </name> <name> <surname>Scher</surname> <given-names>HI</given-names> </name> <name> <surname>Albino</surname> <given-names>AP</given-names> </name> </person-group> <article-title>Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue</article-title> <source>Prostate</source> <year>1997</year> <volume>33</volume> <fpage>225</fpage> <lpage>32</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_265\"> <label>265.</label> <mixed-citation>Dinjens, WN, Ten Kate, J, Kirch, JA, Tanke, HJ, Van der Linden, EP, Van den Ingh, HF. Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas. \t\t\t\t\t<italic>J Pathol</italic> 1990;160:195\u201320. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dinjens</surname> <given-names>WN</given-names> </name> <name> <surname>Ten Kate</surname> <given-names>J</given-names> </name> <name> <surname>Kirch</surname> <given-names>JA</given-names> </name> <name> <surname>Tanke</surname> <given-names>HJ</given-names> </name> <name> <surname>Van der Linden</surname> <given-names>EP</given-names> </name> <name> <surname>Van den Ingh</surname> <given-names>HF</given-names> </name> </person-group> <article-title>Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas</article-title> <source>J Pathol</source> <year>1990</year> <volume>160</volume> <fpage>195</fpage> <lpage>20</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_266\"> <label>266.</label> <mixed-citation>Wesley, UV, McGroarty, M, Homoyouni, A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. \t\t\t\t\t<italic>Cancer Res</italic> 2005;65:1325\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wesley</surname> <given-names>UV</given-names> </name> <name> <surname>McGroarty</surname> <given-names>M</given-names> </name> <name> <surname>Homoyouni</surname> <given-names>A</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway</article-title> <source>Cancer Res</source> <year>2005</year> <volume>65</volume> <fpage>1325</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_267\"> <label>267.</label> <mixed-citation>Urade, M, Komatsu, M, Yamaoka, M, Fukasawa, K, Harada, M, Mima, T. Serum dipeptidyl peptidase activities as a possible marker of oral cancer. \t\t\t\t\t<italic>Cancer</italic> 1989;64:1274\u201380. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Urade</surname> <given-names>M</given-names> </name> <name> <surname>Komatsu</surname> <given-names>M</given-names> </name> <name> <surname>Yamaoka</surname> <given-names>M</given-names> </name> <name> <surname>Fukasawa</surname> <given-names>K</given-names> </name> <name> <surname>Harada</surname> <given-names>M</given-names> </name> <name> <surname>Mima</surname> <given-names>T</given-names> </name> </person-group> <article-title>Serum dipeptidyl peptidase activities as a possible marker of oral cancer</article-title> <source>Cancer</source> <year>1989</year> <volume>64</volume> <fpage>1274</fpage> <lpage>80</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_268\"> <label>268.</label> <mixed-citation>de la Haba-Rodriguez, J, Macho, A, Calzado, MA, Blazquez, MV, Gomez, MA, Munoz, EE. Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma. \t\t\t\t\t<italic>Neoplasma</italic> 2002;49:307\u201311. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>de la Haba-Rodriguez</surname> <given-names>J</given-names> </name> <name> <surname>Macho</surname> <given-names>A</given-names> </name> <name> <surname>Calzado</surname> <given-names>MA</given-names> </name> <name> <surname>Blazquez</surname> <given-names>MV</given-names> </name> <name> <surname>Gomez</surname> <given-names>MA</given-names> </name> <name> <surname>Munoz</surname> <given-names>EE</given-names> </name> </person-group> <article-title>Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma</article-title> <source>Neoplasma</source> <year>2002</year> <volume>49</volume> <fpage>307</fpage> <lpage>11</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_269\"> <label>269.</label> <mixed-citation>Cordero, OJ, Imbernon, M, Chiara, LD, Martinez-Zorzano, VS, Ayude, D, de la Cadena, MP. Potential of soluble CD26 as a serum marker for colorectal cancer detection. \t\t\t\t\t<italic>World J Clin Oncol</italic> 2011;2:245\u201361. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cordero</surname> <given-names>OJ</given-names> </name> <name> <surname>Imbernon</surname> <given-names>M</given-names> </name> <name> <surname>Chiara</surname> <given-names>LD</given-names> </name> <name> <surname>Martinez-Zorzano</surname> <given-names>VS</given-names> </name> <name> <surname>Ayude</surname> <given-names>D</given-names> </name> <name> <surname>de la Cadena</surname> <given-names>MP</given-names> </name> </person-group> <article-title>Potential of soluble CD26 as a serum marker for colorectal cancer detection</article-title> <source>World J Clin Oncol</source> <year>2011</year> <volume>2</volume> <fpage>245</fpage> <lpage>61</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_270\"> <label>270.</label> <mixed-citation>Sedo, A, Krepela, E, Kasafirek, E. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma. \t\t\t\t\t<italic>J Cancer Res Clin Oncol</italic> 1991;117:249\u201353. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Sedo</surname> <given-names>A</given-names> </name> <name> <surname>Krepela</surname> <given-names>E</given-names> </name> <name> <surname>Kasafirek</surname> <given-names>E</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma</article-title> <source>J Cancer Res Clin Oncol</source> <year>1991</year> <volume>117</volume> <fpage>249</fpage> <lpage>53</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_271\"> <label>271.</label> <mixed-citation>Frohlich, E, Maier, E, Wahl, R. Interspecies differences in membrane-associated protease activities of thyrocytes and their relevance for thyroid cancer studies. \t\t\t\t\t<italic>J Exp Clin Cancer Res</italic> 2012;31:45. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Frohlich</surname> <given-names>E</given-names> </name> <name> <surname>Maier</surname> <given-names>E</given-names> </name> <name> <surname>Wahl</surname> <given-names>R</given-names> </name> </person-group> <article-title>Interspecies differences in membrane-associated protease activities of thyrocytes and their relevance for thyroid cancer studies</article-title> <source>J Exp Clin Cancer Res</source> <year>2012</year> <volume>31</volume> <fpage>45</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_272\"> <label>272.</label> <mixed-citation>Pro, B, Dang, NH. CD26/dipeptidyl peptidase IV and its role in cancer. \t\t\t\t\t<italic>Histol Histopathol</italic> 2004, 19, 1345\u201351. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pro</surname> <given-names>B</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> </person-group> <article-title>CD26/dipeptidyl peptidase IV and its role in cancer</article-title> <source>Histol Histopathol</source> <year>2004</year> <volume>19</volume> <fpage>1345</fpage> <lpage>51</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_273\"> <label>273.</label> <mixed-citation>Goscinski, MA, Suo, ZH, Nesland, JM, Florenes, VA, Giercksky, KE. Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines. \t\t\t\t\t<italic>APMIS</italic> 2008;116:823\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Goscinski</surname> <given-names>MA</given-names> </name> <name> <surname>Suo</surname> <given-names>ZH</given-names> </name> <name> <surname>Nesland</surname> <given-names>JM</given-names> </name> <name> <surname>Florenes</surname> <given-names>VA</given-names> </name> <name> <surname>Giercksky</surname> <given-names>KE</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines</article-title> <source>APMIS</source> <year>2008</year> <volume>116</volume> <fpage>823</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_274\"> <label>274.</label> <mixed-citation>Kikkawa, F, Kajiyama, H, Ino, K, Shibata, K, Mizutani, S. Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV. \t\t\t\t\t<italic>Int J Cancer</italic> 2003;105:779\u201383. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kikkawa</surname> <given-names>F</given-names> </name> <name> <surname>Kajiyama</surname> <given-names>H</given-names> </name> <name> <surname>Ino</surname> <given-names>K</given-names> </name> <name> <surname>Shibata</surname> <given-names>K</given-names> </name> <name> <surname>Mizutani</surname> <given-names>S</given-names> </name> </person-group> <article-title>Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV</article-title> <source>Int J Cancer</source> <year>2003</year> <volume>105</volume> <fpage>779</fpage> <lpage>83</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_275\"> <label>275.</label> <mixed-citation>Jiang, YX, Yang, SW, Li, PA, Luo, X, Li, ZY, Hao, YX, et al.. The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. \t\t\t\t\t<italic>Oncogene</italic> 2017;36:1256\u201364. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Jiang</surname> <given-names>YX</given-names> </name> <name> <surname>Yang</surname> <given-names>SW</given-names> </name> <name> <surname>Li</surname> <given-names>PA</given-names> </name> <name> <surname>Luo</surname> <given-names>X</given-names> </name> <name> <surname>Li</surname> <given-names>ZY</given-names> </name> <name> <surname>Hao</surname> <given-names>YX</given-names> </name> <etal/> </person-group> <article-title>The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms</article-title> <source>Oncogene</source> <year>2017</year> <volume>36</volume> <fpage>1256</fpage> <lpage>64</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_276\"> <label>276.</label> <mixed-citation>Bauvois, B, De Meester, I, Dumont, J, Rouillard, D, Zhao, HX, Bosmans, E. Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. \t\t\t\t\t<italic>Br J Cancer</italic> 1999;79:1042\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bauvois</surname> <given-names>B</given-names> </name> <name> <surname>De Meester</surname> <given-names>I</given-names> </name> <name> <surname>Dumont</surname> <given-names>J</given-names> </name> <name> <surname>Rouillard</surname> <given-names>D</given-names> </name> <name> <surname>Zhao</surname> <given-names>HX</given-names> </name> <name> <surname>Bosmans</surname> <given-names>E</given-names> </name> </person-group> <article-title>Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia</article-title> <source>Br J Cancer</source> <year>1999</year> <volume>79</volume> <fpage>1042</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_277\"> <label>277.</label> <mixed-citation>Cro, L, Morabito, F, Zucal, N, Fabris, S, Lionetti, M, Cutrona, G. CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. \t\t\t\t\t<italic>Hematol Oncol</italic> 2009;27:140\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cro</surname> <given-names>L</given-names> </name> <name> <surname>Morabito</surname> <given-names>F</given-names> </name> <name> <surname>Zucal</surname> <given-names>N</given-names> </name> <name> <surname>Fabris</surname> <given-names>S</given-names> </name> <name> <surname>Lionetti</surname> <given-names>M</given-names> </name> <name> <surname>Cutrona</surname> <given-names>G</given-names> </name> </person-group> <article-title>CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL</article-title> <source>Hematol Oncol</source> <year>2009</year> <volume>27</volume> <fpage>140</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_278\"> <label>278.</label> <mixed-citation>Havre, PA, Dang, LH, Ohnuma, K, Iwata, S, Morimoto, C, Dang, NH. CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion. \t\t\t\t\t<italic>BMC Cancer</italic> 2013;13:517. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Havre</surname> <given-names>PA</given-names> </name> <name> <surname>Dang</surname> <given-names>LH</given-names> </name> <name> <surname>Ohnuma</surname> <given-names>K</given-names> </name> <name> <surname>Iwata</surname> <given-names>S</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> </person-group> <article-title>CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion</article-title> <source>BMC Cancer</source> <year>2013</year> <volume>13</volume> <fpage>517</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_279\"> <label>279.</label> <mixed-citation>Carbone, A, Cozzi, M, Gloghini, A, Pinto, A. CD26/dipeptidylpeptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of Tcell non-Hodgkin\u2019s lymphomas. \t\t\t\t\t<italic>Human Pathol</italic> 1994;25:1360\u20135. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Carbone</surname> <given-names>A</given-names> </name> <name> <surname>Cozzi</surname> <given-names>M</given-names> </name> <name> <surname>Gloghini</surname> <given-names>A</given-names> </name> <name> <surname>Pinto</surname> <given-names>A</given-names> </name> </person-group> <article-title>CD26/dipeptidylpeptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of Tcell non-Hodgkin\u2019s lymphomas</article-title> <source>Human Pathol</source> <year>1994</year> <volume>25</volume> <fpage>1360</fpage> <lpage>5</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_280\"> <label>280.</label> <mixed-citation>Carbone, A, Gloghini, A, Zagonel, V, Aldinucci, D, Gattei, V, Degan, M, et al.. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin\u2019s lymphomas/leukemias. \t\t\t\t\t<italic>Blood</italic> 1995;86:4617\u201326. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Carbone</surname> <given-names>A</given-names> </name> <name> <surname>Gloghini</surname> <given-names>A</given-names> </name> <name> <surname>Zagonel</surname> <given-names>V</given-names> </name> <name> <surname>Aldinucci</surname> <given-names>D</given-names> </name> <name> <surname>Gattei</surname> <given-names>V</given-names> </name> <name> <surname>Degan</surname> <given-names>M</given-names> </name> <etal/> </person-group> <article-title>The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin\u2019s lymphomas/leukemias</article-title> <source>Blood</source> <year>1995</year> <volume>86</volume> <fpage>4617</fpage> <lpage>26</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_281\"> <label>281.</label> <mixed-citation>Dang, NH, Aytac, U, Sato, K, O\u2019Brien, S, Melenhorst, J, Morimoto, C, et al.. T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. \t\t\t\t\t<italic>Br J Haematol</italic> 2003;121:857\u201365. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dang</surname> <given-names>NH</given-names> </name> <name> <surname>Aytac</surname> <given-names>U</given-names> </name> <name> <surname>Sato</surname> <given-names>K</given-names> </name> <name> <surname>O\u2019Brien</surname> <given-names>S</given-names> </name> <name> <surname>Melenhorst</surname> <given-names>J</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> <etal/> </person-group> <article-title>T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition</article-title> <source>Br J Haematol</source> <year>2003</year> <volume>121</volume> <fpage>857</fpage> <lpage>65</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_282\"> <label>282.</label> <mixed-citation>Pethiyagoda, CL, Welch, DR, Fleming, TP. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. \t\t\t\t\t<italic>Clin Exp Metast</italic> 2001;18:391\u2013400. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pethiyagoda</surname> <given-names>CL</given-names> </name> <name> <surname>Welch</surname> <given-names>DR</given-names> </name> <name> <surname>Fleming</surname> <given-names>TP</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells</article-title> <source>Clin Exp Metast</source> <year>2001</year> <volume>18</volume> <fpage>391</fpage> <lpage>400</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_283\"> <label>283.</label> <mixed-citation>Novelli, M, Savoia, P, Fierro, MT, Verrone, A, Quaglino, P, BernengoMG. Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases. \t\t\t\t\t<italic>Br J Dermatol</italic> 1996;134:1052\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Novelli</surname> <given-names>M</given-names> </name> <name> <surname>Savoia</surname> <given-names>P</given-names> </name> <name> <surname>Fierro</surname> <given-names>MT</given-names> </name> <name> <surname>Verrone</surname> <given-names>A</given-names> </name> <name> <surname>Quaglino</surname> <given-names>P</given-names> </name> <name> <surname>BernengoMG</surname> </name> </person-group> <article-title>Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases</article-title> <source>Br J Dermatol</source> <year>1996</year> <volume>134</volume> <fpage>1052</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_284\"> <label>284.</label> <mixed-citation>Ansorge, S, Bank, U, Heimburg, A, Helmuth, M, Koch, G, Tadje, J. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions. \t\t\t\t\t<italic>Clin Chem Lab Med</italic> 2009;47:253\u201361. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ansorge</surname> <given-names>S</given-names> </name> <name> <surname>Bank</surname> <given-names>U</given-names> </name> <name> <surname>Heimburg</surname> <given-names>A</given-names> </name> <name> <surname>Helmuth</surname> <given-names>M</given-names> </name> <name> <surname>Koch</surname> <given-names>G</given-names> </name> <name> <surname>Tadje</surname> <given-names>J</given-names> </name> </person-group> <article-title>Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions</article-title> <source>Clin Chem Lab Med</source> <year>2009</year> <volume>47</volume> <fpage>253</fpage> <lpage>61</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_285\"> <label>285.</label> <mixed-citation>Van Der Velden, VH, Hulsmann, AR. Peptidases: structure, function and modulation of peptide-mediated effects in the human lung. \t\t\t\t\t<italic>Clin Exp Allergy</italic> 1999;29:445\u201356. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Van Der Velden</surname> <given-names>VH</given-names> </name> <name> <surname>Hulsmann</surname> <given-names>AR</given-names> </name> </person-group> <article-title>Peptidases: structure, function and modulation of peptide-mediated effects in the human lung</article-title> <source>Clin Exp Allergy</source> <year>1999</year> <volume>29</volume> <fpage>445</fpage> <lpage>56</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_286\"> <label>286.</label> <mixed-citation>Mentlein, R, Dahms, P, Grandt, D, Kruger, R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. \t\t\t\t\t<italic>Regul Pept</italic> 1993;49:133\u201344. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mentlein</surname> <given-names>R</given-names> </name> <name> <surname>Dahms</surname> <given-names>P</given-names> </name> <name> <surname>Grandt</surname> <given-names>D</given-names> </name> <name> <surname>Kruger</surname> <given-names>R</given-names> </name> </person-group> <article-title>Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV</article-title> <source>Regul Pept</source> <year>1993</year> <volume>49</volume> <fpage>133</fpage> <lpage>44</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_287\"> <label>287.</label> <mixed-citation>Ghersi, G, Chen, W, Lee, EW, Zukowska, Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. \t\t\t\t\t<italic>Peptides</italic> 2001;22:453\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ghersi</surname> <given-names>G</given-names> </name> <name> <surname>Chen</surname> <given-names>W</given-names> </name> <name> <surname>Lee</surname> <given-names>EW</given-names> </name> <name> <surname>Zukowska</surname> <given-names>Z</given-names> </name> </person-group> <article-title>Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding</article-title> <source>Peptides</source> <year>2001</year> <volume>22</volume> <fpage>453</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_288\"> <label>288.</label> <mixed-citation>Jang, JH, Janker, F, De Meester, I, Arni, S, Borgeaud, N, Yamada, Y. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity. \t\t\t\t\t<italic>Carcinogenesis</italic> 2019;40:324\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Jang</surname> <given-names>JH</given-names> </name> <name> <surname>Janker</surname> <given-names>F</given-names> </name> <name> <surname>De Meester</surname> <given-names>I</given-names> </name> <name> <surname>Arni</surname> <given-names>S</given-names> </name> <name> <surname>Borgeaud</surname> <given-names>N</given-names> </name> <name> <surname>Yamada</surname> <given-names>Y</given-names> </name> </person-group> <article-title>The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity</article-title> <source>Carcinogenesis</source> <year>2019</year> <volume>40</volume> <fpage>324</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_289\"> <label>289.</label> <mixed-citation>Mathew, S, Morrison, ME, Murty, VV, Houghton, AN, Chaganti, RS. Assignment of the DPP4 gene encoding adenosine deaminase binding protein (CD26/dipeptidylpeptidase IV) to 2q23. \t\t\t\t\t<italic>Genomics</italic> 1994;22:211\u20132. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Mathew</surname> <given-names>S</given-names> </name> <name> <surname>Morrison</surname> <given-names>ME</given-names> </name> <name> <surname>Murty</surname> <given-names>VV</given-names> </name> <name> <surname>Houghton</surname> <given-names>AN</given-names> </name> <name> <surname>Chaganti</surname> <given-names>RS</given-names> </name> </person-group> <article-title>Assignment of the DPP4 gene encoding adenosine deaminase binding protein (CD26/dipeptidylpeptidase IV) to 2q23</article-title> <source>Genomics</source> <year>1994</year> <volume>22</volume> <fpage>211</fpage> <lpage>2</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_290\"> <label>290.</label> <mixed-citation>Otsuka, T, Kohno, T, Mori, M, Noguchi, M, Hirohashi, S, Yokota, J. Deletion mapping of chromosome 2 in human lung carcinoma. \t\t\t\t\t<italic>Genes Chromosomes Cancer</italic> 1996;16:113\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Otsuka</surname> <given-names>T</given-names> </name> <name> <surname>Kohno</surname> <given-names>T</given-names> </name> <name> <surname>Mori</surname> <given-names>M</given-names> </name> <name> <surname>Noguchi</surname> <given-names>M</given-names> </name> <name> <surname>Hirohashi</surname> <given-names>S</given-names> </name> <name> <surname>Yokota</surname> <given-names>J</given-names> </name> </person-group> <article-title>Deletion mapping of chromosome 2 in human lung carcinoma</article-title> <source>Genes Chromosomes Cancer</source> <year>1996</year> <volume>16</volume> <fpage>113</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_291\"> <label>291.</label> <mixed-citation>Dimitrova, M, Ivanov, I, Todorova, R, Stefanova, N, Moskova-Doumanova, V, Topouzova-Hristova, T. Comparison of the activity levels and localization of dipeptidyl peptidase IV in normal and tumour human lung cells. \t\t\t\t\t<italic>Tissue Cell</italic> 2012;44:74\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dimitrova</surname> <given-names>M</given-names> </name> <name> <surname>Ivanov</surname> <given-names>I</given-names> </name> <name> <surname>Todorova</surname> <given-names>R</given-names> </name> <name> <surname>Stefanova</surname> <given-names>N</given-names> </name> <name> <surname>Moskova-Doumanova</surname> <given-names>V</given-names> </name> <name> <surname>Topouzova-Hristova</surname> <given-names>T</given-names> </name> </person-group> <article-title>Comparison of the activity levels and localization of dipeptidyl peptidase IV in normal and tumour human lung cells</article-title> <source>Tissue Cell</source> <year>2012</year> <volume>44</volume> <fpage>74</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_292\"> <label>292.</label> <mixed-citation>Morrison, H, Sherman, LS, Legg, J, Banine, F, Isacke, C, Haipek, CA. The NF2 tumour suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. \t\t\t\t\t<italic>Genes Dev</italic> 2001;15:968\u201380. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Morrison</surname> <given-names>H</given-names> </name> <name> <surname>Sherman</surname> <given-names>LS</given-names> </name> <name> <surname>Legg</surname> <given-names>J</given-names> </name> <name> <surname>Banine</surname> <given-names>F</given-names> </name> <name> <surname>Isacke</surname> <given-names>C</given-names> </name> <name> <surname>Haipek</surname> <given-names>CA</given-names> </name> </person-group> <article-title>The NF2 tumour suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44</article-title> <source>Genes Dev</source> <year>2001</year> <volume>15</volume> <fpage>968</fpage> <lpage>80</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_293\"> <label>293.</label> <mixed-citation>Yan, P, Muhlethaler, A, Bourloud, KB, Beck, MN, Gross, N. Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma. \t\t\t\t\t<italic>Genes Chromosomes Cancer</italic> 2003;36:129\u201338. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yan</surname> <given-names>P</given-names> </name> <name> <surname>Muhlethaler</surname> <given-names>A</given-names> </name> <name> <surname>Bourloud</surname> <given-names>KB</given-names> </name> <name> <surname>Beck</surname> <given-names>MN</given-names> </name> <name> <surname>Gross</surname> <given-names>N</given-names> </name> </person-group> <article-title>Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma</article-title> <source>Genes Chromosomes Cancer</source> <year>2003</year> <volume>36</volume> <fpage>129</fpage> <lpage>38</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_294\"> <label>294.</label> <mixed-citation>Yang, X, Zhang, X, Wu, R, Huang, Q, Jiang, Y, Qin, J, et al.. DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumourigenesis. \t\t\t\t\t<italic>Oncotarget</italic> 2017;8:8679\u201392. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yang</surname> <given-names>X</given-names> </name> <name> <surname>Zhang</surname> <given-names>X</given-names> </name> <name> <surname>Wu</surname> <given-names>R</given-names> </name> <name> <surname>Huang</surname> <given-names>Q</given-names> </name> <name> <surname>Jiang</surname> <given-names>Y</given-names> </name> <name> <surname>Qin</surname> <given-names>J</given-names> </name> <etal/> </person-group> <article-title>DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumourigenesis</article-title> <source>Oncotarget</source> <year>2017</year> <volume>8</volume> <fpage>8679</fpage> <lpage>92</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_295\"> <label>295.</label> <mixed-citation>Kajiyama, H, Kikkawa, F, Maeda, O, Suzuki, T, Ino, K, Mizutani, S. Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients. \t\t\t\t\t<italic>Oncology</italic> 2002;63:158\u201365. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kajiyama</surname> <given-names>H</given-names> </name> <name> <surname>Kikkawa</surname> <given-names>F</given-names> </name> <name> <surname>Maeda</surname> <given-names>O</given-names> </name> <name> <surname>Suzuki</surname> <given-names>T</given-names> </name> <name> <surname>Ino</surname> <given-names>K</given-names> </name> <name> <surname>Mizutani</surname> <given-names>S</given-names> </name> </person-group> <article-title>Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients</article-title> <source>Oncology</source> <year>2002</year> <volume>63</volume> <fpage>158</fpage> <lpage>65</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_296\"> <label>296.</label> <mixed-citation>Ware, JL. Growth factor network disruption in prostate cancer progression. \t\t\t\t\t<italic>Cancer Metastasis Rev</italic> 1998;17:443\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ware</surname> <given-names>JL</given-names> </name> </person-group> <article-title>Growth factor network disruption in prostate cancer progression</article-title> <source>Cancer Metastasis Rev</source> <year>1998</year> <volume>17</volume> <fpage>443</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_297\"> <label>297.</label> <mixed-citation>Giri, D, Ropiquet, F, Ittmann, M. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. \t\t\t\t\t<italic>Clin Cancer Res</italic> 1999;5:1063\u201371. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Giri</surname> <given-names>D</given-names> </name> <name> <surname>Ropiquet</surname> <given-names>F</given-names> </name> <name> <surname>Ittmann</surname> <given-names>M</given-names> </name> </person-group> <article-title>Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer</article-title> <source>Clin Cancer Res</source> <year>1999</year> <volume>5</volume> <fpage>1063</fpage> <lpage>71</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_298\"> <label>298.</label> <mixed-citation>Dow, JK, deVere White, RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumour angiogenesis, and prostate-related mitogenic and oncogenic functions. \t\t\t\t\t<italic>Urology</italic> 2000;55:800\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dow</surname> <given-names>JK</given-names> </name> <name> <surname>deVere White</surname> <given-names>RW</given-names> </name> </person-group> <article-title>Fibroblast growth factor 2: its structure and property, paracrine function, tumour angiogenesis, and prostate-related mitogenic and oncogenic functions</article-title> <source>Urology</source> <year>2000</year> <volume>55</volume> <fpage>800</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_299\"> <label>299.</label> <mixed-citation>Feldman, BJ, Feldman, D. The development of androgen-independent prostate cancer. \t\t\t\t\t<italic>Nat Rev Cancer</italic> 2001;1:34\u201345. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Feldman</surname> <given-names>BJ</given-names> </name> <name> <surname>Feldman</surname> <given-names>D</given-names> </name> </person-group> <article-title>The development of androgen-independent prostate cancer</article-title> <source>Nat Rev Cancer</source> <year>2001</year> <volume>1</volume> <fpage>34</fpage> <lpage>45</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_300\"> <label>300.</label> <mixed-citation>Isaacs, JT, Isaacs, WB. Androgen receptor outwits prostate cancer drugs. \t\t\t\t\t<italic>Nat Med</italic> 2004;10:26\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Isaacs</surname> <given-names>JT</given-names> </name> <name> <surname>Isaacs</surname> <given-names>WB</given-names> </name> </person-group> <article-title>Androgen receptor outwits prostate cancer drugs</article-title> <source>Nat Med</source> <year>2004</year> <volume>10</volume> <fpage>26</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_301\"> <label>301.</label> <mixed-citation>Nakamoto, T, Chang, CS, Li, AK, Chodak, GW. Basic fibroblast growth factor in human prostate cancer cells. \t\t\t\t\t<italic>Cancer Res</italic> 1992;52:571\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nakamoto</surname> <given-names>T</given-names> </name> <name> <surname>Chang</surname> <given-names>CS</given-names> </name> <name> <surname>Li</surname> <given-names>AK</given-names> </name> <name> <surname>Chodak</surname> <given-names>GW</given-names> </name> </person-group> <article-title>Basic fibroblast growth factor in human prostate cancer cells</article-title> <source>Cancer Res</source> <year>1992</year> <volume>52</volume> <fpage>571</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_302\"> <label>302.</label> <mixed-citation>Gioeli, D, Mandell, JW, Petroni, GR, Frierson, HF, Weber, MJ. Activation of mitogen-activated protein kinase associated with prostate cancer progression. \t\t\t\t\t<italic>Cancer Res</italic> 1999;59:279\u201384. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gioeli</surname> <given-names>D</given-names> </name> <name> <surname>Mandell</surname> <given-names>JW</given-names> </name> <name> <surname>Petroni</surname> <given-names>GR</given-names> </name> <name> <surname>Frierson</surname> <given-names>HF</given-names> </name> <name> <surname>Weber</surname> <given-names>MJ</given-names> </name> </person-group> <article-title>Activation of mitogen-activated protein kinase associated with prostate cancer progression</article-title> <source>Cancer Res</source> <year>1999</year> <volume>59</volume> <fpage>279</fpage> <lpage>84</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_303\"> <label>303.</label> <mixed-citation>Pintucci, G, Moscatelli, D, Saponara, F, Biernacki, PR, Baumann, FG, Bizekis, C. Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. \t\t\t\t\t<italic>FASEB J</italic> 2002;16:598\u2013600. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pintucci</surname> <given-names>G</given-names> </name> <name> <surname>Moscatelli</surname> <given-names>D</given-names> </name> <name> <surname>Saponara</surname> <given-names>F</given-names> </name> <name> <surname>Biernacki</surname> <given-names>PR</given-names> </name> <name> <surname>Baumann</surname> <given-names>FG</given-names> </name> <name> <surname>Bizekis</surname> <given-names>C</given-names> </name> </person-group> <article-title>Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells</article-title> <source>FASEB J</source> <year>2002</year> <volume>16</volume> <fpage>598</fpage> <lpage>600</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_304\"> <label>304.</label> <mixed-citation>Giuliani, R, Bastaki, M, Coltrini, D, Presta, M. Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. \t\t\t\t\t<italic>J Cell Sci</italic> 1999;112:2597\u2013606. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Giuliani</surname> <given-names>R</given-names> </name> <name> <surname>Bastaki</surname> <given-names>M</given-names> </name> <name> <surname>Coltrini</surname> <given-names>D</given-names> </name> <name> <surname>Presta</surname> <given-names>M</given-names> </name> </person-group> <article-title>Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2</article-title> <source>J Cell Sci</source> <year>1999</year> <volume>112</volume> <fpage>2597</fpage> <lpage>606</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_305\"> <label>305.</label> <mixed-citation>Rabbani, SA, Mazar, AP. The role of the plasminogen activation system in angiogenesis and metastasis. \t\t\t\t\t<italic>Surg Oncol Clin N Am</italic> 2001;10:393\u2013415. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Rabbani</surname> <given-names>SA</given-names> </name> <name> <surname>Mazar</surname> <given-names>AP</given-names> </name> </person-group> <article-title>The role of the plasminogen activation system in angiogenesis and metastasis</article-title> <source>Surg Oncol Clin N Am</source> <year>2001</year> <volume>10</volume> <fpage>393</fpage> <lpage>415</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_306\"> <label>306.</label> <mixed-citation>Bugler, B, Amalric, F, Prats, H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. \t\t\t\t\t<italic>Mol Cell Biol</italic> 1991;11:573\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bugler</surname> <given-names>B</given-names> </name> <name> <surname>Amalric</surname> <given-names>F</given-names> </name> <name> <surname>Prats</surname> <given-names>H</given-names> </name> </person-group> <article-title>Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor</article-title> <source>Mol Cell Biol</source> <year>1991</year> <volume>11</volume> <fpage>573</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_307\"> <label>307.</label> <mixed-citation>Bikfalvi, A, Klein, S, Pintucci, G, Rifkin, DB. Biological roles of fibroblast growth factor-2. \t\t\t\t\t<italic>Endocr Rev</italic> 1997;18:26\u201345. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bikfalvi</surname> <given-names>A</given-names> </name> <name> <surname>Klein</surname> <given-names>S</given-names> </name> <name> <surname>Pintucci</surname> <given-names>G</given-names> </name> <name> <surname>Rifkin</surname> <given-names>DB</given-names> </name> </person-group> <article-title>Biological roles of fibroblast growth factor-2</article-title> <source>Endocr Rev</source> <year>1997</year> <volume>18</volume> <fpage>26</fpage> <lpage>45</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_308\"> <label>308.</label> <mixed-citation>Delrieu, I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. \t\t\t\t\t<italic>FEBS Lett</italic> 2000;468:6\u201310. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Delrieu</surname> <given-names>I</given-names> </name> </person-group> <article-title>The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism</article-title> <source>FEBS Lett</source> <year>2000</year> <volume>468</volume> <fpage>6</fpage> <lpage>10</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_309\"> <label>309.</label> <mixed-citation>Wilson, MJ, Ruhland, AR, Quast, BJ, Reddy, PK, Ewing, SL, Sinha, AA. Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. \t\t\t\t\t<italic>J Androl</italic> 2000;21:220\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wilson</surname> <given-names>MJ</given-names> </name> <name> <surname>Ruhland</surname> <given-names>AR</given-names> </name> <name> <surname>Quast</surname> <given-names>BJ</given-names> </name> <name> <surname>Reddy</surname> <given-names>PK</given-names> </name> <name> <surname>Ewing</surname> <given-names>SL</given-names> </name> <name> <surname>Sinha</surname> <given-names>AA</given-names> </name> </person-group> <article-title>Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands</article-title> <source>J Androl</source> <year>2000</year> <volume>21</volume> <fpage>220</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_310\"> <label>310.</label> <mixed-citation>Lu, Z, Qi, L, Bo, XJ, Liu, GD, Wang, JM, Li, G. Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters. \t\t\t\t\t<italic>J Res Med Sci</italic> 2013;18:647\u201352. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lu</surname> <given-names>Z</given-names> </name> <name> <surname>Qi</surname> <given-names>L</given-names> </name> <name> <surname>Bo</surname> <given-names>XJ</given-names> </name> <name> <surname>Liu</surname> <given-names>GD</given-names> </name> <name> <surname>Wang</surname> <given-names>JM</given-names> </name> <name> <surname>Li</surname> <given-names>G</given-names> </name> </person-group> <article-title>Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters</article-title> <source>J Res Med Sci</source> <year>2013</year> <volume>18</volume> <fpage>647</fpage> <lpage>52</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_311\"> <label>311.</label> <mixed-citation>Boonacker, E, Van Noorden, CJ. The multifunctional or moonlighting protein CD26/DPPIV. \t\t\t\t\t<italic>Eur J Cell Biol</italic> 2003;82:53\u201373. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Boonacker</surname> <given-names>E</given-names> </name> <name> <surname>Van Noorden</surname> <given-names>CJ</given-names> </name> </person-group> <article-title>The multifunctional or moonlighting protein CD26/DPPIV</article-title> <source>Eur J Cell Biol</source> <year>2003</year> <volume>82</volume> <fpage>53</fpage> <lpage>73</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_312\"> <label>312.</label> <mixed-citation>Proost, P, Struyf, S, Schols, D, Opdenakker, G, Sozzani, S, Allavena, P. Truncation of macrophage-derived chemokine by CD26/ipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. \t\t\t\t\t<italic>J Biol Chem</italic> 1999;274:3988\u201393. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Proost</surname> <given-names>P</given-names> </name> <name> <surname>Struyf</surname> <given-names>S</given-names> </name> <name> <surname>Schols</surname> <given-names>D</given-names> </name> <name> <surname>Opdenakker</surname> <given-names>G</given-names> </name> <name> <surname>Sozzani</surname> <given-names>S</given-names> </name> <name> <surname>Allavena</surname> <given-names>P</given-names> </name> </person-group> <article-title>Truncation of macrophage-derived chemokine by CD26/ipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction</article-title> <source>J Biol Chem</source> <year>1999</year> <volume>274</volume> <fpage>3988</fpage> <lpage>93</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_313\"> <label>313.</label> <mixed-citation>Tang, AC, Raphael, SJ, Lampe, HB, Matthews, TW, Becks, GP. Expression of dipeptidyl aminopeptidase IV activity in thyroid tumours: a possible marker of thyroid malignancy. \t\t\t\t\t<italic>J Otolaryngol</italic> 1996;25:14\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Tang</surname> <given-names>AC</given-names> </name> <name> <surname>Raphael</surname> <given-names>SJ</given-names> </name> <name> <surname>Lampe</surname> <given-names>HB</given-names> </name> <name> <surname>Matthews</surname> <given-names>TW</given-names> </name> <name> <surname>Becks</surname> <given-names>GP</given-names> </name> </person-group> <article-title>Expression of dipeptidyl aminopeptidase IV activity in thyroid tumours: a possible marker of thyroid malignancy</article-title> <source>J Otolaryngol</source> <year>1996</year> <volume>25</volume> <fpage>14</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_314\"> <label>314.</label> <mixed-citation>Lee, JJ, Wang, TY, Liu, CL, Chien, MN, Chen, MJ, Hsu, YC, et al.. Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma. \t\t\t\t\t<italic>J Clin Endocrinol Metab</italic> 2017;102:2930\u201340. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lee</surname> <given-names>JJ</given-names> </name> <name> <surname>Wang</surname> <given-names>TY</given-names> </name> <name> <surname>Liu</surname> <given-names>CL</given-names> </name> <name> <surname>Chien</surname> <given-names>MN</given-names> </name> <name> <surname>Chen</surname> <given-names>MJ</given-names> </name> <name> <surname>Hsu</surname> <given-names>YC</given-names> </name> <etal/> </person-group> <article-title>Dipeptidyl peptidase IV as a prognostic marker and therapeutic target in papillary thyroid carcinoma</article-title> <source>J Clin Endocrinol Metab</source> <year>2017</year> <volume>102</volume> <fpage>2930</fpage> <lpage>40</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_315\"> <label>315.</label> <mixed-citation>Kotani, T, Asada, Y, Aratake, Y, Umeki, K, Yamamoto, I, Tokudome, R. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours. \t\t\t\t\t<italic>J Pathol</italic> 1992;168:41\u20135. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kotani</surname> <given-names>T</given-names> </name> <name> <surname>Asada</surname> <given-names>Y</given-names> </name> <name> <surname>Aratake</surname> <given-names>Y</given-names> </name> <name> <surname>Umeki</surname> <given-names>K</given-names> </name> <name> <surname>Yamamoto</surname> <given-names>I</given-names> </name> <name> <surname>Tokudome</surname> <given-names>R</given-names> </name> </person-group> <article-title>Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours</article-title> <source>J Pathol</source> <year>1992</year> <volume>168</volume> <fpage>41</fpage> <lpage>5</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_316\"> <label>316.</label> <mixed-citation>Maruta, J, Hashimoto, H, Yamashita, H, Yamashita, H, Noguchi, S. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma. \t\t\t\t\t<italic>Arch Surg</italic> 2004;139:83\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Maruta</surname> <given-names>J</given-names> </name> <name> <surname>Hashimoto</surname> <given-names>H</given-names> </name> <name> <surname>Yamashita</surname> <given-names>H</given-names> </name> <name> <surname>Yamashita</surname> <given-names>H</given-names> </name> <name> <surname>Noguchi</surname> <given-names>S</given-names> </name> </person-group> <article-title>Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma</article-title> <source>Arch Surg</source> <year>2004</year> <volume>139</volume> <fpage>83</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_317\"> <label>317.</label> <mixed-citation>Stremenova, J, Krepela, E, Mares, V, Trim, J, Dbaly, V, Marek, J. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. \t\t\t\t\t<italic>Int J Oncol</italic> 2007;31:785\u201392. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Stremenova</surname> <given-names>J</given-names> </name> <name> <surname>Krepela</surname> <given-names>E</given-names> </name> <name> <surname>Mares</surname> <given-names>V</given-names> </name> <name> <surname>Trim</surname> <given-names>J</given-names> </name> <name> <surname>Dbaly</surname> <given-names>V</given-names> </name> <name> <surname>Marek</surname> <given-names>J</given-names> </name> </person-group> <article-title>Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade</article-title> <source>Int J Oncol</source> <year>2007</year> <volume>31</volume> <fpage>785</fpage> <lpage>92</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_318\"> <label>318.</label> <mixed-citation>Ehtesham, M, Winston, JA, Kabos, P, Thompson, RC. CXCR4 expression mediates glioma cell invasiveness. \t\t\t\t\t<italic>Oncogene</italic> 2006;25:2801\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ehtesham</surname> <given-names>M</given-names> </name> <name> <surname>Winston</surname> <given-names>JA</given-names> </name> <name> <surname>Kabos</surname> <given-names>P</given-names> </name> <name> <surname>Thompson</surname> <given-names>RC</given-names> </name> </person-group> <article-title>CXCR4 expression mediates glioma cell invasiveness</article-title> <source>Oncogene</source> <year>2006</year> <volume>25</volume> <fpage>2801</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_319\"> <label>319.</label> <mixed-citation>Christopherson, KW, Hangoc, G, Broxmeyer, HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. \t\t\t\t\t<italic>J Immunol</italic> 2002;169:7000\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Christopherson</surname> <given-names>KW</given-names> </name> <name> <surname>Hangoc</surname> <given-names>G</given-names> </name> <name> <surname>Broxmeyer</surname> <given-names>HE</given-names> </name> </person-group> <article-title>Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells</article-title> <source>J Immunol</source> <year>2002</year> <volume>169</volume> <fpage>7000</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_320\"> <label>320.</label> <mixed-citation>Stremenova, J, Mares, V, Lisa, V, Hilser, M, Krepela, E, Vanickova, Z. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. \t\t\t\t\t<italic>Int J Oncol</italic> 2010;36:351\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Stremenova</surname> <given-names>J</given-names> </name> <name> <surname>Mares</surname> <given-names>V</given-names> </name> <name> <surname>Lisa</surname> <given-names>V</given-names> </name> <name> <surname>Hilser</surname> <given-names>M</given-names> </name> <name> <surname>Krepela</surname> <given-names>E</given-names> </name> <name> <surname>Vanickova</surname> <given-names>Z</given-names> </name> </person-group> <article-title>Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas</article-title> <source>Int J Oncol</source> <year>2010</year> <volume>36</volume> <fpage>351</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_321\"> <label>321.</label> <mixed-citation>Arscott, WT, LaBauve, AE, May, V, Wesley, UV. Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. \t\t\t\t\t<italic>Oncogene</italic> 2009;28:479\u201391. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Arscott</surname> <given-names>WT</given-names> </name> <name> <surname>LaBauve</surname> <given-names>AE</given-names> </name> <name> <surname>May</surname> <given-names>V</given-names> </name> <name> <surname>Wesley</surname> <given-names>UV</given-names> </name> </person-group> <article-title>Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation</article-title> <source>Oncogene</source> <year>2009</year> <volume>28</volume> <fpage>479</fpage> <lpage>91</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_322\"> <label>322.</label> <mixed-citation>Pass, H, Vogelzang, N, Hahn, S, Carbone, M. Malignant pleural mesothelioma. \t\t\t\t\t<italic>Curr Proble Cancer</italic> 2004;28:93\u2013104. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pass</surname> <given-names>H</given-names> </name> <name> <surname>Vogelzang</surname> <given-names>N</given-names> </name> <name> <surname>Hahn</surname> <given-names>S</given-names> </name> <name> <surname>Carbone</surname> <given-names>M</given-names> </name> </person-group> <article-title>Malignant pleural mesothelioma</article-title> <source>Curr Proble Cancer</source> <year>2004</year> <volume>28</volume> <fpage>93</fpage> <lpage>104</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_323\"> <label>323.</label> <mixed-citation>Amatya, V, Takeshima, Y, Kushitani, K, Yamada, T, Morimoto, C. Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines. \t\t\t\t\t<italic>Oncol Rep</italic> 2011;26:1369\u201375. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Amatya</surname> <given-names>V</given-names> </name> <name> <surname>Takeshima</surname> <given-names>Y</given-names> </name> <name> <surname>Kushitani</surname> <given-names>K</given-names> </name> <name> <surname>Yamada</surname> <given-names>T</given-names> </name> <name> <surname>Morimoto</surname> <given-names>C</given-names> </name> </person-group> <article-title>Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines</article-title> <source>Oncol Rep</source> <year>2011</year> <volume>26</volume> <fpage>1369</fpage> <lpage>75</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_324\"> <label>324.</label> <mixed-citation>Angevin, E, Isambert, N, Trillet-Lenoir, V, You, B, Alexandre, J, Zalcman, G, et al.. First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers. \t\t\t\t\t<italic>Br J Cancer</italic> 2017;116:1126\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Angevin</surname> <given-names>E</given-names> </name> <name> <surname>Isambert</surname> <given-names>N</given-names> </name> <name> <surname>Trillet-Lenoir</surname> <given-names>V</given-names> </name> <name> <surname>You</surname> <given-names>B</given-names> </name> <name> <surname>Alexandre</surname> <given-names>J</given-names> </name> <name> <surname>Zalcman</surname> <given-names>G</given-names> </name> <etal/> </person-group> <article-title>First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers</article-title> <source>Br J Cancer</source> <year>2017</year> <volume>116</volume> <fpage>1126</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_325\"> <label>325.</label> <mixed-citation>Ghani, FI, Yamazaki, H, Iwata, S, Okamoto, K, Okabe, K, Mimura, Y, et al.. Identification of cancer stem cell markers in human malignant mesothelioma cells. \t\t\t\t\t<italic>Biochem Biophys Res Commun</italic> 2011;404:735\u201342. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ghani</surname> <given-names>FI</given-names> </name> <name> <surname>Yamazaki</surname> <given-names>H</given-names> </name> <name> <surname>Iwata</surname> <given-names>S</given-names> </name> <name> <surname>Okamoto</surname> <given-names>K</given-names> </name> <name> <surname>Okabe</surname> <given-names>K</given-names> </name> <name> <surname>Mimura</surname> <given-names>Y</given-names> </name> <etal/> </person-group> <article-title>Identification of cancer stem cell markers in human malignant mesothelioma cells</article-title> <source>Biochem Biophys Res Commun</source> <year>2011</year> <volume>404</volume> <fpage>735</fpage> <lpage>42</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_326\"> <label>326.</label> <mixed-citation>Dietrich, P, Wormser, L, Fritz, V, Seitz, T, De Maria, M, Schambony, A, et al.. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer. \t\t\t\t\t<italic>J Clin Investig</italic> 2020;130:2509\u201326. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dietrich</surname> <given-names>P</given-names> </name> <name> <surname>Wormser</surname> <given-names>L</given-names> </name> <name> <surname>Fritz</surname> <given-names>V</given-names> </name> <name> <surname>Seitz</surname> <given-names>T</given-names> </name> <name> <surname>De Maria</surname> <given-names>M</given-names> </name> <name> <surname>Schambony</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer</article-title> <source>J Clin Investig</source> <year>2020</year> <volume>130</volume> <fpage>2509</fpage> <lpage>26</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_327\"> <label>327.</label> <mixed-citation>Stecca, BA, Nardo, B, Chieco, P, Mazziotti, A, Bolondi, L, Cavallari, A. Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma. \t\t\t\t\t<italic>J Hepatol</italic> 1997;27:337\u201345. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Stecca</surname> <given-names>BA</given-names> </name> <name> <surname>Nardo</surname> <given-names>B</given-names> </name> <name> <surname>Chieco</surname> <given-names>P</given-names> </name> <name> <surname>Mazziotti</surname> <given-names>A</given-names> </name> <name> <surname>Bolondi</surname> <given-names>L</given-names> </name> <name> <surname>Cavallari</surname> <given-names>A</given-names> </name> </person-group> <article-title>Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma</article-title> <source>J Hepatol</source> <year>1997</year> <volume>27</volume> <fpage>337</fpage> <lpage>45</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_328\"> <label>328.</label> <mixed-citation>Hollande, C, Boussier, J, Ziai, J, Nozawa, T, Bondet, V, Phung, W, et al.. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumour growth. \t\t\t\t\t<italic>Nat Immunol</italic> 2019;20:257\u201364. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hollande</surname> <given-names>C</given-names> </name> <name> <surname>Boussier</surname> <given-names>J</given-names> </name> <name> <surname>Ziai</surname> <given-names>J</given-names> </name> <name> <surname>Nozawa</surname> <given-names>T</given-names> </name> <name> <surname>Bondet</surname> <given-names>V</given-names> </name> <name> <surname>Phung</surname> <given-names>W</given-names> </name> <etal/> </person-group> <article-title>Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumour growth</article-title> <source>Nat Immunol</source> <year>2019</year> <volume>20</volume> <fpage>257</fpage> <lpage>64</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_329\"> <label>329.</label> <mixed-citation>Nishina, S, Yamauchi, A, Kawaguchi, T, Kaku, K, Goto, M, Sasaki, K, et al.. Dipeptidyl peptidase 4 inhibitors reduce hepatocellular carcinoma by activating lymphocyte chemotaxis in mice. \t\t\t\t\t<italic>Cell Mol Gastroenterol Hepatol</italic> 2019;7:115\u201334. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nishina</surname> <given-names>S</given-names> </name> <name> <surname>Yamauchi</surname> <given-names>A</given-names> </name> <name> <surname>Kawaguchi</surname> <given-names>T</given-names> </name> <name> <surname>Kaku</surname> <given-names>K</given-names> </name> <name> <surname>Goto</surname> <given-names>M</given-names> </name> <name> <surname>Sasaki</surname> <given-names>K</given-names> </name> <etal/> </person-group> <article-title>Dipeptidyl peptidase 4 inhibitors reduce hepatocellular carcinoma by activating lymphocyte chemotaxis in mice</article-title> <source>Cell Mol Gastroenterol Hepatol</source> <year>2019</year> <volume>7</volume> <fpage>115</fpage> <lpage>34</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_330\"> <label>330.</label> <mixed-citation>Henderson, JM, Xiang, MS, Huang, JC, Wetzel, S, Jiang, L, Lai, JH, et al.. Dipeptidyl peptidase inhibition enhances CD8 T cell recruitment and activates Intrahepatic inflammasome in a murine model of hepatocellular carcinoma. \t\t\t\t\t<italic>Cancers</italic> 2021;13:5495. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Henderson</surname> <given-names>JM</given-names> </name> <name> <surname>Xiang</surname> <given-names>MS</given-names> </name> <name> <surname>Huang</surname> <given-names>JC</given-names> </name> <name> <surname>Wetzel</surname> <given-names>S</given-names> </name> <name> <surname>Jiang</surname> <given-names>L</given-names> </name> <name> <surname>Lai</surname> <given-names>JH</given-names> </name> <etal/> </person-group> <article-title>Dipeptidyl peptidase inhibition enhances CD8 T cell recruitment and activates Intrahepatic inflammasome in a murine model of hepatocellular carcinoma</article-title> <source>Cancers</source> <year>2021</year> <volume>13</volume> <fpage>5495</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_331\"> <label>331.</label> <mixed-citation>Gaetaniello, L, Fiore, M, de Filippo, S, Pozzi, N, Tamasi, S, Pignata, C. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells. \t\t\t\t\t<italic>Hepatology</italic> 1998;27:934\u201342. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gaetaniello</surname> <given-names>L</given-names> </name> <name> <surname>Fiore</surname> <given-names>M</given-names> </name> <name> <surname>de Filippo</surname> <given-names>S</given-names> </name> <name> <surname>Pozzi</surname> <given-names>N</given-names> </name> <name> <surname>Tamasi</surname> <given-names>S</given-names> </name> <name> <surname>Pignata</surname> <given-names>C</given-names> </name> </person-group> <article-title>Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells</article-title> <source>Hepatology</source> <year>1998</year> <volume>27</volume> <fpage>934</fpage> <lpage>42</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_332\"> <label>332.</label> <mixed-citation>Itou, M, Kawaguchi, T, Taniguchi, E, Sumie, S, Oriishi, T, Mitsuyama, K, et al.. Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance. \t\t\t\t\t<italic>J Gastroenterol Hepatol</italic> 2008;23:244\u201351. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Itou</surname> <given-names>M</given-names> </name> <name> <surname>Kawaguchi</surname> <given-names>T</given-names> </name> <name> <surname>Taniguchi</surname> <given-names>E</given-names> </name> <name> <surname>Sumie</surname> <given-names>S</given-names> </name> <name> <surname>Oriishi</surname> <given-names>T</given-names> </name> <name> <surname>Mitsuyama</surname> <given-names>K</given-names> </name> <etal/> </person-group> <article-title>Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance</article-title> <source>J Gastroenterol Hepatol</source> <year>2008</year> <volume>23</volume> <fpage>244</fpage> <lpage>51</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_333\"> <label>333.</label> <mixed-citation>Kaji, K, Yoshiji, H, Ikenaka, Y, Noguchi, R, Aihara, Y, Douhara, A, et al.. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. \t\t\t\t\t<italic>J Gastroenterol</italic> 2014;49:481\u201391. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kaji</surname> <given-names>K</given-names> </name> <name> <surname>Yoshiji</surname> <given-names>H</given-names> </name> <name> <surname>Ikenaka</surname> <given-names>Y</given-names> </name> <name> <surname>Noguchi</surname> <given-names>R</given-names> </name> <name> <surname>Aihara</surname> <given-names>Y</given-names> </name> <name> <surname>Douhara</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats</article-title> <source>J Gastroenterol</source> <year>2014</year> <volume>49</volume> <fpage>481</fpage> <lpage>91</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_334\"> <label>334.</label> <mixed-citation>Abd Elmaaboud, M, Khattab, H, Shalaby, S. Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice. \t\t\t\t\t<italic>Can J Physiol Pharmacol</italic> 2021;99:294\u2013302. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Abd Elmaaboud</surname> <given-names>M</given-names> </name> <name> <surname>Khattab</surname> <given-names>H</given-names> </name> <name> <surname>Shalaby</surname> <given-names>S</given-names> </name> </person-group> <article-title>Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice</article-title> <source>Can J Physiol Pharmacol</source> <year>2021</year> <volume>99</volume> <fpage>294</fpage> <lpage>302</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_335\"> <label>335.</label> <mixed-citation>Sokar, SS, El-Sayad, ME, Ghoneim, ME, Shebl, AM. Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats. \t\t\t\t\t<italic>Biomed Pharmacother</italic> 2017;89:98\u2013107. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Sokar</surname> <given-names>SS</given-names> </name> <name> <surname>El-Sayad</surname> <given-names>ME</given-names> </name> <name> <surname>Ghoneim</surname> <given-names>ME</given-names> </name> <name> <surname>Shebl</surname> <given-names>AM</given-names> </name> </person-group> <article-title>Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats</article-title> <source>Biomed Pharmacother</source> <year>2017</year> <volume>89</volume> <fpage>98</fpage> <lpage>107</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_336\"> <label>336.</label> <mixed-citation>Wang, XM, Holz, LE, Chowdhury, S, Cordoba, SP, Evans, KA, Gall, MG, et al.. The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury. \t\t\t\t\t<italic>Immunol Cell Biol</italic> 2017;95:443\u201353. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wang</surname> <given-names>XM</given-names> </name> <name> <surname>Holz</surname> <given-names>LE</given-names> </name> <name> <surname>Chowdhury</surname> <given-names>S</given-names> </name> <name> <surname>Cordoba</surname> <given-names>SP</given-names> </name> <name> <surname>Evans</surname> <given-names>KA</given-names> </name> <name> <surname>Gall</surname> <given-names>MG</given-names> </name> <etal/> </person-group> <article-title>The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury</article-title> <source>Immunol Cell Biol</source> <year>2017</year> <volume>95</volume> <fpage>443</fpage> <lpage>53</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_337\"> <label>337.</label> <mixed-citation>Nagami, Y, Ominami, M, Otani, K, Tanaka, F, Taira, K, Yamagami, H. Endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction. \t\t\t\t\t<italic>Digestion</italic> 2018;97:38\u201344. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nagami</surname> <given-names>Y</given-names> </name> <name> <surname>Ominami</surname> <given-names>M</given-names> </name> <name> <surname>Otani</surname> <given-names>K</given-names> </name> <name> <surname>Tanaka</surname> <given-names>F</given-names> </name> <name> <surname>Taira</surname> <given-names>K</given-names> </name> <name> <surname>Yamagami</surname> <given-names>H</given-names> </name> </person-group> <article-title>Endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction</article-title> <source>Digestion</source> <year>2018</year> <volume>97</volume> <fpage>38</fpage> <lpage>44</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_338\"> <label>338.</label> <mixed-citation>Sharman, P, Sidorenko, EI. Are screening and surveillance for Barrett\u2019s oesophagus really worthwhile. \t\t\t\t\t<italic>Gut</italic> 2005;54:27\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Sharman</surname> <given-names>P</given-names> </name> <name> <surname>Sidorenko</surname> <given-names>EI</given-names> </name> </person-group> <article-title>Are screening and surveillance for Barrett\u2019s oesophagus really worthwhile</article-title> <source>Gut</source> <year>2005</year> <volume>54</volume> <fpage>27</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_339\"> <label>339.</label> <mixed-citation>Omae, M, Fujisaki, J, Shimizu, T, Igarashi, M, Yamamoto, N. Magnifying endoscopy with narrow-band imaging finding in the diagnosis of Barrett\u2019s esophageal adenocarcinoma spreading below squamous epithelium. \t\t\t\t\t<italic>Dig Endosc</italic> 2013;225:162\u20137. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Omae</surname> <given-names>M</given-names> </name> <name> <surname>Fujisaki</surname> <given-names>J</given-names> </name> <name> <surname>Shimizu</surname> <given-names>T</given-names> </name> <name> <surname>Igarashi</surname> <given-names>M</given-names> </name> <name> <surname>Yamamoto</surname> <given-names>N</given-names> </name> </person-group> <article-title>Magnifying endoscopy with narrow-band imaging finding in the diagnosis of Barrett\u2019s esophageal adenocarcinoma spreading below squamous epithelium</article-title> <source>Dig Endosc</source> <year>2013</year> <volume>225</volume> <fpage>162</fpage> <lpage>7</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_340\"> <label>340.</label> <mixed-citation>Yamamoto, K, Ohnishi, S, Mizushima, T, Kodaira, J, Ono, M, Hatanaka, Y, et al.. Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV. \t\t\t\t\t<italic>BMC Cancer</italic> 2020;20:64. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yamamoto</surname> <given-names>K</given-names> </name> <name> <surname>Ohnishi</surname> <given-names>S</given-names> </name> <name> <surname>Mizushima</surname> <given-names>T</given-names> </name> <name> <surname>Kodaira</surname> <given-names>J</given-names> </name> <name> <surname>Ono</surname> <given-names>M</given-names> </name> <name> <surname>Hatanaka</surname> <given-names>Y</given-names> </name> <etal/> </person-group> <article-title>Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV</article-title> <source>BMC Cancer</source> <year>2020</year> <volume>20</volume> <fpage>64</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_341\"> <label>341.</label> <mixed-citation>Onoyama, H, Kamiya, M, Kuriki, Y, Komatsu, T, Abe, H, Tsuji, Y. Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV. \t\t\t\t\t<italic>Sci Rep</italic> 2016;6:26399. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Onoyama</surname> <given-names>H</given-names> </name> <name> <surname>Kamiya</surname> <given-names>M</given-names> </name> <name> <surname>Kuriki</surname> <given-names>Y</given-names> </name> <name> <surname>Komatsu</surname> <given-names>T</given-names> </name> <name> <surname>Abe</surname> <given-names>H</given-names> </name> <name> <surname>Tsuji</surname> <given-names>Y</given-names> </name> </person-group> <article-title>Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV</article-title> <source>Sci Rep</source> <year>2016</year> <volume>6</volume> <elocation-id>26399</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_342\"> <label>342.</label> <mixed-citation>Larrinaga, G, Perez, I, Sanz, B, Beitia, M, Errarte, P, Fernandez, A, et al.. Dipeptidylpeptidase IV activity is correlated with colorectal cancer prognosis. \t\t\t\t\t<italic>PLoS One</italic> 2015;10:e0119436. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Larrinaga</surname> <given-names>G</given-names> </name> <name> <surname>Perez</surname> <given-names>I</given-names> </name> <name> <surname>Sanz</surname> <given-names>B</given-names> </name> <name> <surname>Beitia</surname> <given-names>M</given-names> </name> <name> <surname>Errarte</surname> <given-names>P</given-names> </name> <name> <surname>Fernandez</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Dipeptidylpeptidase IV activity is correlated with colorectal cancer prognosis</article-title> <source>PLoS One</source> <year>2015</year> <volume>10</volume> <elocation-id>e0119436</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_343\"> <label>343.</label> <mixed-citation>Pang, R, Law, WL, Chu, AC, Poon, JT, Lam, CS, Chow, AK, et al.. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. \t\t\t\t\t<italic>Cell Stem Cell</italic> 2010;6:603\u201315. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pang</surname> <given-names>R</given-names> </name> <name> <surname>Law</surname> <given-names>WL</given-names> </name> <name> <surname>Chu</surname> <given-names>AC</given-names> </name> <name> <surname>Poon</surname> <given-names>JT</given-names> </name> <name> <surname>Lam</surname> <given-names>CS</given-names> </name> <name> <surname>Chow</surname> <given-names>AK</given-names> </name> <etal/> </person-group> <article-title>A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer</article-title> <source>Cell Stem Cell</source> <year>2010</year> <volume>6</volume> <fpage>603</fpage> <lpage>15</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_344\"> <label>344.</label> <mixed-citation>Kumaravelu, P, Chellathai, D. Evaluation of anti cancer effects of DPP-4Inhibitors in colon cancer- an Invitro study. \t\t\t\t\t<italic>J Clin Diagn Res</italic> 2015;9:14\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kumaravelu</surname> <given-names>P</given-names> </name> <name> <surname>Chellathai</surname> <given-names>D</given-names> </name> </person-group> <article-title>Evaluation of anti cancer effects of DPP-4Inhibitors in colon cancer- an Invitro study</article-title> <source>J Clin Diagn Res</source> <year>2015</year> <volume>9</volume> <fpage>14</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_345\"> <label>345.</label> <mixed-citation>Gorrell, MD, Gysbers, V, McCaughan, GW. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. \t\t\t\t\t<italic>Scand J Immunol</italic> 2001;54:249\u201364. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gorrell</surname> <given-names>MD</given-names> </name> <name> <surname>Gysbers</surname> <given-names>V</given-names> </name> <name> <surname>McCaughan</surname> <given-names>GW</given-names> </name> </person-group> <article-title>CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes</article-title> <source>Scand J Immunol</source> <year>2001</year> <volume>54</volume> <fpage>249</fpage> <lpage>64</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_346\"> <label>346.</label> <mixed-citation>Gonzalez-Gronow, M, Misra, UK, Gawdi, G, Pizzo, SV. Association of plasminogen with dipeptidyl peptidase IV and Na+/H+ exchanger isoform NHE3 regulates invasion of human 1-LN prostate tumour cells. \t\t\t\t\t<italic>J Biol Chem</italic> 2005;280:27173\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gonzalez-Gronow</surname> <given-names>M</given-names> </name> <name> <surname>Misra</surname> <given-names>UK</given-names> </name> <name> <surname>Gawdi</surname> <given-names>G</given-names> </name> <name> <surname>Pizzo</surname> <given-names>SV</given-names> </name> </person-group> <article-title>Association of plasminogen with dipeptidyl peptidase IV and Na+/H+ exchanger isoform NHE3 regulates invasion of human 1-LN prostate tumour cells</article-title> <source>J Biol Chem</source> <year>2005</year> <volume>280</volume> <fpage>27173</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_347\"> <label>347.</label> <mixed-citation>Cheng, HC, Abdel-Ghany, M, Elble, RC, Pauli, BU. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumour cell surface-associated fibronectin. \t\t\t\t\t<italic>J Biol Chem</italic> 1998;273:24207\u201315. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cheng</surname> <given-names>HC</given-names> </name> <name> <surname>Abdel-Ghany</surname> <given-names>M</given-names> </name> <name> <surname>Elble</surname> <given-names>RC</given-names> </name> <name> <surname>Pauli</surname> <given-names>BU</given-names> </name> </person-group> <article-title>Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumour cell surface-associated fibronectin</article-title> <source>J Biol Chem</source> <year>1998</year> <volume>273</volume> <fpage>24207</fpage> <lpage>15</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_348\"> <label>348.</label> <mixed-citation>Korach, S, Poupon, MF, Du Villard, JA, Becker, M. Differential adhesiveness of rhabdomyosarcoma-derived cloned metastatic cell lines to vascular endothelial monolayers. \t\t\t\t\t<italic>Cancer Res</italic> 1986;46:3624\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Korach</surname> <given-names>S</given-names> </name> <name> <surname>Poupon</surname> <given-names>MF</given-names> </name> <name> <surname>Du Villard</surname> <given-names>JA</given-names> </name> <name> <surname>Becker</surname> <given-names>M</given-names> </name> </person-group> <article-title>Differential adhesiveness of rhabdomyosarcoma-derived cloned metastatic cell lines to vascular endothelial monolayers</article-title> <source>Cancer Res</source> <year>1986</year> <volume>46</volume> <fpage>3624</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_349\"> <label>349.</label> <mixed-citation>Kato, Y, Saijo, N. Developed new agents for lung cancer. \t\t\t\t\t<italic>Nihon Geka Gakkai Zasshi</italic> 2002;103:218\u201323. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kato</surname> <given-names>Y</given-names> </name> <name> <surname>Saijo</surname> <given-names>N</given-names> </name> </person-group> <article-title>Developed new agents for lung cancer</article-title> <source>Nihon Geka Gakkai Zasshi</source> <year>2002</year> <volume>103</volume> <fpage>218</fpage> <lpage>23</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_350\"> <label>350.</label> <mixed-citation>Beckenkamp, A, Davies, S, Willig, JB, Buffon, A. DPPIV/CD26: a tumour suppressor or a marker of malignancy. \t\t\t\t\t<italic>Tumour Biol</italic> 2016;37:7059\u201373. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Beckenkamp</surname> <given-names>A</given-names> </name> <name> <surname>Davies</surname> <given-names>S</given-names> </name> <name> <surname>Willig</surname> <given-names>JB</given-names> </name> <name> <surname>Buffon</surname> <given-names>A</given-names> </name> </person-group> <article-title>DPPIV/CD26: a tumour suppressor or a marker of malignancy</article-title> <source>Tumour Biol</source> <year>2016</year> <volume>37</volume> <fpage>7059</fpage> <lpage>73</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_351\"> <label>351.</label> <mixed-citation>Ehtesham, M, Winston, JA, Kabos, P, Thompson, RC. CXCR4 expression mediates glioma cell invasiveness. \t\t\t\t\t<italic>Oncogene</italic> 2006;25:2801\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ehtesham</surname> <given-names>M</given-names> </name> <name> <surname>Winston</surname> <given-names>JA</given-names> </name> <name> <surname>Kabos</surname> <given-names>P</given-names> </name> <name> <surname>Thompson</surname> <given-names>RC</given-names> </name> </person-group> <article-title>CXCR4 expression mediates glioma cell invasiveness</article-title> <source>Oncogene</source> <year>2006</year> <volume>25</volume> <fpage>2801</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_352\"> <label>352.</label> <mixed-citation>Vangoitsenhoven, R, Mathieu, C, Van der Schueren, B. GLP1 and cancer: friend or foe? \t\t\t\t\t<italic>Endocr Relat Cancer</italic> 2012;19:F77\u201388. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Vangoitsenhoven</surname> <given-names>R</given-names> </name> <name> <surname>Mathieu</surname> <given-names>C</given-names> </name> <name> <surname>Van der Schueren</surname> <given-names>B</given-names> </name> </person-group> <article-title>GLP1 and cancer: friend or foe?</article-title> <source>Endocr Relat Cancer</source> <year>2012</year> <volume>19</volume> <fpage>F77</fpage> <lpage>88</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_353\"> <label>353.</label> <mixed-citation>Korner, M, Stockli, M, Waser, B, Reubi, JC. GLP-1 receptor expression in human tumours and human normal tissues: potential for in vivo targeting. \t\t\t\t\t<italic>J Nucl Med</italic> 2007;48:736\u201343. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Korner</surname> <given-names>M</given-names> </name> <name> <surname>Stockli</surname> <given-names>M</given-names> </name> <name> <surname>Waser</surname> <given-names>B</given-names> </name> <name> <surname>Reubi</surname> <given-names>JC</given-names> </name> </person-group> <article-title>GLP-1 receptor expression in human tumours and human normal tissues: potential for in vivo targeting</article-title> <source>J Nucl Med</source> <year>2007</year> <volume>48</volume> <fpage>736</fpage> <lpage>43</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_354\"> <label>354.</label> <mixed-citation>Koehler, JA, Drucker, DJ. Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells. \t\t\t\t\t<italic>Diabetes</italic> 2006;55:1369\u201379. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Koehler</surname> <given-names>JA</given-names> </name> <name> <surname>Drucker</surname> <given-names>DJ</given-names> </name> </person-group> <article-title>Activation of glucagon-like peptide-1 receptor signaling does not modify the growth or apoptosis of human pancreatic cancer cells</article-title> <source>Diabetes</source> <year>2006</year> <volume>55</volume> <fpage>1369</fpage> <lpage>79</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_355\"> <label>355.</label> <mixed-citation>Girman, CJ, Kou, TD, Cai, B, Alexander, CM, O\u2019Neill, EA, Williams-Herman, DE. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2010;2:766\u201371. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Girman</surname> <given-names>CJ</given-names> </name> <name> <surname>Kou</surname> <given-names>TD</given-names> </name> <name> <surname>Cai</surname> <given-names>B</given-names> </name> <name> <surname>Alexander</surname> <given-names>CM</given-names> </name> <name> <surname>O\u2019Neill</surname> <given-names>EA</given-names> </name> <name> <surname>Williams-Herman</surname> <given-names>DE</given-names> </name> </person-group> <article-title>Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes</article-title> <source>Diabetes Obes Metab</source> <year>2010</year> <volume>2</volume> <fpage>766</fpage> <lpage>71</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_356\"> <label>356.</label> <mixed-citation>Garg, R, Chen, W, Pendergrass, M. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. \t\t\t\t\t<italic>Diabetes Care</italic> 2010;33:2349\u201354. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Garg</surname> <given-names>R</given-names> </name> <name> <surname>Chen</surname> <given-names>W</given-names> </name> <name> <surname>Pendergrass</surname> <given-names>M</given-names> </name> </person-group> <article-title>Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis</article-title> <source>Diabetes Care</source> <year>2010</year> <volume>33</volume> <fpage>2349</fpage> <lpage>54</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_357\"> <label>357.</label> <mixed-citation>Dore, DD, Bloomgren, GL, Wenten, M, Hoffman, C, Clifford, CR, Quinn, SG, et al.. A cohort study of acute pancreatitis in relation to exenatide use. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2011;13:559\u201366. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Dore</surname> <given-names>DD</given-names> </name> <name> <surname>Bloomgren</surname> <given-names>GL</given-names> </name> <name> <surname>Wenten</surname> <given-names>M</given-names> </name> <name> <surname>Hoffman</surname> <given-names>C</given-names> </name> <name> <surname>Clifford</surname> <given-names>CR</given-names> </name> <name> <surname>Quinn</surname> <given-names>SG</given-names> </name> <etal/> </person-group> <article-title>A cohort study of acute pancreatitis in relation to exenatide use</article-title> <source>Diabetes Obes Metab</source> <year>2011</year> <volume>13</volume> <fpage>559</fpage> <lpage>66</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_358\"> <label>358.</label> <mixed-citation>Ueberberg, S, Jutte, H, Uhl, W, Schmidt, W, Nauck, M, Montanya, E, et al.. Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2016;18:1253\u201362. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ueberberg</surname> <given-names>S</given-names> </name> <name> <surname>Jutte</surname> <given-names>H</given-names> </name> <name> <surname>Uhl</surname> <given-names>W</given-names> </name> <name> <surname>Schmidt</surname> <given-names>W</given-names> </name> <name> <surname>Nauck</surname> <given-names>M</given-names> </name> <name> <surname>Montanya</surname> <given-names>E</given-names> </name> <etal/> </person-group> <article-title>Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies</article-title> <source>Diabetes Obes Metab</source> <year>2016</year> <volume>18</volume> <fpage>1253</fpage> <lpage>62</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_359\"> <label>359.</label> <mixed-citation>Aston-Mourney, K, Subramanian, SL, Zraika, S, Samarasekera, T, Meier, DT, Goldstein, LC, et al.. One year of sitagliptin treatment protects against islet amyloid-associated beta-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice. \t\t\t\t\t<italic>Am J Physiol Endocrinol Metab</italic> 2013;305:E475\u2013E484. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Aston-Mourney</surname> <given-names>K</given-names> </name> <name> <surname>Subramanian</surname> <given-names>SL</given-names> </name> <name> <surname>Zraika</surname> <given-names>S</given-names> </name> <name> <surname>Samarasekera</surname> <given-names>T</given-names> </name> <name> <surname>Meier</surname> <given-names>DT</given-names> </name> <name> <surname>Goldstein</surname> <given-names>LC</given-names> </name> <etal/> </person-group> <article-title>One year of sitagliptin treatment protects against islet amyloid-associated beta-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice</article-title> <source>Am J Physiol Endocrinol Metab</source> <year>2013</year> <volume>305</volume> <fpage>E475</fpage> <lpage>E484</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_360\"> <label>360.</label> <mixed-citation>Cox, AR, Lam, CJ, Rankin, MM, Rios, JS, Chavez, J, Bonnyman, CW, et al.. Incretin therapies do not expand beta-cell mass or alter pancreatic histology in young male mice. \t\t\t\t\t<italic>Endocrinology</italic> 2017;158:1701\u201314. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Cox</surname> <given-names>AR</given-names> </name> <name> <surname>Lam</surname> <given-names>CJ</given-names> </name> <name> <surname>Rankin</surname> <given-names>MM</given-names> </name> <name> <surname>Rios</surname> <given-names>JS</given-names> </name> <name> <surname>Chavez</surname> <given-names>J</given-names> </name> <name> <surname>Bonnyman</surname> <given-names>CW</given-names> </name> <etal/> </person-group> <article-title>Incretin therapies do not expand beta-cell mass or alter pancreatic histology in young male mice</article-title> <source>Endocrinology</source> <year>2017</year> <volume>158</volume> <fpage>1701</fpage> <lpage>14</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_361\"> <label>361.</label> <mixed-citation>Busch, SJ, Hoffmann, P, Sahota, P, Johnson, R, Kothny, W, Meyer, F, et al.. Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man. \t\t\t\t\t<italic>Diabetes Obes Metab</italic> 2013;15:72\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Busch</surname> <given-names>SJ</given-names> </name> <name> <surname>Hoffmann</surname> <given-names>P</given-names> </name> <name> <surname>Sahota</surname> <given-names>P</given-names> </name> <name> <surname>Johnson</surname> <given-names>R</given-names> </name> <name> <surname>Kothny</surname> <given-names>W</given-names> </name> <name> <surname>Meyer</surname> <given-names>F</given-names> </name> <etal/> </person-group> <article-title>Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man</article-title> <source>Diabetes Obes Metab</source> <year>2013</year> <volume>15</volume> <fpage>72</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_362\"> <label>362.</label> <mixed-citation>Bjerre Knudsen, L, Madsen, LW, Andersen, S, Almholt, K, de Boer, AS, Drucker, DJ. Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. \t\t\t\t\t<italic>Endocrinology</italic> 2010;151:1473\u201386. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bjerre Knudsen</surname> <given-names>L</given-names> </name> <name> <surname>Madsen</surname> <given-names>LW</given-names> </name> <name> <surname>Andersen</surname> <given-names>S</given-names> </name> <name> <surname>Almholt</surname> <given-names>K</given-names> </name> <name> <surname>de Boer</surname> <given-names>AS</given-names> </name> <name> <surname>Drucker</surname> <given-names>DJ</given-names> </name> </person-group> <article-title>Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation</article-title> <source>Endocrinology</source> <year>2010</year> <volume>151</volume> <fpage>1473</fpage> <lpage>86</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_363\"> <label>363.</label> <mixed-citation>Waser, B, Beetschen, K, Pellegata, NS, Reubi, JC. Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy. \t\t\t\t\t<italic>Neuroendocrinology</italic> 2011;94:291\u2013301. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Waser</surname> <given-names>B</given-names> </name> <name> <surname>Beetschen</surname> <given-names>K</given-names> </name> <name> <surname>Pellegata</surname> <given-names>NS</given-names> </name> <name> <surname>Reubi</surname> <given-names>JC</given-names> </name> </person-group> <article-title>Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy</article-title> <source>Neuroendocrinology</source> <year>2011</year> <volume>94</volume> <fpage>291</fpage> <lpage>301</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_364\"> <label>364.</label> <mixed-citation>Roman, S, Lin, R, Sosa, JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. \t\t\t\t\t<italic>Cancer</italic> 2006;107:2134\u201342. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Roman</surname> <given-names>S</given-names> </name> <name> <surname>Lin</surname> <given-names>R</given-names> </name> <name> <surname>Sosa</surname> <given-names>JA</given-names> </name> </person-group> <article-title>Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases</article-title> <source>Cancer</source> <year>2006</year> <volume>107</volume> <fpage>2134</fpage> <lpage>42</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_365\"> <label>365.</label> <mixed-citation>Koehler, JA, Kain, T, Drucker, DJ. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells. \t\t\t\t\t<italic>Endocrinology</italic> 2011;152:3362\u201372. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Koehler</surname> <given-names>JA</given-names> </name> <name> <surname>Kain</surname> <given-names>T</given-names> </name> <name> <surname>Drucker</surname> <given-names>DJ</given-names> </name> </person-group> <article-title>Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells</article-title> <source>Endocrinology</source> <year>2011</year> <volume>152</volume> <fpage>3362</fpage> <lpage>72</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_366\"> <label>366.</label> <mixed-citation>Greenberg, ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. \t\t\t\t\t<italic>Science</italic> 1995;270:1326\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Greenberg</surname> <given-names>ME</given-names> </name> </person-group> <article-title>Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis</article-title> <source>Science</source> <year>1995</year> <volume>270</volume> <fpage>1326</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_367\"> <label>367.</label> <mixed-citation>Arrebola, Y, D\u00edaz, L, Garc\u00eda, G, Pascual, I. Dipeptidil peptidasa IV: inhibidores y sus potenciales aplicaciones biom\u00e9dicas. \t\t\t\t\t<italic>Rev Cuba Cien Biol</italic> 2014;3:14\u201326. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Arrebola</surname> <given-names>Y</given-names> </name> <name> <surname>D\u00edaz</surname> <given-names>L</given-names> </name> <name> <surname>Garc\u00eda</surname> <given-names>G</given-names> </name> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> </person-group> <article-title>Dipeptidil peptidasa IV: inhibidores y sus potenciales aplicaciones biom\u00e9dicas</article-title> <source>Rev Cuba Cien Biol</source> <year>2014</year> <volume>3</volume> <fpage>14</fpage> <lpage>26</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_368\"> <label>368.</label> <mixed-citation>Pascual, I, Arrebola, Y, Almeida, F, Vald\u00e9s, ME, Rivera, L, Hern\u00e1ndez-Zanuy, A, et al.. Marine and coastal organisms: a source of biomedically relevant dipeptidyl peptidase IV inhibitors. \t\t\t\t\t<italic>Rev Cuba Cien Biol</italic> 2020;8:1\u201316. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Arrebola</surname> <given-names>Y</given-names> </name> <name> <surname>Almeida</surname> <given-names>F</given-names> </name> <name> <surname>Vald\u00e9s</surname> <given-names>ME</given-names> </name> <name> <surname>Rivera</surname> <given-names>L</given-names> </name> <name> <surname>Hern\u00e1ndez-Zanuy</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Marine and coastal organisms: a source of biomedically relevant dipeptidyl peptidase IV inhibitors</article-title> <source>Rev Cuba Cien Biol</source> <year>2020</year> <volume>8</volume> <fpage>1</fpage> <lpage>16</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_369\"> <label>369.</label> <mixed-citation>Lu, Y, Lu, P, Wang, Y, Fang, X. A novel dipeptidyl peptidase IV inhibitory tea peptide improves pancreatic \u03b2-cell function and reduces \u03b1-cell proliferation in StreptozotocinInduced diabetic mice. \t\t\t\t\t<italic>Int J Mol Sci</italic> 2019;20:322. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lu</surname> <given-names>Y</given-names> </name> <name> <surname>Lu</surname> <given-names>P</given-names> </name> <name> <surname>Wang</surname> <given-names>Y</given-names> </name> <name> <surname>Fang</surname> <given-names>X</given-names> </name> </person-group> <article-title>A novel dipeptidyl peptidase IV inhibitory tea peptide improves pancreatic \u03b2-cell function and reduces \u03b1-cell proliferation in StreptozotocinInduced diabetic mice</article-title> <source>Int J Mol Sci</source> <year>2019</year> <volume>20</volume> <fpage>322</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_370\"> <label>370.</label> <mixed-citation>Lin, SR, Chang, CH, Tsai, MJ, Cheng, H. The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo. \t\t\t\t\t<italic>Thera Adv Chron Dis</italic> 2019;10:2040622319875305. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lin</surname> <given-names>SR</given-names> </name> <name> <surname>Chang</surname> <given-names>CH</given-names> </name> <name> <surname>Tsai</surname> <given-names>MJ</given-names> </name> <name> <surname>Cheng</surname> <given-names>H</given-names> </name> </person-group> <article-title>The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo</article-title> <source>Thera Adv Chron Dis</source> <year>2019</year> <volume>10</volume> <elocation-id>2040622319875305</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_371\"> <label>371.</label> <mixed-citation>Pascual, I, Lop\u00e9z, A, G\u00f3mez, H, Chapp\u00e9, M. Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms. \t\t\t\t\t<italic>Enz Microb Tech</italic> 2007;40:414\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Lop\u00e9z</surname> <given-names>A</given-names> </name> <name> <surname>G\u00f3mez</surname> <given-names>H</given-names> </name> <name> <surname>Chapp\u00e9</surname> <given-names>M</given-names> </name> </person-group> <article-title>Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms</article-title> <source>Enz Microb Tech</source> <year>2007</year> <volume>40</volume> <fpage>414</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_372\"> <label>372.</label> <mixed-citation>Turdu, G, Gao, H, Jiang, Y, Kabas, M. Plant dipeptidyl peptidase-iv inhibitors as antidiabetic agents: a brief review. \t\t\t\t\t<italic>Future Med Chem</italic> 2018;10:1229\u201339. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Turdu</surname> <given-names>G</given-names> </name> <name> <surname>Gao</surname> <given-names>H</given-names> </name> <name> <surname>Jiang</surname> <given-names>Y</given-names> </name> <name> <surname>Kabas</surname> <given-names>M</given-names> </name> </person-group> <article-title>Plant dipeptidyl peptidase-iv inhibitors as antidiabetic agents: a brief review</article-title> <source>Future Med Chem</source> <year>2018</year> <volume>10</volume> <fpage>1229</fpage> <lpage>39</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_373\"> <label>373.</label> <mixed-citation>Singh, AK, Patel, PK, Choudhary, K, Joshi, J. Quercetin and coumarin inhibit dipeptidyl peptidase-IV and exhibits antioxidant properties: in silico, in vitro, ex vivo. \t\t\t\t\t<italic>Biomolecules</italic> 2020;10:207. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Singh</surname> <given-names>AK</given-names> </name> <name> <surname>Patel</surname> <given-names>PK</given-names> </name> <name> <surname>Choudhary</surname> <given-names>K</given-names> </name> <name> <surname>Joshi</surname> <given-names>J</given-names> </name> </person-group> <article-title>Quercetin and coumarin inhibit dipeptidyl peptidase-IV and exhibits antioxidant properties: in silico, in vitro, ex vivo</article-title> <source>Biomolecules</source> <year>2020</year> <volume>10</volume> <fpage>207</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_374\"> <label>374.</label> <mixed-citation>Liu, R, Cheng, J, Wu, H. Discovery of food-derived dipeptidyl peptidase IV inhibitory peptides: a review. \t\t\t\t\t<italic>Int J Mol Sci</italic> 2019;20:3463. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Liu</surname> <given-names>R</given-names> </name> <name> <surname>Cheng</surname> <given-names>J</given-names> </name> <name> <surname>Wu</surname> <given-names>H</given-names> </name> </person-group> <article-title>Discovery of food-derived dipeptidyl peptidase IV inhibitory peptides: a review</article-title> <source>Int J Mol Sci</source> <year>2019</year> <volume>20</volume> <fpage>3463</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_375\"> <label>375.</label> <mixed-citation>Gomez, HL, Peralta, JP, Tejano, LA, Chang, YW. In silico and in vitro assessment of Portuguese oyster (Crassostrea angulata) proteins as precursor of bioactive peptides. \t\t\t\t\t<italic>Int J Mol Sci</italic> 2019, 20, 5191. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Gomez</surname> <given-names>HL</given-names> </name> <name> <surname>Peralta</surname> <given-names>JP</given-names> </name> <name> <surname>Tejano</surname> <given-names>LA</given-names> </name> <name> <surname>Chang</surname> <given-names>YW</given-names> </name> </person-group> <article-title>In silico and in vitro assessment of Portuguese oyster (Crassostrea angulata) proteins as precursor of bioactive peptides</article-title> <source>Int J Mol Sci</source> <year>2019</year> <volume>20</volume> <fpage>5191</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_376\"> <label>376.</label> <mixed-citation>Chakraborty, K, Joy, M. Anti-diabetic and anti-inflammatory activities of commonly available cephalopods. \t\t\t\t\t<italic>Int J Food Prop</italic> 2017;20:1655\u201365. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Chakraborty</surname> <given-names>K</given-names> </name> <name> <surname>Joy</surname> <given-names>M</given-names> </name> </person-group> <article-title>Anti-diabetic and anti-inflammatory activities of commonly available cephalopods</article-title> <source>Int J Food Prop</source> <year>2017</year> <volume>20</volume> <fpage>1655</fpage> <lpage>65</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_377\"> <label>377.</label> <mixed-citation>Lauritano, C, Ianora, A. Marine organisms with anti-diabetes properties. \t\t\t\t\t<italic>Mar Drugs</italic> 2016;14:220. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lauritano</surname> <given-names>C</given-names> </name> <name> <surname>Ianora</surname> <given-names>A</given-names> </name> </person-group> <article-title>Marine organisms with anti-diabetes properties</article-title> <source>Mar Drugs</source> <year>2016</year> <volume>14</volume> <fpage>220</fpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_378\"> <label>378.</label> <mixed-citation>Nongonierma, A, Mooney, C, Shields, D, FitzGerald, R. Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides. \t\t\t\t\t<italic>Food Chem</italic> 2013;141:644\u201353. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nongonierma</surname> <given-names>A</given-names> </name> <name> <surname>Mooney</surname> <given-names>C</given-names> </name> <name> <surname>Shields</surname> <given-names>D</given-names> </name> <name> <surname>FitzGerald</surname> <given-names>R</given-names> </name> </person-group> <article-title>Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides</article-title> <source>Food Chem</source> <year>2013</year> <volume>141</volume> <fpage>644</fpage> <lpage>53</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_379\"> <label>379.</label> <mixed-citation>Kelly, TA, Adams, J, Bachovchin, WW, Barton, RW, Campbell, SJ, Coutts, SJ, et al.. Immunosuppressive boronic acid dipeptides: correlation between conformation and activity. \t\t\t\t\t<italic>J Am Chem Soc</italic> 1993;115:12637\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kelly</surname> <given-names>TA</given-names> </name> <name> <surname>Adams</surname> <given-names>J</given-names> </name> <name> <surname>Bachovchin</surname> <given-names>WW</given-names> </name> <name> <surname>Barton</surname> <given-names>RW</given-names> </name> <name> <surname>Campbell</surname> <given-names>SJ</given-names> </name> <name> <surname>Coutts</surname> <given-names>SJ</given-names> </name> <etal/> </person-group> <article-title>Immunosuppressive boronic acid dipeptides: correlation between conformation and activity</article-title> <source>J Am Chem Soc</source> <year>1993</year> <volume>115</volume> <fpage>12637</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_380\"> <label>380.</label> <mixed-citation>Lam, B, Zhang, Z, Stafford, J, Skene, R, Shi, L, Gwaltney, S. Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors. \t\t\t\t\t<italic>Bioorg Med Chem Lett</italic> 2012;22:6628\u201331. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Lam</surname> <given-names>B</given-names> </name> <name> <surname>Zhang</surname> <given-names>Z</given-names> </name> <name> <surname>Stafford</surname> <given-names>J</given-names> </name> <name> <surname>Skene</surname> <given-names>R</given-names> </name> <name> <surname>Shi</surname> <given-names>L</given-names> </name> <name> <surname>Gwaltney</surname> <given-names>S</given-names> </name> </person-group> <article-title>Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors</article-title> <source>Bioorg Med Chem Lett</source> <year>2012</year> <volume>22</volume> <fpage>6628</fpage> <lpage>31</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_381\"> <label>381.</label> <mixed-citation>Motoshima, K, Sugita, K, Hashimoto, Y, Ishikawa, M. Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related a-glucosidase inhibitors and liver X receptor antagonists. \t\t\t\t\t<italic>Bioorg Med Chem Lett</italic> 2011;21:3041\u20135. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Motoshima</surname> <given-names>K</given-names> </name> <name> <surname>Sugita</surname> <given-names>K</given-names> </name> <name> <surname>Hashimoto</surname> <given-names>Y</given-names> </name> <name> <surname>Ishikawa</surname> <given-names>M</given-names> </name> </person-group> <article-title>Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related a-glucosidase inhibitors and liver X receptor antagonists</article-title> <source>Bioorg Med Chem Lett</source> <year>2011</year> <volume>21</volume> <fpage>3041</fpage> <lpage>5</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_382\"> <label>382.</label> <mixed-citation>G\u00f3mez, H, Chapp\u00e9, M, Valiente, P, Pons, T. Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV. \t\t\t\t\t<italic>J Biosci</italic> 2013;38:1\u20139. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>G\u00f3mez</surname> <given-names>H</given-names> </name> <name> <surname>Chapp\u00e9</surname> <given-names>M</given-names> </name> <name> <surname>Valiente</surname> <given-names>P</given-names> </name> <name> <surname>Pons</surname> <given-names>T</given-names> </name> </person-group> <article-title>Effect of zinc and calcium ions on the rat kidney membrane-bound form of dipeptidyl peptidase IV</article-title> <source>J Biosci</source> <year>2013</year> <volume>38</volume> <fpage>1</fpage> <lpage>9</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_383\"> <label>383.</label> <mixed-citation>Pascual, I, G\u00f3mez, H, Pons, T, Chapp\u00e9, M. Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV. \t\t\t\t\t<italic>Int J Biochem Cell Biol</italic> 2011;4:2\u201316. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>G\u00f3mez</surname> <given-names>H</given-names> </name> <name> <surname>Pons</surname> <given-names>T</given-names> </name> <name> <surname>Chapp\u00e9</surname> <given-names>M</given-names> </name> </person-group> <article-title>Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV</article-title> <source>Int J Biochem Cell Biol</source> <year>2011</year> <volume>4</volume> <fpage>2</fpage> <lpage>16</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_384\"> <label>384.</label> <mixed-citation>Pascual, I, Valiente, P, Vald\u00e9s-Tresanco, ME, Arrebola, Y, Almeida, F, D\u00edaz, L, et al.. \t\t\t\t\t<italic>Int J Biol Macromol</italic> 2022;196:120\u201330. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pascual</surname> <given-names>I</given-names> </name> <name> <surname>Valiente</surname> <given-names>P</given-names> </name> <name> <surname>Vald\u00e9s-Tresanco</surname> <given-names>ME</given-names> </name> <name> <surname>Arrebola</surname> <given-names>Y</given-names> </name> <name> <surname>Almeida</surname> <given-names>F</given-names> </name> <name> <surname>D\u00edaz</surname> <given-names>L</given-names> </name> <etal/> </person-group> <source>Int J Biol Macromol</source> <year>2022</year> <volume>196</volume> <fpage>120</fpage> <lpage>30</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_385\"> <label>385.</label> <mixed-citation>Wang, H, Liu, X, Long, M, Huang, Y, Zhang, L, Zhang, R, et al.. NRF2 activation by antioxidant antidiabetic agents accelerates tumour metastasis. \t\t\t\t\t<italic>Sci Transl Med</italic> 2016;8:334\u201351. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wang</surname> <given-names>H</given-names> </name> <name> <surname>Liu</surname> <given-names>X</given-names> </name> <name> <surname>Long</surname> <given-names>M</given-names> </name> <name> <surname>Huang</surname> <given-names>Y</given-names> </name> <name> <surname>Zhang</surname> <given-names>L</given-names> </name> <name> <surname>Zhang</surname> <given-names>R</given-names> </name> <etal/> </person-group> <article-title>NRF2 activation by antioxidant antidiabetic agents accelerates tumour metastasis</article-title> <source>Sci Transl Med</source> <year>2016</year> <volume>8</volume> <fpage>334</fpage> <lpage>51</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_386\"> <label>386.</label> <mixed-citation>Russo, JW, Gao, C, Bhasin, SS, Voznesensky, OS, Calagua, C, Arai, S, et al.. Downregulation of dipeptidyl peptidase 4 accelerates progression to castration-resistant prostate cancer. \t\t\t\t\t<italic>Cancer Res</italic> 2018;78:6354\u201362. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Russo</surname> <given-names>JW</given-names> </name> <name> <surname>Gao</surname> <given-names>C</given-names> </name> <name> <surname>Bhasin</surname> <given-names>SS</given-names> </name> <name> <surname>Voznesensky</surname> <given-names>OS</given-names> </name> <name> <surname>Calagua</surname> <given-names>C</given-names> </name> <name> <surname>Arai</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title>Downregulation of dipeptidyl peptidase 4 accelerates progression to castration-resistant prostate cancer</article-title> <source>Cancer Res</source> <year>2018</year> <volume>78</volume> <fpage>6354</fpage> <lpage>62</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_387\"> <label>387.</label> <mixed-citation>Yang, F, Takagaki, Y, Yoshitomi, Y, Ikeda, T, Li, J, Kitada, M, et al.. Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR Axis. \t\t\t\t\t<italic>Cancer Res</italic> 2019;79:735\u201346. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yang</surname> <given-names>F</given-names> </name> <name> <surname>Takagaki</surname> <given-names>Y</given-names> </name> <name> <surname>Yoshitomi</surname> <given-names>Y</given-names> </name> <name> <surname>Ikeda</surname> <given-names>T</given-names> </name> <name> <surname>Li</surname> <given-names>J</given-names> </name> <name> <surname>Kitada</surname> <given-names>M</given-names> </name> <etal/> </person-group> <article-title>Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12/CXCR4/mTOR Axis</article-title> <source>Cancer Res</source> <year>2019</year> <volume>79</volume> <fpage>735</fpage> <lpage>46</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_388\"> <label>388.</label> <mixed-citation>Pech, V, Abusaada, K, Alemany, C. Dipeptidyl peptidase-4 inhibition may stimulate progression of carcinoid tumour. \t\t\t\t\t<italic>Case Rep Endocrinol</italic> 2015;2015:952019. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Pech</surname> <given-names>V</given-names> </name> <name> <surname>Abusaada</surname> <given-names>K</given-names> </name> <name> <surname>Alemany</surname> <given-names>C</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase-4 inhibition may stimulate progression of carcinoid tumour</article-title> <source>Case Rep Endocrinol</source> <year>2015</year> <volume>2015</volume> <elocation-id>952019</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_389\"> <label>389.</label> <mixed-citation>Ali, A, Fuentes, A, Skelton, WP, Wang, Y, Mcgorray, S, Shah, C. A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers. \t\t\t\t\t<italic>Mol Clin Oncol</italic> 2019;10:118\u201324. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Ali</surname> <given-names>A</given-names> </name> <name> <surname>Fuentes</surname> <given-names>A</given-names> </name> <name> <surname>Skelton</surname> <given-names>WP</given-names> </name> <name> <surname>Wang</surname> <given-names>Y</given-names> </name> <name> <surname>Mcgorray</surname> <given-names>S</given-names> </name> <name> <surname>Shah</surname> <given-names>C</given-names> </name> </person-group> <article-title>A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers</article-title> <source>Mol Clin Oncol</source> <year>2019</year> <volume>10</volume> <fpage>118</fpage> <lpage>24</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_390\"> <label>390.</label> <mixed-citation>Bishnoi, R, Hong, YR, Shah, C, Ali, A, Skelton, WP, Huo, J. Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: a surveillance epidemiology and endpoint research medicare study. \t\t\t\t\t<italic>Cancer Med</italic> 2019;8:3918\u201327. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Bishnoi</surname> <given-names>R</given-names> </name> <name> <surname>Hong</surname> <given-names>YR</given-names> </name> <name> <surname>Shah</surname> <given-names>C</given-names> </name> <name> <surname>Ali</surname> <given-names>A</given-names> </name> <name> <surname>Skelton</surname> <given-names>WP</given-names> </name> <name> <surname>Huo</surname> <given-names>J</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: a surveillance epidemiology and endpoint research medicare study</article-title> <source>Cancer Med</source> <year>2019</year> <volume>8</volume> <fpage>3918</fpage> <lpage>27</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_391\"> <label>391.</label> <mixed-citation>Tseng, CH. Sitagliptin may reduce breast cancer risk in women with type 2 diabetes. \t\t\t\t\t<italic>Clin Breast Cancer</italic> 2017;17:211\u20138. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Tseng</surname> <given-names>CH</given-names> </name> </person-group> <article-title>Sitagliptin may reduce breast cancer risk in women with type 2 diabetes</article-title> <source>Clin Breast Cancer</source> <year>2017</year> <volume>17</volume> <fpage>211</fpage> <lpage>8</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_392\"> <label>392.</label> <mixed-citation>Tseng, CH. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes. \t\t\t\t\t<italic>Oncotarget</italic> 2017;8:19057\u201364. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Tseng</surname> <given-names>CH</given-names> </name> </person-group> <article-title>Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes</article-title> <source>Oncotarget</source> <year>2017</year> <volume>8</volume> <fpage>19057</fpage> <lpage>64</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_393\"> <label>393.</label> <mixed-citation>Hsu, WH, Sue, SP, Liang, HL, Tseng, CW, Lin, HC, Wen, WL, et al.. Dipeptidyl peptidase 4 inhibitors decrease the risk of hepatocellular carcinoma in patients with chronic hepatitis C infection and type 2 diabetes mellitus: a Nationwide study in Taiwan. \t\t\t\t\t<italic>Front Public Health</italic> 2021;9:711723. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Hsu</surname> <given-names>WH</given-names> </name> <name> <surname>Sue</surname> <given-names>SP</given-names> </name> <name> <surname>Liang</surname> <given-names>HL</given-names> </name> <name> <surname>Tseng</surname> <given-names>CW</given-names> </name> <name> <surname>Lin</surname> <given-names>HC</given-names> </name> <name> <surname>Wen</surname> <given-names>WL</given-names> </name> <etal/> </person-group> <article-title>Dipeptidyl peptidase 4 inhibitors decrease the risk of hepatocellular carcinoma in patients with chronic hepatitis C infection and type 2 diabetes mellitus: a Nationwide study in Taiwan</article-title> <source>Front Public Health</source> <year>2021</year> <volume>9</volume> <elocation-id>711723</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_394\"> <label>394.</label> <mixed-citation>Kamada, S, Namekawa, T, Ikeda, K, Suzuki, T, Kagawa, M, Takeshita, H, et al.. Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma. \t\t\t\t\t<italic>Oncogene</italic> 2021;40:3899\u2013913. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kamada</surname> <given-names>S</given-names> </name> <name> <surname>Namekawa</surname> <given-names>T</given-names> </name> <name> <surname>Ikeda</surname> <given-names>K</given-names> </name> <name> <surname>Suzuki</surname> <given-names>T</given-names> </name> <name> <surname>Kagawa</surname> <given-names>M</given-names> </name> <name> <surname>Takeshita</surname> <given-names>H</given-names> </name> <etal/> </person-group> <article-title>Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma</article-title> <source>Oncogene</source> <year>2021</year> <volume>40</volume> <fpage>3899</fpage> <lpage>913</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_395\"> <label>395.</label> <mixed-citation>Kabel, AM, Atef, A, Estfanous, RS. Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma. \t\t\t\t\t<italic>Biomed Pharmacother</italic> 2018;97:667\u201374. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Kabel</surname> <given-names>AM</given-names> </name> <name> <surname>Atef</surname> <given-names>A</given-names> </name> <name> <surname>Estfanous</surname> <given-names>RS</given-names> </name> </person-group> <article-title>Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma</article-title> <source>Biomed Pharmacother</source> <year>2018</year> <volume>97</volume> <fpage>667</fpage> <lpage>74</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_396\"> <label>396.</label> <mixed-citation>Arwert, EN, Mentink, RA, Driskell, RR, Hoste, E, Goldie, SJ, Quist, WFM. Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation. \t\t\t\t\t<italic>Oncogene</italic> 2012;31:992\u20131000. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Arwert</surname> <given-names>EN</given-names> </name> <name> <surname>Mentink</surname> <given-names>RA</given-names> </name> <name> <surname>Driskell</surname> <given-names>RR</given-names> </name> <name> <surname>Hoste</surname> <given-names>E</given-names> </name> <name> <surname>Goldie</surname> <given-names>SJ</given-names> </name> <name> <surname>Quist</surname> <given-names>WFM</given-names> </name> </person-group> <article-title>Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation</article-title> <source>Oncogene</source> <year>2012</year> <volume>31</volume> <fpage>992</fpage> <lpage>1000</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_397\"> <label>397.</label> <mixed-citation>Choi, HJ, Kim, JY, Lim, SC, Kim, G, Yun, HJ, Choi, HS. Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression. \t\t\t\t\t<italic>Br J Pharmacol</italic> 2015;172:5096\u2013109. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Choi</surname> <given-names>HJ</given-names> </name> <name> <surname>Kim</surname> <given-names>JY</given-names> </name> <name> <surname>Lim</surname> <given-names>SC</given-names> </name> <name> <surname>Kim</surname> <given-names>G</given-names> </name> <name> <surname>Yun</surname> <given-names>HJ</given-names> </name> <name> <surname>Choi</surname> <given-names>HS</given-names> </name> </person-group> <article-title>Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression</article-title> <source>Br J Pharmacol</source> <year>2015</year> <volume>172</volume> <fpage>5096</fpage> <lpage>109</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_398\"> <label>398.</label> <mixed-citation>Wang, Q, Lu, P, Wang, T, Zheng, Q, Li, Y, Leng, SX, et al.. Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation. \t\t\t\t\t<italic>Cancer Med</italic> 2020;9:3816\u201328. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Wang</surname> <given-names>Q</given-names> </name> <name> <surname>Lu</surname> <given-names>P</given-names> </name> <name> <surname>Wang</surname> <given-names>T</given-names> </name> <name> <surname>Zheng</surname> <given-names>Q</given-names> </name> <name> <surname>Li</surname> <given-names>Y</given-names> </name> <name> <surname>Leng</surname> <given-names>SX</given-names> </name> <etal/> </person-group> <article-title>Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation</article-title> <source>Cancer Med</source> <year>2020</year> <volume>9</volume> <fpage>3816</fpage> <lpage>28</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_399\"> <label>399.</label> <mixed-citation>Sliwinska, A, Rogalska, A, Marczak, A, Kasznicki, J, Drzewoski, J. Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death. \t\t\t\t\t<italic>Toxicol Vitr</italic> 2015;29:1116\u201323. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Sliwinska</surname> <given-names>A</given-names> </name> <name> <surname>Rogalska</surname> <given-names>A</given-names> </name> <name> <surname>Marczak</surname> <given-names>A</given-names> </name> <name> <surname>Kasznicki</surname> <given-names>J</given-names> </name> <name> <surname>Drzewoski</surname> <given-names>J</given-names> </name> </person-group> <article-title>Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death</article-title> <source>Toxicol Vitr</source> <year>2015</year> <volume>29</volume> <fpage>1116</fpage> <lpage>23</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_400\"> <label>400.</label> <mixed-citation>Beckenkamp, A, Willig, JB, Santana, DB, Nascimento, J, Paccez, JD, Zerbini, LF, et al.. Differential expression and enzymatic activity of DPPIV/CD26 affects migration ability of cervical carcinoma cells. \t\t\t\t\t<italic>PLoS One</italic> 2015;10:e0134305. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Beckenkamp</surname> <given-names>A</given-names> </name> <name> <surname>Willig</surname> <given-names>JB</given-names> </name> <name> <surname>Santana</surname> <given-names>DB</given-names> </name> <name> <surname>Nascimento</surname> <given-names>J</given-names> </name> <name> <surname>Paccez</surname> <given-names>JD</given-names> </name> <name> <surname>Zerbini</surname> <given-names>LF</given-names> </name> <etal/> </person-group> <article-title>Differential expression and enzymatic activity of DPPIV/CD26 affects migration ability of cervical carcinoma cells</article-title> <source>PLoS One</source> <year>2015</year> <volume>10</volume> <elocation-id>e0134305</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_401\"> <label>401.</label> <mixed-citation>Herrmann, H, Sadovnik, I, Cerny-Reiterer, S, Rulicke, T, Stefanzl, G, Willmann, M, et al.. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. \t\t\t\t\t<italic>Blood</italic> 2014;123:3951\u201362. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Herrmann</surname> <given-names>H</given-names> </name> <name> <surname>Sadovnik</surname> <given-names>I</given-names> </name> <name> <surname>Cerny-Reiterer</surname> <given-names>S</given-names> </name> <name> <surname>Rulicke</surname> <given-names>T</given-names> </name> <name> <surname>Stefanzl</surname> <given-names>G</given-names> </name> <name> <surname>Willmann</surname> <given-names>M</given-names> </name> <etal/> </person-group> <article-title>Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia</article-title> <source>Blood</source> <year>2014</year> <volume>123</volume> <fpage>3951</fpage> <lpage>62</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_402\"> <label>402.</label> <mixed-citation>Spagnuolo, PA, Hurren, R, Gronda, M, MacLean, N, Datti, A, Basheer, A, et al.. Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide\u2019s anti-leukemic activity. \t\t\t\t\t<italic>Leukemia</italic> 2013;27:1236\u201344. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Spagnuolo</surname> <given-names>PA</given-names> </name> <name> <surname>Hurren</surname> <given-names>R</given-names> </name> <name> <surname>Gronda</surname> <given-names>M</given-names> </name> <name> <surname>MacLean</surname> <given-names>N</given-names> </name> <name> <surname>Datti</surname> <given-names>A</given-names> </name> <name> <surname>Basheer</surname> <given-names>A</given-names> </name> <etal/> </person-group> <article-title>Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide\u2019s anti-leukemic activity</article-title> <source>Leukemia</source> <year>2013</year> <volume>27</volume> <fpage>1236</fpage> <lpage>44</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_403\"> <label>403.</label> <mixed-citation>Sato, T, Tatekoshi, A, Takada, K, Iyama, S, Kamihara, Y, Jawaid, P, et al.. DPP8 is a novel therapeutic target for multiple myeloma. \t\t\t\t\t<italic>Sci Rep</italic> 2019;9:18094. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Sato</surname> <given-names>T</given-names> </name> <name> <surname>Tatekoshi</surname> <given-names>A</given-names> </name> <name> <surname>Takada</surname> <given-names>K</given-names> </name> <name> <surname>Iyama</surname> <given-names>S</given-names> </name> <name> <surname>Kamihara</surname> <given-names>Y</given-names> </name> <name> <surname>Jawaid</surname> <given-names>P</given-names> </name> <etal/> </person-group> <article-title>DPP8 is a novel therapeutic target for multiple myeloma</article-title> <source>Sci Rep</source> <year>2019</year> <volume>9</volume> <elocation-id>18094</elocation-id> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_404\"> <label>404.</label> <mixed-citation>Nabeno, M, Akahoshi, F, Kishida, H, Miyaguchi, I, Tanaka, Y, Ishii, S, et al.. A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site. \t\t\t\t\t<italic>Biochem Biophys Res Commun</italic> 2013;434:191\u20136. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Nabeno</surname> <given-names>M</given-names> </name> <name> <surname>Akahoshi</surname> <given-names>F</given-names> </name> <name> <surname>Kishida</surname> <given-names>H</given-names> </name> <name> <surname>Miyaguchi</surname> <given-names>I</given-names> </name> <name> <surname>Tanaka</surname> <given-names>Y</given-names> </name> <name> <surname>Ishii</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title>A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site</article-title> <source>Biochem Biophys Res Commun</source> <year>2013</year> <volume>434</volume> <fpage>191</fpage> <lpage>6</lpage> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_405\"> <label>405.</label> <mixed-citation>Roppongi, S, Suzuki, Y, Tateoka, C, Fujimoto, M, Morisawa, S, Iizuka, I, et al.. Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues. \t\t\t\t\t<italic>Sci Rep</italic>, 2018, 8:2714, 1\u201318. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Roppongi</surname> <given-names>S</given-names> </name> <name> <surname>Suzuki</surname> <given-names>Y</given-names> </name> <name> <surname>Tateoka</surname> <given-names>C</given-names> </name> <name> <surname>Fujimoto</surname> <given-names>M</given-names> </name> <name> <surname>Morisawa</surname> <given-names>S</given-names> </name> <name> <surname>Iizuka</surname> <given-names>I</given-names> </name> <etal/> </person-group> <article-title>Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues</article-title> <source>Sci Rep</source> <year>2018</year> <volume>8</volume> <fpage>2714</fpage> <comment>, 1\u201318</comment> </element-citation> </ref>",
    "<ref id=\"j_psr-2022-0288_ref_406\"> <label>406.</label> <mixed-citation>Yoshida, T, Akahoshi, F, Sakashita, H, Kitajima, H, Nakamura, M, Sonda, S, et al.. Discovery and preclinical profile of teneleglptin (3-[(2S,4S)-4[4-(3-methyl-1-phenyl-1H-pyrazol-5yl)piperazin-1yl]pyrrolidin-2-ylcarbonyl]thiazolidyne): a highly potent, selective, longlasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. \t\t\t\t\t<italic>Bioorg Med Chem</italic> 2012;20:5705\u201319. \t\t\t\t</mixed-citation> <element-citation publication-type=\"journal\"> <person-group person-group-type=\"author\"> <name> <surname>Yoshida</surname> <given-names>T</given-names> </name> <name> <surname>Akahoshi</surname> <given-names>F</given-names> </name> <name> <surname>Sakashita</surname> <given-names>H</given-names> </name> <name> <surname>Kitajima</surname> <given-names>H</given-names> </name> <name> <surname>Nakamura</surname> <given-names>M</given-names> </name> <name> <surname>Sonda</surname> <given-names>S</given-names> </name> <etal/> </person-group> <article-title>Discovery and preclinical profile of teneleglptin (3-[(2S,4S)-4[4-(3-methyl-1-phenyl-1H-pyrazol-5yl)piperazin-1yl]pyrrolidin-2-ylcarbonyl]thiazolidyne): a highly potent, selective, longlasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</article-title> <source>Bioorg Med Chem</source> <year>2012</year> <volume>20</volume> <fpage>5705</fpage> <lpage>19</lpage> </element-citation> </ref>"
  ],
  "title": {
    "textEnglish": "Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer"
  }
}
